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Biochemistry and Biophysics

A Structural and Biochemical Study on Ric-8A, an Intracellular Guanine Nucleotide Exchange
Factor and Folding Chaperone for Gαi1
Chairperson: Stephen Sprang
Heterotrimeric G-proteins (Gαβγ) regulate many cellular processes in the G-protein signaling
pathways. The α-subunit (Gα) in the heterotrimer is activated by G-protein-coupled receptor
(GPCR) as the guanine-nucleotide exchange factor (GEF), which catalyzes the GDP-release and
GTP-binding reactions at Gα nucleotide-binding site, at the cell membrane. Intracellular GEFs
for Gα subunits have been identified; among them, the mammalian isoform A of resistance to
inhibitors of cholinesterase-8 (Ric-8A) catalyzes nucleotide exchange and functions as a folding
chaperone for inhibitory Gα (Gαi1). In a nucleotide-free complex with Gαi1, Ric-8A likely
assumes the GEF and chaperone roles by inducing a molten globule-like state. Tall et al.
recently discovered that Casein Kinase II phosphorylates Ric-8A at two conserved sites (S435
and T440), which upon phosphorylation, elevate both the GEF and chaperone activities.

To understand the molecular mechanism under which Ric-8A interacts with Gαi1, we conducted
hydrogen-deuterium exchange coupled to mass spectrometry (HDX-MS) and identified a
putative protein-protein interactive site (residues 454-470) on Ric-8A. Site-directed mutagenesis
generated single alanine mutants of Ric-8A along the putative Gαi1-binding sequence and
tryptophan fluorescence GEF assays identified five residues (V455, T456, R458, P466, and
G469) as binding “hotspot”. We also solved a 2.2Å resolution, X-ray crystal structure of a 452residue long fragment (R452) of the full-length Ric-8A. The crystal structure depicts a
phosphorylated Ric-8A 1-452 molecule (pR452). Mapping sequence conservation scores and

ii

HDX protection profile on the pR452 crystal structure provides insights about the Ric-8A, Gαi1
interaction. Low-resolution, solution structures of both R452 and pR452 were also determined
using Small Angle X-ray Scattering (SAXS). Phosphorylation of R452 at S435 and T440 likely
induces subtle conformational changes on the molecule. Steady-State GTPase assay results
indicated that not only does R452 retain measurable GEF activity towards Gαi1, phosphorylation
of R452 also elevates the GEF activity at high Ric-8A concentrations.

With information from the biochemical assessments and Ric-8A protein structures, we conclude
that (A) Gαi1 likely binds to Ric-8A residues 454 to 470 and other under-characterized sites on
Ric-8A because (B) R452 retains important structural elements for the GEF activity towards
Gαi1 and (C) phosphorylation of Ric-8A induces elevated Ric-8A GEF activity which is
accompanied by conformational changes.
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Chapter I: Introduction
Over forty years ago, heterotrimeric G-protein alpha subunits (Gα) were recognized as regulatory
Ras-family GTPases activated by G-protein-coupled receptors (GPCR) such as β2-adrenergic
receptors (β2AR) and rhodopsin. At the time, the discovery drastically changed common
knowledge about regulation of cellular processes by cyclic adenosine monophosphate (cAMP),
which is the secondary messenger in the signaling cascade as discovered by Sutherland et al.
(109) β2AR and adenylyl cyclase (AC), however, were thought to be two domains of a large
integral membrane protein. (Figure 1-1) We now know that Gα fills the gap between activation
of β2AR by hormone (adrenaline) and the activation of trans-membrane adenylyl cyclase
(tmAC), which produces cAMP from adenosine triphosphate (ATP).
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Figure 1-1. Schematic representation of the second messengers concept

(109)
As more information about the Gα family of proteins was unveiled, the scope of research on
heterotrimeric G-proteins expanded because cells that express G-proteins respond to extracellular stimuli and regulate intra-cellular processes such as metabolism, secretion, protein
expression, electrical conductivity, and cellular motility via the important Gα family of signaling
protein molecules. The classical GPCR-driven G-protein activation pathway biochemistry as
well as the structural changes of molecules involved thus became a more vigorous field of study
in biochemical and biomedical research. After the 90’s when the first X-ray crystal structures of
inhibitory G-protein α-subunit, rat isoform 1 (Gαi1) and transducin (Gαt) bound to guanosine 5'O-[gamma-thio]triphosphate (GTPγS) were solved(95, 99), even more attention was directed to
the field. Alfred G. Gilman and Martin Rodbell won the Nobel Prize in Physiology or Medicine
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in 1994 for the discovery and biochemical characterization of G-proteins. The structure of Gαi1,
bound to GTPγS (Figure 1-2, PDB:1GIA) was solved the same year. (95) The structure and the
transducin counterpart (99) demonstrated how the α-helical domain distinguishes Gα from other
members of the Ras GTPase family of small GTPases and the molecular mechanism by which
Gα binds GTP and forms an active complex. (88) Although the involvement of GTP in the Gprotein signaling cascade was already discovered prior to the discovery of G-proteins (108, 110),
the structural information of a nucleotide-bound Gα was novel and intriguing.

Figure 1-2. Crystal structure of rat Gαi1:GTPγS complex showing the secondary structural

elements of Gαi1 in cartoon representation in rainbow colors, GTPγS in sticks, and Mg2+ in
ball. (95) (PDB:1GIA)

3

1.1 Heterotrimeric G-Proteins
1.1.1 The G-protein Cycle

Figure 1-3. The heterotrimeric G-protein cycle.
(Starting from far-left) Inactive heterotrimeric G protein complex consisting of Gα·GDP and Gβγ, a
guanine-nucleotide dissociation inhibitor (GDI), tethered to the plasma membrane, where inactive
integral membrane GPCR is inserted. Binding of extracellular agonist, such as adrenalin, activates
GPCR; activated GPCR interacts with the inactive G-protein heterotrimer and promotes nucleotide
exchange at Gα as a guanine-nucleotide exchange factor (GEF). Interaction with GPCR leads to the
formation of activated Gα·GTP, which dissociates from Gβγ. Gα·GTP and Gβγ interact with their
corresponding effector molecules to perform signaling tasks. GTP is hydrolyzed into GDP and
inorganic phosphate (Pi) intrinsically by the GTPase domain of Gα or with the help of a GTPase
activating protein (GAP), such as regulator of G-protein signaling (RGS); Pi is released and Gα·GDP
re-associates with Gβγ to form the inactive heterotrimer (back to the beginning), completing one Gprotein cycle. (41)

Heterotrimeric G-proteins are composed of α (~40 kDa), β(~36 kDa) and γ (~7.8 kDa) subunits.
In human, there are several classes of Gα subunits including Gαs, Gαi, Gαo, Gαq, Gαt
(transducin), etc.; each class is specific for interacting with different effector molecules; there are
five G-protein beta subunits (Gβ) isoforms and twelve G-protein gamma subunits (Gγ) isoforms
known to-date. (14) In general, a Gα subunit contains a characteristic α-helical domain and a
GTPase domain (also called Ras-homology domain), which hydrolyzes bound-GTP, while the
4

Gβ and Gγ subunits exhibit no intrinsic GTPase activity. The activity of Gα subunits is guaninenucleotide-dependent and is switched on (GTP-bound) and off (guanosine diphosphate, GDP, bound) rapidly with the help of co-factors, which will be discussed in detail later. When a GPCR
becomes activated by agonist, it catalyzes the exchange of GDP for GTP on Gα; the activated,
GTP-bound Gα subunit dissociates from Gβγ subunits (88, 103). Specific members of Gα
subunits, when activated, modulate the activity of specific effector molecules, such as tmAC,
phospholipase Cβ, and nucleotide exchange factors for the small GTPase Rho, etc. (84, 88) The
GTPase domain of Gα hydrolyzes the bound GTP to GDP; the now deactivated Gα subunit rebinds Gβγ to form the inactive heterotrimer, thus completing the cycle. (Figure 1-3) (103)
1.1.2 Regulators of G-protein Signaling: GAPs, GEFs, and GDIs
Gα signaling is regulated by altering the rate of two processes, GTP hydrolysis and guanine
nucleotide exchange, which switch the Gα between the active (GTP-bound) and inactive (GDPbound) states. Gα intrinsically hydrolyzes its bound GTP slowly and becomes deactivated.
Isolated Gα subunits hydrolyze bound GTP with rate constants (k hyd) between 0.1 min−1 (Gz) and
2 to 4 min−1 (Gs, Gi, Go, Gt) at 30 oC. (80) When a GTPase activating protein (GAP) such as
regulator of G-protein signaling (RGS) binds the GTP-bound Gα, it accelerates hydrolysis of the
bound GTP >2000-fold by stabilizing a transition state-like intermediate. (80, 88)

Gα activity can also be regulated through means of enhancing or blocking the nucleotide
exchange reaction. Just like the intrinsically slow GTPase activity, the intrinsic rate of
nucleotide exchange is also slow in Gα subunits (88, 104), ranging from immeasurable (Gαq) to
0.16 min-1 (Gαo). (72) Nucleotide exchange in Gα subunits can be described as a two-step
process, GDP release and GTP binding. Of the two, the release of GDP from Gα is considered
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the rate limiting step (88, 103, 105); guanine-nucleotide exchange factors (GEF) and guaninenucleotide dissociation inhibitors (GDI) regulate the rate of GDP release.

GEFs accelerate the rate of GDP to GTP exchange in G-proteins. (88) Until the discovery of
resistance to inhibitors of cholinesterase-8 (Ric-8), a family of soluble proteins that exhibit GEF
activity towards Gα subunits in vitro, the heptahelical, trans-membrane GPCRs were the only
known GEFs for Gα and have been studied extensively. (62, 72) The other class of modulators
of guanine-nucleotide exchange, GDIs, also bind specifically to the GDP-bound state of Gα
subunits; instead of catalyzing the exchange reaction, GDIs inhibit the dissociation of GDP from
Gα by stabilizing the GDP bound state. The Gβγ heterodimer is a GDI. (88) A new class of GDIs
typified by activator of G-protein signaling 3 (AGS-3) was also discovered. Like Gβγ
heterodimer, AGS-3 binds specifically to the GDP-bound state of Gα and acts as a GDI. (26, 58,
68, 78) GAPs, GEFs, and GDIs together function in precise and rapid manners to regulate Gprotein signaling; in certain cases, interesting synergetic effects are observed between GEFs and
GAPs.
1.1.3 Gα:GDP vs. Gα:GTP Structural Changes
As mentioned above, the identity of the guanine nucleotide (GDP or GTP) bound to Gα governs
the two major conformational states of this important signaling macromolecule. At the structural
level, Gα undergoes substantial structural changes as it transitions between the GDP- and GTPbound states. Regulators and effectors of Gα show preference in interacting with specific states
of Gα. The crystal structures of both states of Gαi1 and Gαt that were determined two decades
ago elucidate those structural rearrangements. (93, 95, 98, 99) The crystal structures of the
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RGS4:Gαi1:GDP-AlF4- complex as well as its Gαt counterpart even captured the transition statelike intermediate of GTP-hydrolysis. (90)

By comparing the crystal structures of GDP- and GTP-bound states of Gαi1 and Gαt, large
conformational changes are observed at certain regions called the switch regions, which are
designated switch I, switch II, switch III, and the Gαi1-specific switch IV. Gαi1 contains all four
switches; switch I spans residues 177-187, switch II 199-219, switch III 231-242, and switch IV
111-119. Switch II and III are disordered and were not modelled in the Gαi1:GDP structure
while in the Gαi1:GTPγS structure, these regions were structured and modelled successfully.
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Figure 1-4 Comparison of Gαi1 structure in the GDP- and GTPγS-bound conformations

(A) Crystal structure of Gαi1·GDP (Mixon et al. 1995, PDB Code: 1GDD). Switch regions
are shown in orange. (B) Crystal structure of Gαi1·GTPγS·Mg2+ (Coleman et al. 1994, PDB
Code: 1GIA). Switch regions are shown in red. (C) Superposition of (A) and (B). Switch
regions are marked as S I (switch I), S II (switch II), S III (switch III), and S IV (switch IV).
The α-helical and Ras-homology (GTPase) domains are labeled. Guanine-nucleotides are
shown as sticks. (58)
Switch II folds into an α-helix in the Gαi1:GTPγS structure and is stabilized by interaction with
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Mg2+ and γ-phosphate of GTPγS. Other important sites of structural rearrangement are the Nand C-termini of Gαi1. In the Gαi1:GTPγS structure, the terminal regions are disordered but
form a structured domain in the Gαi1:GDP structure. (93, 95) (Figure 1-4) For transducin (Gαt),
the structural changes in switch regions are also observed, however, these changes do not
entirely resemble those of Gαi1. Most noticeably, switch II and III of transducin seem to retain
some ordered structure even in the GDP-bound form. (98, 99) The nucleotide-dependent
structural changes in switch regions of G-protein α-subunits led to the speculation that the
switches are responsible for effector/regulator interactions. Subsequent studies confirmed the
validity of the speculation, for example, the structures of Gαi1·GDP·AlF 4- bound to the RGS
domain of RGS4, Gαi1·GDP in complex with Gβ1γ2, stimulatory G-protein α-subunit (Gαs) in
complex with the soluble domain of tmAC, and most recently the receptor:G-protein complex, in
which Gα maintains its contact with Gβγ while bound to a CPCR. (41, 89, 90, 92, 94)
1.1.4 Canonical GPCR-Activation of G-Protein
The canonical GPCR activation of G-proteins has been characterized to a great extent both in
vitro and in vivo. (2, 14, 18, 19, 38, 41, 70) G-proteins mediate a wide range of physiological
signals from the outside of the cell. The signals, which can be a change in concentration of
peptides, hormones, lipids, neurotransmitters, ions, odorants, tastants, etc., or simply an influx of
photons, stimulate specific GPCRs on the cell membrane. Around half of all current medications
act through these receptors, among them β-blockers, antihistamines and various kinds of
psychiatric medications. GPCRs pass these signals to the inside of the cell by activating specific
G-proteins, especially Gα subunit in the heterotrimeric complex, triggering a series of regulatory
reactions involving other proteins, nucleotides and metal ions, which result in appropriate
cellular and physiological responses.
9

An important physiological example of GPCR activation of Gα is the initiation of fight-or-flight
response in mammals. When threatened by imminent danger, the adrenal medulla of an animal
produces adrenaline, among many other hormones; binding of adrenaline to the extracellular
surface of β2AR activates the GPCR, which in turn activates Gαs by catalyzing the guaninenucleotide exchange reaction on Gαs. Activated Gαs:GTP complex continues to activate tmAC,
which converts ATP into cAMP, an important secondary messenger molecule. cAMP leads to
the activation of protein kinase A (PKA), one of many down-stream protein targets of cAMP; the
kinase in turn phosphorylates enzymes and transcription factors that are necessary to ultimately
accomplish the fight-or-flight response. The complicated, yet lightning-fast physiological
response is essential for survival.
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Figure 1-5 Receptor-mediated conformational changes in Gα.
(a) Structural comparison of nucleotide-free Gαs (red) coupled to β2AR (gray, PDB 3SN6) and
GTPγS-bound Gαs (orange, PDB 1AZT). GTPγS is shown as spheres. Receptor-binding of Gαs
induces an outward movement of the α-helical domain of Gαs (Gαs AHD) relative to its position in
the GTPγS-bound state. (b) Structural rearrangements caused by activated GPRC-binding near the
nucleotide binding site of Gαs. (41)

Recently, the fruit of almost twenty years of advancement in biotechnology, protein engineering,
and biophysics was the atomic-resolution crystal structure of the activated β2AR complexed to a
heterotrimeric G-protein (Gαβγ). (41) The structure illustrated a transient, but important
intermediate, demonstrating for the first time in structural detail the well-understood role of
GPCRs as GEFs for Gα. (Figure 1-5, PDB:3SN6) The structure depicts the agonist-induced
conformational changes in the receptor:G-protein complex that favor GDP release by Gαs. The
receptor engages the C-terminus of Gαs, causing a cascade of structural events in Gαs and
eventually leading to the separation of Ras and helical domain, and forming an exit path for
GDP. (41) However, Gα domain separation occurs spontaneously and frequently even in the
absence of a receptor, therefore, is necessary but not sufficient for GDP release. More
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substantial conformational changes that favor nucleotide release are observed using different
biophysical methods. (18) Briefly, the α5 helix of Gαs inserts itself into a cavity in the activated
receptor formed by outward movement of transmembrane helices TM5 and TM6. Due to the
movement of α5, the β6–α5 loop and the hydrophobic core interaction between α5, β2 and β3
and α1 are perturbed. Rearrangement of the β6–α5 loop and destabilization of α1 lead to
weakened binding of the purine ring and the phosphates of GDP. Interaction between the
intracellular loop 2 (ICL2) of the receptor and the αN–β1 hinge region of Gαs appears to shift β1
and the adjacent P-loop that are crucial in nucleotide binding. (2) These structural
rearrangements observed in the complex structure are highly conserved amongst different types
of GPCRs and Gα interactions in the interruption of the contacts between α1 and α5.(19) In
addition to the Ras domain, the helical domain, which distinguishes Gα from other Ras GTPases
from the same family, also becomes more flexible in the receptor-bound, nucleotide-free form.
(40)
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1.2 Ric-8A
1.2.1 Discovery of Ric-8 and Biological Significance
G-protein signaling mechanisms are important for our current understanding of biological
systems. Yet, the role(s) of intracellular regulators, especially intracellular GEFs, of G-proteins
have received far less attention than trans-membrane GEFs, the GPCRs. Unlike the GPCRs,
which act upon heterotrimeric complexes of G-proteins near the plasma membrane, resistance to
inhibitors of cholinesterase 8 (Ric-8), 60 kDa cytosolic proteins that catalyze the release of GDP
from many classes of Gα, acts exclusively on GDP-bound monomeric Gα. Ric-8 is also called
“synembryn” to reflect its dual functions in synaptic transmission and early embryogenesis. (77)
1.2.1.a Synaptic Transmission

Ric-8 proteins were first identified in a Caenorhabditis elegans genetic screen for synaptic
transmission mutants. (91) Reducing intracellular Ric-8 levels apparently alleviates toxic
accumulation of acetylcholine caused by the presence of inhibitors of cholinesterase, such as
aldicarb. (Figure 1-6) It was later discovered that the highly-conserved Ric-8 family of proteins
controls neurotransmitter release by regulating G-protein(o) α-subunit (Gαo) and G-protein(q) αsubunit (Gαq). (79) Ric-8 regulates cellular abundance of Gαq therefore also regulates Gαqdependent neurotransmitter release; knocking-down Ric-8 thereby indirectly reduces the synaptic
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concentration of acetylcholine. (32)

Figure 1-6 Ric-8 (ric-8) knock-down C.
elegans mutants exhibit similar
phenotypical defects as Gαq (egl-30)
knock-down mutant in its response to
inhibitors of cholinesterase, aldicarb. egl30 and ric-8 mutants, in addition to being
aldicarb resistant, are both bloated with eggs
and exhibit decreased body flexion
phenotypes that are characteristic of the
subclass of aldicarb resistance mutants with
defects in the Goα–Gqα signaling network.
(77)

1.2.1.b Asymmetric Cell Division and Embryogenesis
In C. elegans, Gαo is a key component of a signaling network that regulates neurotransmitter
secretion. Early studies demonstrated that reduction of Ric-8 or Gαo results in partial embryonic lethality
by causing defects in centrosome movements during early embryogenesis. (79) Asymmetric cell division
is of fundamental importance for the initial stage of embryogenesis. Again, in the C. elegans embryo
model, spindle positioning has been shown to depend on heterotrimeric G-protein signaling. Reduction
of Ric-8 expression results in cell division phenotypes very similar to that of Gαo knockouts. (Figure 1-7)
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Figure 1-7 Ric-8 is required for asymmetric cell division
(A+D) WT (A) and Ric-8 RNAi-knockdown (D) embryos, elapsed time is indicated, arrowheads
point to spindle poles. (B+E) Positions of anterior and posterior spindle poles at the end of anaphase.
(64)
Ric-8 also binds Gαo:GDP preferentially, therefore is consistent with a GEF role in the worm model. (65)
It was suggested that Ric-8 could also act upstream of the GoLoco protein GPR-1/2 in the sequence of
events leading to Gαo activation. (64) In addition to Gαo, Gαi is also involved in asymmetric cell
division through a signaling pathway that regulates microtubule pulling forces during mitotic movement
of chromosomes. Other co-factors such as GPR or GoLoco domain-containing proteins, and RGS
proteins are also involved. In the rat model, the GoLoco domain-containing protein LGN (GPSM2), the
LGN- and microtubule-binding nuclear mitotic apparatus protein (NuMA), and Gαi1 regulate a similar
process. It was demonstrated in vitro that Ric-8A releases Gαi1 and NuMA from NuMA:LGN:Gαi:GDP
complexes and the Gαi1 released is in GTP-bound form. (63) In the Drosophila model, Frizzled and Gprotein signaling act in opposition to ensure that the spindle aligns correctly. Ric-8 localizes Gαi and
GPA-16 to the cell cortex to orient mitotic spindle during asymmetric cell division. (59, 60) Recently,
Boularan et al. found that inhibition of Ric-8A or Gαi1 activity decreases the production of PtdIns(3)P
through Vps34 therefore indirectly contributes to cytokinesis during abscission, a late-stage event in cell
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division. (27) Taken together, the involvement of Ric-8 proteins in development is crucial in a G-proteindependent manner across species.

1.2.2 G-protein, Ric-8 Biochemistry, in vitro and in Cell Models
In mammals, Ric-8A and Resistance to inhibitors of cholinesterase 8, isoform B (Ric-8B)
isoforms have been found to act both as in vivo chaperones and/or in vitro guanine nucleotide
exchange factors (GEFs) for different classes of Gα. (31, 72) For instance, Itoh et al.
demonstrated that Ric-8B inhibits the ubiquitination-dependent degradation of Gαs and has in
vitro GEF activity towards Gαs. (36, 45) Ric-8A, on the other hand, inhibits ubiquitination in
vivo and accelerates nucleotide exchange in vitro for Gαi and Gαq, as seen by Tall, el al. and
Sumimoto et al. (32, 72) Tall et al. also reported that manipulating Ric-8A level in embryonic
stem cells affects Gαi1 expression in an mRNA-independent fashion. In cell-free expression
systems, the presence of mRNA encoding Ric-8 is required to prevent accumulation of unfolded
Gα. Generally, knocking-down Ric-8 in a variety of cultured cell lines reduces Gα abundance
(39). Therefore, in some cases, Ric-8 regulation of Gα signaling could simply be an indirect
effect of increased/stabilized Gα biogenesis. With that said, a direct GEF functional role for Ric8 on Gα remains an open discussion because functional Gαs and Gαi can be abundantly
expressed without any Ric-8 homologs in recombinant Escherichia coli, but co-expression of
Ric-8A in insect cells significantly amplifies the production of Gαq, G-protein(13) α-subunit
(Gα13), and olfactory G-protein α-subunit (Gαolf). (37) Hence, it is conceivable that the cytosolic
Gα levels are more strictly regulated at the protein synthesis stage in eukaryotic cells than is
currently understood.
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In the rat model, Ric-8A functions in vitro as a cytosolic GEF for Gαi1 by accelerating the
release of GDP and forming a nucleotide-free Ric-8A:Gαi1 complex, which readily accepts GTP
as a substrate; Ric-8A:Gαi1 complex dissociation immediately follows GTP association.(72)
(Figure 1-8)

Figure 1-8 Nucleotide-free Gαi1:Ric-8A complex
Gαi1:GDP complex releases GDP slowly, Ric-8A
binding to Gαi1:GDP catalyzes the release step,
resulting in a stable, nucleotide-free Gαi1:Ric-8A
complex. Size-exclusion chromatographic profile of
samples of (A) excess Gαi1:GDP incubated with Ric8A, forming a nucleotide-free Gαi1:Ric-8A complex,
and (B) excess Gαi1:GTPγS incubated with
Gαi1:Ric-8A complex, dissociating the complex.
The closed circles in each chromatogram represent
guanine-nucleotides (GDP or GTPγS) that are bound
to Gαi1, therefore, eluted at the same elution volume
as Gαi1. SDS-PAGEs of sample fractions under the
curve are shown above the chromatograms. (72)

A few studies (8, 23) supported the proposal that Ric-8A binding induces local and global
conformational changes as well as dynamic motions in Gαi1. Ric-8A-bound, nucleotide-free
Gαi1 (Gαi1[ ]) is more accessible to trypsinolysis than Gαi1:GDP, but less so than free Gαi1[ ].
The nuclear magnetic resonance (NMR) heteronuclear single quantum coherence (HSQC)
spectrum of [15N]Gαi1[ ] in the Gαi1:Ric-8A complex shows a significant loss of peaks relative
to that of [15N]Gαi1:GDP, indicating Ric-8A-induced dynamic motions of Gαi1[ ]. Hydrogendeuterium exchange (HDX) on Gαi1[ ] bound to Ric-8A is 1.5-fold more extensive than in
Gαi1:GDP, suggesting that Ric-8A-binding possibly causes partial destabilization of Gαi1
tertiary and/or secondary structural elements, therefore increases overall solvent accessibility of
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the protein. The study also concluded that the C-terminus of Gαi1 is a critical binding element
for Ric-8A since the C-terminal peptide of Gαi1 not only binds Ric-8A but also inhibits fulllength Gαi1 binding to Ric-8A, as it is the case for GPCR-Gα interaction.(41, 42) These findings
suggest that both Ric-8A and GPCR might promote nucleotide release by similar mechanisms,
acting as folding chaperones and inducing temporary unfolding to favor an unstable and dynamic
nucleotide-free state of Gα. (55) However, the Ric-8A-activated Gαi1 shows large
conformational changes in switch II region of Gαi1 (10), changes that are not evident in the
GPCR activation scheme, suggesting that the Ric-8A-activated Gαi1 is conformationally and/or
functionally different than the GPCR-activated Gαi1.

The double electron-electron resonance (DEER) spectroscopy study provided global distance
constraints that identified discrete members of Gαi1 conformational ensemble in the Gαi1:Ric8A complex. In the complex, the helical and Ras-like domains of Gαi1 move apart with
displacements as large as 25 Ångströms (Å). The domain displacement appears to be different
from that observed in the Gαs:β2AR complex. Moreover, the Ras domain exhibits structural
plasticity at the nucleotide-binding site, the switch I and switch II regions, which are known to
adopt different conformations in the GDP- and GTP-bound states of Gαi1. (23) Taken together,
the data confirmed previous studies that Ric-8A induces a conformationally dynamic state of
Gαi1.
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1.3 Hypothesis and Goals
The dual function of Ric-8A in Gα biosynthesis in vivo and the apparent in vitro GEF activity
suggests that like many other cell-signaling molecules, the Gα family of proteins are regulated
elsewhere than solely near the plasma membrane. Recently published evidence about Ric-8
phosphorylation, which enhances the Ric-8 GEF activity (3), further implies an intricate
alternative pathway for Gα activation remote from the plasma membrane, where signals are
transduced from the exterior to the interior of a cell. Understanding the intracellular, Ric-8regulated Gα signaling pathway could shine light on the development of alternative therapeutics
targeting abnormal expression and activation of Gα in diseases.

Up to this point, no homolog of Ric-8A has been crystallized or its structure solved. Based on structural
information predicted from the amino acid sequence of Ric-8A, the polypeptide consists mainly of a
specific type of α-helical repeats called Armadillo (ARM) repeats.(76) Circular dichroism (CD) studies
on purified Ric-8A further illustrated that the protein is well-folded in solution and indeed is >90% αhelical. (48) This dissertation aims to answer at least parts of the questions regarding the regulation of
Ric-8 by Casein Kinase-II (CKII) phosphorylation (3), the structures of Ric-8 and its complex with Gα,
and finally, how the two macromolecules interact.

In chapter II, a putative Gαi1 binding site on Ric-8A, as suggested by hydrogen-deuterium exchange
(HDX) experiments, will be tested in vitro through biochemical assays. Chapter III and IV will focus on
the molecular structures of Ric-8A determined by X-ray crystallography and small-angle X-ray scattering.
The activation of GEF functions of Ric-8A by phosphorylation will also be further examined in these two
chapters. Lastly, in chapter V, some future directions and preliminary results will be discussed.
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Chapter II: A Putative Gαi1 Interactive Site on Ric-8A
2.1 Introduction
The ultimate goal for the study on Ric-8A:Gαi1 interaction is to understand comprehensively the
molecular mechanism by which Ric-8A catalyzes nucleotide exchange for mature (properly
folded) Gαi1 and folds nascent (freshly synthesized by ribosome) Gαi1. Using hydrogendeuterium exchange coupled with mass-spectrometry (HDX-MS), the protein-protein binding
surface of Ric-8A and Gαi1, as well as conformational changes induced by complex formation,
were studied by analyzing the HDX protection profiles of pepsin-digested peptide fragments of
each protein component in the complex. In this chapter, I will briefly discuss the putative
protein-protein interaction sites and conformational changes on Gαi1 and on Ric-8A,
extrapolated from HDX-MS results generated by our collaborators, Brian Bothner’s group at
Montana State University (MSU). (10) Then I will focus on characterizations, which were
biochemical and biophysical experiments conducted in the Sprang lab at the University of
Montana (UM), of a putative Gαi1 binding site on Ric-8A using site-directed mutagenesis,
circular dichroism (CD), differential scanning fluorimetry (DSF), and fluorescence spectroscopy.
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2.1.1 Insights from HDX-MS: A Putative Gαi1 Binding Site

Figure 2-1 Intrinsic and Ric-8A-catalyzed GTPγS binding rates of Gαi1

Intrinsic and Ric-8A-catalyzed kinetics of binding of GTPγS to wild-type Gαi1, W258AGαi1, NΔ25Gαi1, Gαi1CΔ9 and Gαi1-GαsC12 were measured using a fluorescence binding
assay. 400 µL of protein (1 µM) in the GDP-bound form was equilibrated for 10–15 min at
25oC in a cuvette. A 10-fold excess of GTPγS was added and fluorescence at 340 nm upon
excitation at 290 nm was monitored in the absence (open bars) or presence (filled bars) of
Ric-8A (1 µM). Error bars represent +/- one standard deviation apparent first-order rate
constants determined in three replicates. (42)
As discussed in Chapter 1 section 1.2.2, the span of 18 residues (DAVTDVIIKNNLKDCGLF) at
the extreme C-terminus of Gαi1 appears to bind Ric-8A and renders Gαi1 unresponsive to the
GEF activation by Ric-8A upon partial removal or substitution with Gαs C-terminus.(42)
(Figure 2-1) The fact that β2AR also interacts with the C-terminus of Gαs (41) suggests that
Ric-8A might promote GDP release for Gαi1 through similar mechanism as β2AR does for Gαs.
For Ric-8A, however, no information about Gαi1 binding site(s) were available until recently.
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Without direct crystallographic structural information about the complex, we turned to HDX-MS
for more insights about the Gαi1-Ric-8A interaction.

In an HDX-MS experiment, protein samples were diluted rapidly into heavy water (D 2O); labile
hydrogens, for example those on the solvent accessible peptide amide bonds, exchange almost
instantaneously for deuterium. If the amides are hydrogen-bonded or protected, HDX will
proceed more slowly. (107) For single-component HDX experiments, the extent and time frame
of protection from HDX provide information about protein dynamics and how local structural
elements fold. For multi-component systems, for instance the Ric-8A and Gαi1 complex, HDX
is useful for revealing potential binding interfaces, which are lined with presumably protected
amide hydrogens. It is therefore possible to obtain valuable structural information about the
protein-protein interaction without information from a high-resolution crystal structure of the
protein complex. HDX also avoids misleading crystallographic artifacts, such as nonphysiological crystal contacts or oligomerization states, in X-ray crystal structures.
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Figure 2-2 HDX protection profile of Gαi1 and Ric-8A in the complex
(A) HDX-MS of Gαi1 and (B) Ric-8A showing both protection (magenta) and deprotection (green)
regions in the complex compared to free-Gαi1 and Ric-8A, respectively. HDX protection profiles
were color-rendered on the crystal structure of Gαi1:GDP (1GDD) and a Rosetta (Bradley et al. 2005)
model of Ric-8A. (10)

In a collaborative effort with Brian Bothner’s group at MSU, we completed the HDX-MS
experiments for Gαi1:GDP, Gαi1:Ric-8A complex, and Ric-8A. In aggregate, overlapping
peptide fragments recovered from pepsinolysis represent the entire amino acid sequence of Gai1
and 87% of that of Ric-8A for the three species mentioned above. Throughout its primary
structure, Ric-8A is highly susceptible to HDX, with nearly half of the observed peptide
segments incorporating deuterium at 60% of exchangeable sites. Upon binding to Gai1, Ric-8A
undergoes changes in accessibility to HDX throughout its amino acid sequence (Figure 2-2).
Many Ric-8A-derived peptides show 5–15% changes in deuteration relative to free Ric-8A at
successive amino acid repeats, suggestive of distributive conformational changes. (10) Notably, a
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seventeen-residue span near the C-terminus of Ric-8A is highly protected (25% decrease in
deuteration) from HDX when Ric-8A is complexed to Gαi1. (Figure 2-2) Although it is not the
only region protected, the immediate hypothesis is that the protected region (residues 454-470
with the amino acid sequence “PVTGRVEEKPPNPMEGM”) on Ric-8A forms intimate contacts
with Gαi1. With that said, Ric-8A conformational changes induced allosterically by Gαi1 can be
alternative sources of observed HDX protection and deprotection, instead of direct proteinprotein contacts.
2.1.2 Experimental Designs to Test the Putative Gαi1 Binding Site
To test the hypothesis that Ric-8A 454-470 is a Gαi1 binding site, I first performed an alanine
screen by site-directed mutagenesis to create seventeen single alanine mutants, using the Ric-8A
1-491 construct (R491) as a template, through residues 454-470. With the hope to identify
functional and binding “hotspots” on Ric-8A for Gαi1, I tested these mutants for their ability to
(a) facilitate nucleotide exchange for Gαi1 and (b) form complexes with Gαi1. Three different
experimental approaches were adopted to assess the GEF activities of Ric-8A alanine mutants, a
tryptophan fluorescence GTPγS-binding assay, a 2'/3'-O-(N-Methyl-anthraniloyl) (MANT)
fluorescence MANT-GTPγS-binding FRET assay, and a conventional 35S-GTPγS filter binding
assay. Data obtained from the tryptophan fluorescence GTPγS-binding assays were the most
comprehensive, therefore, should be considered the primary data set for assessment of the GEF
activities of the Ric-8A mutants. Using size-exclusion chromatography, the Ric-8A:Gαi1
complex-formation profile of each Ric-8A alanine mutant was assessed. As a quality control,
thermal stability of all mutant Ric-8A 1-491 protein products was tested by heat denaturation
using circular dichroism(CD) and differential scanning fluorimetry (DSF).
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Three major protein constructs were selected for the GEF functional assays, Ric-8A 1-491
(R491), Gαi1 W258A (Gαi1), and myristoylated Gαi1 (mGαi1). As described previously (42),
R491 appears to be the shortest fragment of the rat Ric-8A construct to retain maximum GEF
activity of, if not better than, the full-length protein; therefore, is adequate for the purpose of the
assays. The structure and functions of the E. coli-expressed Gαi1 W258A (Gαi1) have been
studied extensively by the Sprang lab in the past (42, 52, 58), therefore, it is an appropriate
construct for un-post-translationally modified Gαi1. The tryptophan-258 to alanine mutation
does not affect any major functions of Gαi1 (Figure 2-1); among the three tryptophan residues in
rat Gαi1, W211 in switch II region undergoes the largest change in its fluorescence environment
upon GTP-binding (73, 102, 104), therefore, the W258A mutation only improves signals for the
tryptophan fluorescence assays. (42) It is also a legacy mutant designed to improve packing
interactions between Gαi1 molecules in crystals. The myristoylated Gαi1 (mGαi1) construct,
engineered by Linder et al., is the only post-translationally modified Gαi1 available. It harbors
an internal His-tag, which does not affect the functions of the protein (96), for easy purification
and enabling N-terminal myristoylation of the G-protein. Additionally, a short peptide
encompassing Ric-8A residues 454-470 and a GST-fusion construct of Ric-8A 399-491 were
purchased and created, respectively. The 454-470 peptide was used for pull-down assays; the
GST-Ric-8A 399-491 was assayed both for its own GEF activity and inhibition of GEF activity
of R491 towards Gαi1. Both Gαi1 and mGαi1 were used in the tryptophan fluorescence assays;
only Gαi1 was used in the complex-formation/size-exclusion assays, the peptide competition
pull-down assays, and the GST-Ric-8A 399-491 assays; only mGαi1 was used in both the FRET
assay and 35S-GTPγS isotope assay.
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2.2 Results and Discussion
2.2.1 HDX-MS Reveals Putative Binding Sites on Gαi1 and Ric-8A
By comparing the HDX protection profiles of Gαi1:GDP and Gαi1:Ric-8A complex (Figure 22), we propose a large, putative protein-protein interactive surface on Gαi1 that includes
structural elements at the helical and Ras domain interface, Switch I and II, and the termini.
HDX protection of the Gαi1 C-terminus confirms the previous finding that it may directly
contact Ric-8A. It is conceivable that in the complex, Ric-8A disrupts structured regions near
the GDP-binding site of Gαi1, destabilizes the interface between the Ras and helical domains,
facilitates domain separation and eventually leads to GDP release. It appears that the Ric-8Ainduced Gαi1 conformational changes and solvent exposure are reversible by GTP-binding and
Ric-8A dissociation.

On the side of Ric-8A, HDX of the complex identifies an extensively deprotected sequence
corresponding to peptide fragment from residue 419 to the C-terminus (residue 491) of the Ric8A construct used in the study. The C-terminal segment of Ric-8A in the complex exhibits a 10–
15% increase in deuteration relative to free Ric-8A. The pattern, however, is interrupted by a
highly protected (25% decrease in deuteration) peptide comprising residues 454–470. The 17residue peptide, which is rich in proline and acidic residues, as well as regions flanking it, are
highly conserved in its primary amino acid sequence among vertebrates. (Figure 2-3) Based on
the secondary structure analysis of a library of Ric-8A homologs, this peptide is predicted to be
largely unstructured. (10)
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Figure 2-3 Multiple sequence alignment of vertebrate Ric-8A homologs
Residues within the putative binding site (residues 454-470) are highly conserved among vertebrate
species. (NCBI MSA Tool)

Overall, HDX-MS confirms that like the GPCRs, Ric-8A binds the C-terminus of Gαi1. (38) Yet
distinct from GPCRs, Ric-8A also interacts with Switches I and II and possibly at the Ras-helical
domain interface. These extensive interactions provide both allosteric and direct catalysis of
GDP unbinding/release and GTP binding. (10) The noticeable protection of the peptide
comprising Ric-8A residues 454–470 in the complex implies that the segment is a possible Gαi1
binding site. To test this hypothesis, we created seventeen single-residue mutants and assayed
the GEF activity of each using a tryptophan fluorescence assay that monitors the exchange of
GDP for GTPγS at Gαi1. All mutants expressed and purified similarly to WT R491 except for
M470A mutant, which behaved poorly during the last step of the purification.

For each WT or mutant Ric-8A, two types of assays were performed to measure different aspects
of the guanine-nucleotide exchange reaction. (Figure 2-4) I first measured the GEF-stimulated
initial rate of Gαi1 nucleotide exchange by adding GTPγS and Ric-8A simultaneously to GDPbound Gαi1. This assay is termed the “nucleotide exchange” assay because it measured the rate
of the entire nucleotide exchange reaction; both GDP-release and GTPγS-binding steps were
assayed. I then measured the initial rate of GTPγS-binding to nucleotide-free Gαi1 in complex
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with Ric-8A. The rate of GTPγS-binding reaction was not combined with that of the GDPrelease step because the second assay only measured the rate of GTPγS-binding reaction. I refer
to the second assay as the “GTP-binding” assay. I expect the results from these two assays to
differ for the same Ric-8A WT or mutant since the “GTP-binding” assay only measured 2 nd half
of the reaction (Figure 2-4). For instance, if GDP-release were the rate-limiting for the full
reaction, the “nucleotide exchange” assay should always proceed slower than the “GTP-binding”
assay because the rate-limiting step was skipped in the “GTP-binding” assay.

Figure 2-4 A simple schematic of Ric-8A catalyzed Gαi1 nucleotide exchange

G=Gαi1, GDP=guanosine-5’- diphosphate, R=Ric-8A, GTPγS= guanosine 5'-O-[gammathio]triphosphate, G:GDP=GDP-bound Gαi1 (inactive), G:R=Ric-8A-bound
Gαi1(nucleotide-free), G*:GTPγS= GTPγS-bound Gαi1 (active)

2.2.2 Mutagenesis and Protein Expression and Purification
As mentioned above, the C-terminal region (residues 454-470) of Ric-8A is a putative Gαi1
binding site. In order to test the hypothesis, we performed an alanine scan by making pointmutations along the putative binding sequence. All seventeen mutant Ric-8A plasmids were
sequenced and protein expression confirmed by Western Blot analysis. (Figure 2-5) Established
protein expression and purification protocols for Ric-8A WT (42) were sufficient to purify most
Ric-8A mutants except V455A, T456A, K462A, and M470A, which exhibited minor to medium
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solubility issues during the routine purification process. To accommodate these mutants, the
purification protocol was altered. (See Materials & Methods)

Figure 2-5 Expression and purification of representative R491 mutants

(A), SDS-PAGE protein standards. (B) SDS-PAGE (stained with Coomassie dye) results
showing whole cell lysate of representative Ric-8A mutants, P454A, V455A, T456A,
G457A, R458A, V459A, and R470. (C) Western-Blot of the SDS-PAGE on top-right panel
blotted with 6x-His Tag Monoclonal Antibody (Invitrogen), followed by an HRP-conjugated
goat anti-mouse IgG (Fc) secondary antibody (Invitrogen) and detected by Immun-Blot®
Opti-4CN™ Colorimetric Kits (Bio-Rad). (D) SDS-PAGE analysis of purified R491 mutants
used to perform experiments.
His-tagged constructs of R491, Ric-8A 1-470 (R470), Ric-8A 1-452 (R452) in pET28a vector all
expressed in large quantities (>100 mg/Liter of cells) in BL21 DE3 RIPL E. coli using the
protocol described in the method section of this chapter. Purification of R470, R452, and Ric-8A
1-425 (R425) were also straightforward using the standard R491 purification protocol with minor
adjustments to accommodate less stable truncation mutants such as R452. Typical yield after the
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anion exchange step of the purification, where the samples were more than 95% homogeneous,
was about 50 mg TEV-digested, purified, monomeric recombinant protein per liter of cells.

All mutants but M470A were successfully purified by anion-exchange and size-exclusion
chromatography (SEC). M470A precipitated heavily on the size-exclusion column. The original
gel-filtration buffer (50mM HEPES pH 8.0, 150mM NaCl, 2mM β-mercaptoethanol, 0.01%
Decaethylene glycol monodecyl ether (E10C12)) and assay buffer for the tryptophan
fluorescence assay (50mM HEPES pH 8.0, 10mM MgCl 2, 150mM NaCl, 2mM βmercaptoethanol, 0.01% E10C12) (42) were eventually changed (gel-filtration: 50mM HEPES
8.0, 150mM NaCl, 1mM TCEP; assay: 50mM HEPES 8.0, 10mM MgCl 2, 150mM NaCl, 1mM
TCEP) for all protein samples used in the study; E10C12 was removed altogether from the
recipes. The removal of detergent from the SEC running buffer drastically improved sample
solubility in solution for Ric-8A mutants and did not affect the tryptophan fluorescence assay.
Gαi1 and mGαi1 were expressed and purified as previously described (see materials and
methods) without complications. (Figure 2-6)
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Figure 2-6 Anion exchange chromatography profile of mGαi1
Samples run on the SDS-PAGE (inset) correspond to fractions under the peak.

2.2.3 Thermal Stability of Secondary Structural Folds of Ric-8A Mutants
Using differential scanning fluorimetry as well as circular dichroism spectrometry, we found that
most of the mutants were slightly destabilized. CD spectra of Ric-8A WT and mutants exhibited
no noticeable difference in the initial scan, indicating similar secondary structural features
(mainly α-helical) for all protein samples at 4oC, consistent with previous findings. (42, 48)
(Figure 2-7) While wild type Ric-8A and mutants with wild-type-like GEF activities underwent
cooperative denaturation at ~40 °C, a few mutants appeared to start precipitating heavily at that
temperature. After unfolding, no significant refolding was observed after cooling the samples
back to 4 °C, possibly due to the high upper temperature limit (90 oC) since most mammalian
proteins denature irreversibly at 90oC. Therefore, these CD experiments should be repeated
using lower upper temperature limit (i.e. 60oC) to determine Ric-8A refolding capability.
Nevertheless, we did not notice significant denaturation of any of the sixteen mutants during the
tryptophan fluorescence assay, which was carried out at 25oC.
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Figure 2-7 Heat denaturation of Ric-8A and Gαi1 using CD spectroscopy

(A) Full-wavelength scan from 200nm to 250nm of Ric-8A samples before and after heat
denaturation. (B) Temperature course of ellipticity at 222nm of WT Ric-8A vs. mutant Ric8A, showing a WT-like mutant (V459A) and a destabilized mutant (V455A). (C) Meltingtemperatures (Tm) ensemble of all mutants of Ric-8A and Gαi1. Error bars represent the
standard deviation among three replicates. See Materials and Methods for details.
All temperature denaturation experiments were performed in the buffer described in Materials
and Methods section. The 1mM TCEP in the buffer interferes slightly with CD signal between
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wavelengths 200nm – 205nm, however, it was not replaced with other reducing agents because
the interference range does not affect the overall quality of CD spectrum or ellipticity signal at
222nm. TCEP is also the reducing agent used in the assay buffer for the tryptophan fluorescence
assay, therefore, the CD spectra obtained describe closely the secondary structural properties of
proteins used in the GEF assays. The noise level of some data sets deterred us from determining
precisely the melting temperature of some samples (i.e. E461A, K462A); however, it is safe to
conclude, at the level of secondary structure, that no Ric-8A sample was globally denatured
during the nucleotide binding assays because all mutants were stable during the thermal
denaturation experiments, CD or DSF (Figure 2-8), up to ~30 °C with the majority remaining
stable up to 35oC. Therefore, the effects on GEF activity that we observed from mutant Ric-8A’s
were largely due to either the loss of crucial protein-protein interaction elements or local,
functional conformational change(s).
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Figure 2-8 Differential scanning fluorimetry of Ric-8A and its mutants
See Materials and Methods for details. (10)

2.2.4 GEF Activity of Mutants Spanning Putative Binding Sequence
Now that all sixteen Ric-8A mutants were expressed, purified, and their thermal stability
determined, it is safe to conclude that the alanine point mutations did not induce global structural
perturbation on Ric-8A and the mutant proteins are suitable for functional assessments. Initially,
I performed the “GTP-binding” tryptophan fluorescence assay using the unmodified Gαi1. I saw
very mild effects for all mutants and was not able to draw any clear conclusion from the results.
(data not shown)
After replacing unmodified Gαi1 with myristoylated Gαi1, the reduction of GEF activity in a few
mutants became more pronounced and significant, compared to WT Ric-8A. (Figure 2-9)
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Therefore, the tryptophan fluorescence assay results obtained with myristoylated Gαi1 were
chosen as the primary data set and were triplicated to account for statistical variations and to
ensure scientific rigor. Two alternative assay methods, which will be discussed in later sections,
were attempted but the results were only used to validate the primary data set.

Figure 2-9 Typical mGαi1 GTPγS-binding assay time courses monitoring intrinsic tryptophan
fluorescence change of residue W211 in mGαi1 upon nucleotide exchange. Initial rates of
Ric-8A-stimulated or intrinsic GTPγS-binding are in parenthesis. 2μM of mGαi1 were
allowed to form complex with buffer control (for intrinsic exchange rate) or 2μM of WT or
G469A mutant Ric-8A 1-491 for five minutes and 20μM GTPγS was added to start the
reaction. (See Materials & Methods for details.)

2.2.4a Tryptophan Fluorescence Assay

The alanine screen revealed several ‘hotspots’ for GEF activity, V455, T456, R458, P466 and
G469. These Ric-8A mutants catalyze nucleotide exchange at a reduced initial rate
corresponding to 12–20% that of WT Ric-8A. It is worth mentioning that comparable loss of
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GEF activity was observed for Ric-8A 452, which does not contain the protected sequence at all.
The Ric-8A 1-470 construct, which contains the putative Gαi1 binding site, showed partial
recovery of GEF activity compared to the 1-452 construct (42); therefore, residues within the Cterminal segment from residue 471 to 491 might be involved in Ric-8A GEF activity or required
for proper folding of 454-470. Alanine mutants at residues P454 and E468 exhibited
significantly slower rates for the overall exchange reaction than for binding to the Gαi1:Ric-8A
intermediate. Mutating these residues appears to favor GTPγS-binding to Gαi1:Ric-8A complex
and possibly the release of Ric-8A. (Figure 2-10, Table 2-1)

Figure 2-10 GEF activity of Ric-8A 1-491 point mutants expressed as percent of Ric-8A 491 WT
activity
Blue bars (“nucleotide exchange” assays) represent the initial velocity of GDP to GTPγS exchange
when Ric-8A (2μM) and GTPγS (20μM) were added simultaneously to mGαi1:GDP (2μM). Orange
bars (“GTP-binding” assays) represent results of the nucleotide-binding reactions where GTPγS were
added to pre-incubated, nucleotide-free mGαi1:Ric-8A (2μM) complexes. Error bars show standard
deviation of three independent measurements. Asterisks above bars indicate significance of the
differences: *p<0.01; **p<0.005; ***p<0.001. (10)
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Table 2-1 Initial velocities of Ric-8A mutant guanine nucleotide exchange activity
Assays were conducted as described in Materials& Methods section. For measurement of v1, reaction
buffer (50 mM HEPES pH 8.0, 150 mM NaCl, 10 mM MgCl2, and 1 mM TCEP) at 25 °C contained 2
μM mGαi1:GDP, 2 μM Ric-8A and 20 μM GTPγS (initial concentration); for measurement of v2, 2
μM mGαi1:GDP, 2 μM Ric-8A were incubated for 5 minutes before addition of 20 μM GTPγS.
*v1 for the reaction: mGαi1:GDP + GTPγS + Ric-8A  mGαi1:GTPγS + Ric-8A + GDP;
v2 for the reaction: mGαi1:Ric-8A + GTPγS  mGαi1:GTPγS + Ric-8A;
Values in parentheses are the standard deviation for three independent experiments. (10)

The experimental method we adopted presents uncertainties from various sources including, but
not limited to temperature, sample integrity (i.e. effective concentration of proteins), and
incubation time. For example, the rate of Ric-8A activated nucleotide exchange varies with
reaction temperature, the temperature of Ric-8A samples right before adding to the reaction, the
age of samples (i.e. time samples spent in gel-filtration buffer before experiments), the time Ric8A is allowed to react with Gαi1:GDP before GTPγS joins the reaction. We control for most of
these factors by controlling reaction temperature and timing crucial steps of the reaction. Mostly
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importantly, each mutant Ric-8A GEF activity was reported as ratios of rates catalyzed by the
mutant and WT Ric-8A, which were both purified by size-exclusion chromatography the same
day.

Variations among experiments decrease significantly when properly controlled. However, the
initial mixing stage of the experiments appears to be the most error-prone stage among all others.
This is most noticeable for fast initial binding rates. Therefore, a stopped-flow approach to assay
exchange activity for the same set of mutants might help resolve the issue. Regardless, the data
we collected is quite clear in determining activity knockdowns in Ric-8A mutants V455A,
T456A, R458A, P466A, G469A, as well as the truncated 1-452 construct. The apparent gain of
function in certain mutants requires more careful assessment with lower GEF concentrations or
stopped-flow experiments to confirm.

Based on the alanine screen result, a few binding “hotspots” were proposed on the Ric-8A Cterminal region. Three residues were selected for a round of double alanine mutational study,
E460, P466, and M467. We selected E460 and M467 because they were either mildly inhibitory
or not inhibitory when mutated individually (Figure 2-10) and we were interested to see what
would happen in a double alanine mutation at the two residues. P466 was selected because we
know that proline residues usually do not make direct protein-protein contacts so mutating the
proline to an alanine might have disrupted the Ric-8A structure locally to produce the inhibitory
effect (Figure 2-10). If both double mutants of P466A with E460A and M467A exhibit the
same level of reduction in GEF activity as P466A single mutant, we can postulate that P466 is a
structural element crucial for GEF activity of Ric-8A. Three double mutant plasmids,
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E460A+P466A, P466A+M467A, and E460A + M467A, were generated using the same
mutagenesis method described for single mutants. All double mutant proteins expressed but only
two, E460A+M467A and P466A+M467A were purified adequately with the purification
protocol optimized for single mutants. Alongside the double mutants, three charge-reversal or
charge-addition single mutant plasmids, E460R, E460K, and M467E, were generated. By
reverting the charge on E460, we hope to see more pronounced changes to the GEF activity than
what we saw for the E460A mutant (Figure 2-10) if it forms ionic interaction with a positively
charged residue on Gαi1. By replacing M467 with a glutamate, we introduced a negative charge
at the position without changing the size of the side-chain. E460R and M467E expressed well
and could be purified; but to my surprise, E460K aggregated heavily.

The mutants described above that were expressed and purified (E460A+M467A,
P466A+M467A, E460R and M467E) were assayed for their GEF activity towards Gαi1 W258A,
not mGαi1. The “GTP-binding” tryptophan fluorescence assays for these mutants were each
performed once, therefore, the result is still preliminary and qualitative. (Figure 2-11) Since unmyristoylated Gαi1 was used instead of mGαi1, the single alanine mutants (E460A, P466A, and
M467A) were assayed alongside for comparison. At first glance, the E460R, charge reversal
mutant regained a portion of its lost GEF activity from E460A, suggesting that the glutamate
residue might simply serve as a “space filler” and not participate in salt-bridge formation with
basic side-chain(s). Similar comments can be made for M467E mutant since the substitution of
an acidic side-chain for a neutral residue returned the GEF activity to near WT level from
M467A level. The E460A+M467A double mutant, received from the mutations mild additive
effect on its GEF activity, as expected. The P466A+M467A double mutant, on the other hand,
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not only fully rescued the activity reduction observed for each single mutant but is a mild gainof-function mutant by being slightly more active than WT protein. (Figure 2-11) These double
alanine mutants and charge-reversal/addition mutants need to be assayed more carefully using
mGαi1 in order to draw clear conclusions about the effects of mutations.

In conclusion, the tryptophan fluorescence assay results confirmed that the C-terminal region of
Ric-8A (454-470), which was predicted to adopt a random coil secondary structure but is highly
protected from HDX in the Ric-8A:Gαi1 complex, is an important peptide segment for
interaction with Gαi1 and possibly comprises crucial structural elements for the GEF function of
full-length Ric-8A.

Figure 2-11 GEF activity of additional Ric-8A 1-491 mutants expressed as fraction of Ric-8A
491 WT activity using the “GTP-binding” tryptophan fluorescence assay. 2μM of Gαi1 were
allowed to form complex with buffer control or 2μM of WT or mutant Ric-8A 1-491 for five
minutes and 20μM GTPγS was added to start the reaction.
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2.2.4b Alternative Approach-I: Filter-binding Assay with γ 35S-GTPγS
Although the assay method adapted here was established long ago (104), there are limitations to the
tryptophan fluorescence GTPγS binding assay. For instance, the signal generated from emitting
tryptophan residues is protein concentration dependent, but the major source of noise is background
signal fluctuation from solution agitation and spectrometer optics, therefore, absolute noise level is almost
constant for all concentrations of sample; the overall signal observed reflects the changes mainly in the
fluorescence environment of W211 on switch II, which becomes ordered upon GTPγS binding, but is not
a direct measurement of nucleotide-binding to Gαi1. When I attempted to perform a Gαi1:GDP
concentration-dependent assay at a fixed concentration of Ric-8A to tease out kinetic parameters such as
KM and Vmax for the nucleotide exchange reaction catalyst, Ric-8A, the results were too noisy to be
interpretable at low Gαi1 concentrations (<0.5 µM) due to the Gαi1 concentration-dependent signal:noise
ratio. Therefore, I attempted another well-established assay, which uses the isotope labelled nucleotide,
γ35S-GTPγS, as the substrate. (106)

The isotope assay involves spotting nucleotide-bound protein onto BA85 nitrocellulose membrane
(Millipore Sigma) and washing the membrane so only protein:nucleotide complex bound to the
membrane is counted under a scintillation counter(106). With the help of Suneela Ramineni from Prof.
John Hepler’s lab at Emory University, the protocol was modified for the filter-binding assay for WT Ric8A and Gαi1. The original filter-binding assay protocol from the Hepler lab was designed for assaying
inhibition of GDP-release from Gα by GDIs, which do not require NaCl for solubility in solution. For no
obvious reason(s), addition of either 150mM NaCl or 0.01% E10C12 into the reaction buffer (50mM Tris
pH 8.0, 1mM DTT, 1mM EDTA, 10mM MgSO4) interfered with retainment of isotopes on the
nitrocellulose filter discs. Therefore, the detergent (E10C12) as well as NaCl were both omitted from the
reaction buffer so the assay can be performed without technical issues.
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Figure 2-12 Filter-binding assay using γ-35S-GTPγS as non-hydrolysable GTP analog

1.25µM of mGαi1 were added to 0.5µM Ric-8A 491 WT and 2µM GTPγS doped with
(2000cpm/pmol) γ35S-GTPγS in reaction buffer (50mM Tris pH 8.0, 1mM DTT, 1mM
EDTA, 10mM MgSO4) and multiple time points (1, 5, 15, 30, 45, 60-minutes) were taken.
Initial rates of γ35S-GTPγS-binding are in parenthesis. Red dotted-lines represent the singleexponential rise-to-maxima fit of the data points as described in section 2.3.4.
The assay system with γ35S-GTPγS worked reasonably well for WT Ric-8A, however, the changes made
to the reaction buffer composition rendered the assay unsuitable for many mutants of Ric-8A due to the
absence of NaCl in the reaction buffer. Therefore, the result of the isotope assay shown here (Figure 212) could only serve as a direct proof that the fluorescence signal change observed in the tryptophan
fluorescence GTPγS-binding assays correlates with GTPγS binding. The isotope assay protocol needs to
be further modified in order to be applicable to the unstable Ric-8A mutants.
2.2.4c Alternative Approach-II: FRET Assay with MANT-GTPγS
I have also attempted to perform the nucleotide-binding assay using Förster resonance energy transfer
(FRET). The FRET experiment is a more direct measurement of nucleotide-binding to mGαi1 than the
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tryptophan fluorescence assay because the FRET efficiency will only be high enough for measurable
signal to be generated if the donor and acceptor come in close proximity, as in the case of a nucleotide
binding event. The fluorescence signal is emitted from the nucleotide analog, MANT-GTPγS, instead of
mGαi1; therefore, the protein samples used in the reaction contribute less to the background FRET signal.
In the contrary, all protein samples in the reaction mixture emit photons at 350nm when excited at 295nm
in the tryptophan fluorescence assay; therefore, for the “nucleotide exchange” assays, background
fluorescence should be measured by running proper negative controls and subtracted from raw data.
(Figure 2-13)
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Figure 2-13 A comparison of raw data between “GTP-binding” assay and “nucleotide
exchange” assay
The orange curve consists of three segments, 0 to 1 minute (2 µM mGαi1), 1 to 6 minutes (2 µM
mGαi1 + 2 µM Ric-8A), and 6 to 19 minutes (2 µM mGαi1 + 2 µM Ric-8A + 20 µM GTPγS). The
blue curve consists of two segments, 0 to 1 minute (2 µM mGαi1), and 1 to 15 minutes (2 µM mGαi1
+ 2 µM Ric-8A+20 µM GTPγS)
Addition of protein samples (mGαi1 and Ric-8A) increases tryptophan fluorescence; therefore, a time
course for a negative control (2 µM mGαi1 + 2 µM Ric-8A + 0 µM GTPγS) was measured for, and
subtracted from, each “nucleotide exchange” assay.

Unfortunately, the FRET data set was not complete due to unknown complications with the
R458A mutant, which was not an issue for the tryptophan fluorescence assays. In addition, the
MANT-labelled substrate appears to bind mGαi1 with different binding affinity than GTPγS
possibly due to the MANT group. Therefore, the MANT FRET data set was only used to
compare with the tryptophan fluorescence results, which used GTPγS as the GTP analog, and
was not published.
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Qualitatively, the FRET assays arrived at the same conclusion as the tryptophan fluorescence
assays regarding the GEF activities of Ric-8A mutants. (Figure 2-14, 2-15, and blue bars in
Figure 2-10) For the functionally knocked-down, WT-like, and apparent gain-of-function
mutants (P454A, G457A, V459A, E460A, E461A, K462A, P463A, P464A, N465A, M467A,
and E468A), the FRET assay results do not always agree quantitatively with the tryptophan
fluorescence assay results but the general trend of GEF activity changes caused by alanine point
mutations is still clear because V455A, T456A, P466A, and G469A all exhibited severely
(>75%) reduced/knocked-out GEF activities towards mGαi1 compared to WT Ric-8A, as
observed by the tryptophan fluorescence assays.
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Figure 2-14 Examples of MANT-GTPγS binding curves

Each reaction mix was excited at 295 nm (tryptophan excitation wavelength) and emission
recorded at 448 nm (MANT emission wavelength). 1µM Ric-8A and 5µM MANT-GTPγS
were added simultaneously to 1µM mGαi1:GDP to start the reaction (“nucleotide exchange”
assays).
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Figure 2-15 GEF activity of the same set of Ric-8A mutants using MANT-GTPγS-binding assay
method

Nucleotide binding is more directly assessed since FRET efficiency would be too low to
detect if the MANT group is not within maximum FRET distance to residue W211 on switch
II of Gαi1. Error bars represent the standard deviation among three replicates.
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Ric-8A Mutant W.F. Ratio W.F. Error MANT Ratio MANT Error
P454A
65.2
18.0
72.3
1.9
V455A
18.6
1.1
20.0
0.7
T456A
13.4
0.9
24.9
0.9
G457A
152.2
48.5
43.2
13.7
R458A
27.7
3.3 No Data
No Data
V459A
93.7
11.3
52.9
25.8
E460A
108.5
13.8
73.2
4.0
E461A
123.6
10.8
105.1
17.0
K462A
126.6
26.1
90.7
2.1
P463A
81.9
19.4
135.1
11.4
P464A
79.9
26.6
88.7
3.6
N465A
98.0
44.8
87.8
4.7
P466A
20.6
0.6
17.5
4.6
M467A
94.6
2.7
43.2
14.2
E468A
131.6
19.0
74.4
2.4
G469A
21.8
2.7
39.4
0.8
Ric-8A 452
24.5
6.2 No Data
No Data
Table 2-2 Comparison of “nucleotide exchange” assay results from tryptophan
fluorescence assays and FRET assays
Data from Figure 2-10 (blue bars) are compared with data from Figure 2-15. GEF activities
of Ric-8A mutants are normalized and expressed in percent WT Ric-8A initial GTPγS (W.F.
Ratio) or MANT-GTPγS (MANT Ratio) binding rate determined the same day. Errors
represent standard deviation of three independent measurements.

2.2.5 Size-exclusion Chromatography to Assess Ric-8A:Gαi1 Complex Formation
The original hypothesis states that making single mutations along the Ric-8A sequence 454-470 hinders
Ric-8A Gαi1 interaction. Since WT Ric-8A forms a stable heterodimeric complex with Gαi1 and the
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complex almost does not dissociate once formed, we consistently isolate nucleotide-free Ric-8A:Gαi1
complex using size-exclusion chromatography (SEC).

The nature of the activity knockdowns is not completely characterized by the nucleotide exchange assays.
By running incubated protein complex on an SEC column, we made preliminary, qualitative assessment
on the ability of mutants to form complexes with Gαi1. Although some of the activity knock-out mutants
also showed defects in complex-formation, the size exclusion chromatography results of the incubated
product of Gαi1:GDP and Ric-8A mutants did not always agree with the nucleotide-binding assay results.
(i.e. Knock-down Ric-8A mutants were not always deficient in forming complex with Gαi1) For example,
G469A mutant forms Gαi1 complex just like WT Ric-8A while M467A mutant showed significantly
decreased complex-formation while catalyzing nucleotide exchange similar to WT Ric-8A. (Figure 2-16)
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Figure 2-16 Size-exclusion chromatography to assess Ric-8A:Gαi1 complex formation

(Top) Gel-filtration traces showing the extent of complex-formation for WT or mutant Ric8A with Gαi1. Samples of purified Gαi1 W258A and Ric-8A mutants and WT were gelfiltered separately before mixing. 5μM of Gαi1 and Ric-8A were mixed and incubated on
ice for 1-2 hours before injecting into an S200 gel-filtration column for separation. Peaks at
13.2mL, 14.1mL, 15mL, and 19.8mL are identified by SDS-PAGE as Ric-8A:Gai1 complex,
free Ric-8A, Gαi1, and GDP, respectively. (Bottom) Red stars mark mutants of Ric-8A that
show deficiency in forming complex with Gαi1. (10)
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2.2.6 Ric-8A 454-470 peptide and Ric-8A 399-491
The synthetic Ric-8A C-terminal peptide (up to 0.5 mM) does not appear to inhibit Gαi1:Ric-8A
binding interaction significantly based on the pull-down result. On the other hand, the
competitive inhibition activity can be small if 454-470 is not the only Gαi1 binding site. As
reflected on the tryptophan fluorescence assay result using GST-Ric-8A 399-491 as an
alternative competitive inhibitor, I observed (a) no GEF activity from the construct and (b)
relatively mild inhibition effect. Taken together, the C-terminal region of Ric-8A might still be
an important Gαi1 binding site, however, definitely not the only one. (Figure 2-17, Figure 2-18)
Figure 2-17 Pull-down assay result
showing no obvious peptide
competition for Gαi1 binding
---Gel Lane--1.
100 µM peptide, Gαi1, buffer
2.
0 µM peptide, Gαi1, Ric-8A
3.
10 µM peptide, Gαi1, Ric-8A
4.
50 µM peptide, Gαi1, Ric-8A
5.
100 µM peptide, Gαi1, Ric-8A
6.
500 µM peptide, Gαi1, Ric-8A
7.
ladder
8.
Ric-8A loading
9.
Gαi1 loading
10.
Lane 6 IMAC Flow-through
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Figure 2-18 Tryptophan fluorescence GTPγS-binding assay showing minimal inhibition of Ric8A GEF activity by GST-Ric-8A 399-491

2µM of Gαi1 W258A was preincubated with 2µM of GST-Ric-8A 399-491 or buffer
negative control for 15min at room temperature with stirring. Then 2µM of His-Ric-8A 1491 or buffer negative control were added to the mixture and incubated for 5 minutes before
the addition of 20µM GTPγS to start the binding experiments.
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2.3 Materials & Methods
2.3.1 Mutagenesis, Protein Expression and Purification
The W258A mutant of rat Gαi1, encoded in a Gateway pDEST15 vector (Thermo Fisher
Scientific, Waltham, MA), was expressed as a tobacco etch virus protease (TEV)-cleavable, Nterminal glutathione-S-transferase (GST) fusion protein and purified as described (52). GSTfusion construct of Ric-8A 399-491 was expressed and purified using a protocol similar to that of
Gαi1 W258A.

Myristoylated Gαi1, which will be referred as mGαi1 for simplicity, was expressed and purified
as previously described(71, 96). Briefly, internally hexa-histidine tagged rat Gαi1 construct in
pQE60 expression vector(71) was co-expressed in JM109 E. coli cells with yeast Nmyristoyltransferase in pBB131 vector(96). Cells were grown in T7 media at 37 oC and induced
at O.D.600 = 0.40 with 30 µM Isopropyl β-D-1-thiogalactopyranoside (IPTG) overnight at 30 oC.
After cell lysis using an EmulsiFlex-C5 cell disruptor (Avestin) in lysis buffer (50mM Tris pH
8.0, 100mM NaCl, 5mM β-mercaptoethanol, 10µM GDP, 2mM phenylmethane sulfonyl fluoride
(PMSF)) and clarification of lysate by centrifugation at 18,000 rpm in an SS34 rotor (Sorvall) for
1 hour at 4oC, His-tagged mGαi1 was isolated from the soluble faction by a gravity Nickel
nitrilotriacetic acid (NTA) (Qiagen) column and eluted with elution buffer (50mM Tris pH 8.0,
100mM NaCl, 5mM β-mercaptoethanol, 10µM GDP, 2mM PMSF, 150mM imidazole). The
imidazole and NaCl were removed by dialysis (50mM Tris pH 8.0, 2mM dithiothreitol) and
protein was further purified by loading onto a HiTrap Q Sepharose FF column (GE Healthcare)
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and eluted with a NaCl gradient (0mM to 500mM) on an AKTA Pure FPLC system (GE
Healthcare); mGαi1 elutes near 150mM salt.

Figure 2-19 Amino acid sequence of His-tagged Ric-8A 1-491 construct in pET28a vector

The original WT plasmid that encodes the amino acid sequence of rat Ric-8A 1-491 in pET28a
vector expresses an N-terminally hexa-histidine tagged protein(42) (Figure 2-19). Mutants of
Ric-8A were generated from the WT plasmid by using the QuikChange II XL kit (Agilent
Technologies). Mutagenesis primers were designed using the QuikChange® Primer Design
Program(Agilent Technologies) and purchased as synthesized, lyophilized oligos from IDT
(Integrated DNA Technologies). The resulting mutant plasmids of Ric-8A 1-491 were sent for
sequencing to Eurofins Operon. Sequencing results were compared to wild-type (WT) rat Ric8A sequence in the NCBI online database using protein BLAST(NCBI).
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WT and alanine single-mutant Ric-8A 1-491 proteins were expressed and purified as described
previously (42) with some alterations. We used either an Avestin cell disruptor or the
combination of lysozyme and DNase I to lyse cells expressing stable Ric-8A mutants or less
soluble mutants, respectively. After the first step of fractionation (centrifugation of lysate) in
lysis buffer (50mM Tris, pH 8.0; 250mM NaCl; 5% Glycerol; 2mM β-mercaptoethanol; 2mM
PMSF), the supernatant, which contains soluble fraction of cells, was incubated for 15 minutes at
4oC with Profinity Immobilized Metal Affinity Chromatography (IMAC) resin (Bio-Rad) in
suspension with constant, gentle rocking in a flat-bottom glass culture flask. The lysate/resin
mixture was poured into an empty glass gravity column (Bio-Rad) and the lysate was usually
allowed to elute by gravity. For Ric-8A mutants that aggregated heavily during this step of the
purification, the incubation time was reduced to 2-5 minutes and lysate was then forced to drain
out by applying positive pressure to the glass column. By doing so, we suffered a loss of total
yield due to shorter lysate-resin contact time but regained ability to purify less soluble proteins
without heavily congesting the IMAC column with protein aggregates. After extensive wash
with lysis buffer, the target proteins were eluted from the IMAC column by elution buffer
(50mM Tris, pH 8.0; 250mM NaCl; 5% Glycerol; 2mM β-mercaptoethanol; 2mM PMSF;
300mM Imidazole) and immediately dialyzed in dialysis buffer, which is also Q-column bufferA (50mM Tris pH 8.0, 5mM β-mercaptoethanol) to remove the imidazole. In certain cases, 5%
glycerol and 50mM NaCl were added to the dialysis buffer to stabilize the protein for long-term
storage or subsequent anion exchange chromatography purification. From this point on, all Ric8A mutant proteins stayed soluble even at high concentrations (5 - 10 mg/mL). The dialyzed
protein was then loaded onto a HiTrap Q XL anion exchange column (GE Healthcare) and eluted
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with a NaCl gradient (0mM to 500mM). Ric-8A eluted at about 200mM NaCl and is already at
high purity after elution from anion exchange column.

Expression, and purification steps of Ric-8A truncation mutants, R452 and R470, were similar to
those of Ric-8A 1-491 and discussed in more detail in Chapter III, “Ric-8A Crystal Structure”.
The only difference is that the R452 and R470 samples used in this chapter were still His-tagged
while proteins used for crystallization were tag-less, therefore, no TEV protease digestion was
performed for any Ric-8A constructs used for experiments described in this Chapter. (See
Chapter III for information about removing His-tag)

A final polishing step using a Superdex 200 10/300 GL size-exclusion chromatography column
(GE Healthcare) was performed to isolate monodisperse, monomeric proteins (Ric-8A and Gαi1)
from aggregated protein and to buffer exchange the sample into gel-filtration buffer (50mM
HEPES, pH 8.0, 150mM NaCl and 1mM tris(2-carboxyethyl)phosphine) right before
experiments.
2.3.1a Standard Conditions for Sample Quantification and Storage of Purified Samples

Unless otherwise noted, all purified protein samples mentioned in this dissertation were
quantified by reading sample solution absorbance at 280nm (A280) using a NanoDrop™ 2000
spectrophotometer (Thermo Scientific). Actual protein concentrations were calculated by
dividing A280 value by the estimated extinction coefficient at 280nm based on sample amino
acid (and/or nucleic acid) composition and Beer’s Law (A=ε*l*c). (67)
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All protein samples used in assays or crystallogenesis experiments described in this dissertation are
purified to >95% homogeneity exemplified by the sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) analysis shown. (Figure 2-6 inset) Before flash-freezing in liquid nitrogen
for long-term storage in -80oC, Q-column-purified protein samples were concentrated to 5-10mg/mL and
glycerol was added to reach 5% (v/v) final concentration if not already present in Q-column running
buffers. All thawed samples were also re-purified to monodispersity and buffer exchanged into fresh gelfiltration buffer, 50mM HEPES, pH 8.0, 150mM NaCl and 1mM TCEP, using a Superdex 200 column
(GE Healthcare) prior to experiments.

2.3.2 Circular Dichroism
Ric-8A WT and mutants at 5µM each in 50 mM HEPES, pH 8.0, 150 mM NaCl and 1 mM
TCEP were dispensed into a 300-µl quartz cuvette with a 1 mm path length. CD spectra in the
range of 210–250 nm were measured at a scan rate of 1 nm/min using a J-815 CD spectrometer
(Jasco). The CD spectrum of the buffer was subtracted. The optical path and the cuvette
chamber were continuously flushed with a nitrogen flow throughout the course of the
experiment. Thermal denaturation experiments were carried out in the same buffer as described
above. Samples were heated steadily (2 oC/min) from 4oC to 90oC while monitoring the
ellipticity at 222nm (θ222). Once the end temperature is reached, samples were steadily cooled
back to the starting temperature to determine recovery of secondary structures. Data were fitted
with the “Protein Temperature Melt” function in the SigmaPlot enzyme kinetics module (Figure
2-20) (Systat Software) and triplicated and standard deviation shown as error bars.
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Figure 2-20 A typical CD thermal denaturation curve monitoring θ222
The data is fitted with the “Protein Temperature Melt” function in the SigmaPlot enzyme kinetics
module. (Systat Software)

To fit the raw data, the θ222 output was first normalized from θ222 values to fraction of protein
unfolded (funfolded):
𝑓

=

(1)

where for every temperature point (T), θobs = observed θ222, θfolded = minimal θ222, θunfolded =
maximal θ222;
to correct for change in heat capacity (ΔCp),
θfolded = ls*T+li

(2)

where “ls” and “li” equal the slope and y-intercept of the baseline of folded species, respectively;
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θunfolded = rs*T+ri

(3)

where “rs” and “ri” equal the slope and y-intercept of the baseline of unfolded species,
respectively.
ΔCp = rs/ls

(4)

Since

(5)
where Keq = equilibrium constant of folding and

(6)
where ΔG = Gibb’s free energy of unfolding, R = the gas constant = 1.98 cal/mol, and T = the
absolute temperature in Kelvin, funfolded is converted to ΔG and plotted against T. The ΔG vs. T
plot is fitted with

(7)
where ΔH = change in enthalpy, TM = Melting temperature where funfolded = 0.5. (56)
2.3.3 Differential Scanning Fluorimetry
Samples (10µL) of wild type Ric-8A(1–491) and mutants (~1 mg/ml) in 50mM HEPES, pH 8.0,
150 mM NaCl and 1 mM TCEP were dispensed into glass capillaries and placed into the sample
chamber of a Prometheus NT.48 differential scanning fluorimeter (NanoTemper Technologies,
Inc, Munich, Germany). Samples were subjected to a time-dependent temperature gradient over
20–75°C at a rate of 1°C/min. Fluorescence emission at 330nm and 350nm (excitation
wavelength, 295 nm) was recorded at seven second intervals. The transition temperature for
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thermal denaturation (Tm) is defined as the temperature at the maximum first derivative of the
ratio of fluorescence emission at 350 and 330 nm (F350/F330) as determined by a polynomial fit
to the temperature-fluorescence ratio curve implemented in the manufacturer’s software.
2.3.4 Tryptophan Fluorescence GTPγS-Binding Assay to Assess GEF Activity
Ric-8A catalyzed binding of GTPγS to mGαi1 (“nucleotide exchange” assay) was followed by
monitoring the change in intrinsic fluorescence of mGαi1 at 340nm upon exchange of GDP with
GTPγS. (102) 2µM of mGαi:GDP in buffer composed of 50mM HEPES pH 8.0, 150mM NaCl,
10mM MgCl2, and 1mM TCEP in a reaction volume of 500µl was allowed to equilibrate for
5min at 25°C in a quartz fluorescence cuvette (quartz SUPRASIL macro/semi-micro cell,
PerkinElmer B0631132) with stirring. Ric-8A samples were equilibrated separately at 25°C
simultaneously. 20µM GTPγS was added to the reaction mixture in the absence or presence of
2µM Ric-8A, and the increase in fluorescence at 340nm was monitored upon excitation at
295nm. Fluorescence measurements were conducted using an LS55 spectrofluorometer
(PerkinElmer Life Sciences). The excitation and emission slit widths were set to 2.5nm. All
excitation light was eliminated by the use of a 290nm cut-off filter positioned in front of the
emission photomultiplier.

In the case of the “GTP-binding” assays, 2µM Ric-8A were first added to the cuvette containing
2µM mGαi:GDP and allowed to incubate for 5 min. 20µM GTPγS was subsequently added to
start the nucleotide-binding reaction with the incubated product. 10-minutes time courses of
GTPγS binding events were recorded and fit to a single exponential equation using SigmaPlot
(Systat Software):
y = a*(1-e-kt)

(8)
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where y = change in tryptophan fluorescence at time t; a = maximum achievable change in
tryptophan fluorescence; k = rate constant, t = time in minutes.
The initial rates of change in tryptophan fluorescence were calculated by taking the first
derivative of the equation at t = 0:
v(t) = dy/dt = a*k*e-kt

(9)

v(0) = a*k

(10)

Rates of nucleotide exchange were then calculated by correlating maximum changes in
tryptophan fluorescence with the maximum possible amount of mGαi1: GTPγS being formed in
the reaction volume. The relative activity of each Ric-8A mutant was computed as the ratio of
its GEF activity, v(0), to that of WT Ric-8A. For each Ric-8A mutant, relative activities were
determined for each of three samples derived from the same stock solution of protein and the
average relative activity and standard deviation computed. Assays were conducted over a period
of several days, using the same stock of mGαi1 and WT Ric-8A, and the activity of WT Ric-8A
re-determined each day from a single sample.

P-values associated with the difference between the GEF activities of mutant versus WT Ric-8A
were conducted using a two-tailed Student’s t-test based on the mean and variances of three
determinations for the activities of each mutant and eight determinations of the activity of WT
Ric-8A.
2.3.5 FRET Assay Using MANT-GTPγS
The FRET assays were performed in similar fashion as the “nucleotide exchange” tryptophan
fluorescence GTPγS-binding assay except MANT-GTPγS was used as the nucleotide and
fluorescence signal at 448nm, instead of 340nm, was monitored. Final concentration of samples
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in the reaction were also decreased to 1µM mGαi1, 1µM Ric-8A, and 5µM MANT-GTPγS due
to scarcity of MANT-GTPγS at the time the assays were performed. When 2’/3’-O-(N-Methylanthraniloyl)-guanosine-5’-(γ-thio)-triphosphate (MANT-GTPγS, Jena Bioscience) (Figure 221) was excited directly at λex = 355nm and its fluorescent emission measured at λ em =448nm as
Gαi1 binds, a poor signal-to-background ratio was observed. (data not shown) By using W131
and W211 as a FRET donors (73, 97) for incoming MANT-GTPγS and exciting the nucleotide
binding reaction at λex = 295nm and detecting for emission at λem = 448nm, signal-to-background
was significantly improved, therefore, the MANT FRET assay results were performed thrice and
treated as the primary data set over the direct MANT fluorescence assay results. Data fitting and
normalization were performed using identical procedures as the tryptophan fluorescence assay.

Figure 2-21 Structure of MANT-GTPγS

(Jena Bioscience Reagent Data Sheet)

2.3.6 Filter-Binding Assay Using γ35S-GTPγS
Protein samples of interest were gel-filtered in reaction buffer (50mM Tris pH 8.0, 1mM DTT, 1mM
EDTA, 10mM MgSO4) prior to the assays. 1.25µM of mGαi1 were added to 0.5µM Ric-8A 491 WT and
2µM GTPγS doped with (2000cpm/pmol) γ35S-GTPγS and multiple time points (1, 5, 15, 30, 45, 60-
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minutes) were taken and filtered through pre-washed nitrocellulose BA35 membrane discs with the aid of
a 1225 sampling manifold (Millipore). The membrane discs were then washed three times with cold
reaction buffer while on the vacuum manifold and completely dissolved in 2mL of 2-metholyethanol
followed with 8mL of 3a70b scintillation cocktail (RPI) before counting. Each data point was duplicated
by spotting and filter reaction from the same time-point twice to control for technical errors.

2.3.7 Ric-8A 454-470 Peptide and GST-Ric-8A 399-491 Competition Assays
A synthetic peptide corresponding to rat Ric-8A residues 454-470 was purchased from
GenScript. To see whether the peptide competes with Ric-8A 491 for Gαi1 binding site(s), a
pull-down assay was performed. 3.6µM of Gαi1 was preincubated with a range of
concentrations (0 to 500µM) of the Ric-8A peptide for 15 minutes at room temperature. 1µM of
His-tagged Ric-8A 491 WT or buffer control were then added to the mixture and incubated for
another 15 minutes at room temperature. The incubated samples were passed through spincolumns (Thermal Fisher) packed with 200µL of Profinity IMAC resins (Bio-Rad) pre-washed
with gel-filtration buffer (50mM HEPES pH 8.0, 150mM NaCl, 2mM β-mercaptoethanol, 0.01%
E10C12) three times to capture His-tagged protein. The IMAC columns were then washed
thoroughly with gel-filtration buffer. Protein was eluted with 30µL of elution buffer (300mM
imidazole in gel-filtration buffer). The eluate as well as the loading and flow-through were
analyzed by SDS-PAGE.

The GST-fusion Ric-8A 399-491 protein contains the putative Gαi1 binding site (454-470),
therefore was tested for its own GEF activity as well as competitive inhibitor activity towards the
GEF activity of Ric-8A 491 on Gαi1. Tryptophan fluorescence GTPγS binding assay was used
for the assessment. Briefly, 2µM of Gαi1 was preincubated with 2µM of GST-Ric-8A 399-491
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or buffer negative control for 15 minutes at room temperature with stirring. Then 2µM of HisRic-8A 1-491 or buffer negative control were added to the mixture and incubated for 5 minutes
before the addition of 20µM GTPγS to start the binding experiment as described earlier.
2.3.8 Size-Exclusion Chromatography to Assess Gαi1 Complex Formation
To test the Ric-8A mutants for their ability to form complex with Gαi1, one molar equivalent of
Gαi1 is allowed to react and form complex with one molar equivalent of Ric-8A WT or mutant
for 1 hour on ice. Analytical quantity (~1mg) of the incubated mixture is then run through a
Superdex 200 10/300 GL size-exclusion chromatography column (GE Healthcare) at 0.5mL/min
to assess the extent of complex-formation. Molecular weights (kDa) of protein species eluting
from the column were estimated by the elution volume (mL) and a standard curve generated by
running gel-filtration standard (Bio-Rad #1511901) through the same column.
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Chapter III: Ric-8A Crystal Structure
3.1 Introduction
As described in Chapter I, Ric-8 appears to function as a GEF in similar fashion as the GPCRs,
the nucleotide exchange reaction proceeds with the formation of a stable nucleotide-free Ric8:Gα complex intermediate in the absence of GTP. Biophysical investigations of this complex
revealed that nucleotide-free Gαi1 adopts a molten-globule-like state when bound to Ric-8A and
is structurally heterogeneous.(23, 42) In the Ric-8A:Gαi1 complex, the secondary structure
scaffold that supports the nucleotide binding site in the Gαi1 Ras-like domain becomes
accessible to HD exchange and is therefore likely destabilized.(10) It has been lately discovered
that Ric-8A phosphorylation at five casein kinase II (CKII) sites, which are highly conserved
across Ric-8A phylogeny, activates both the GEF and chaperone activity of Ric-8A. (3) Thus,
whereas Gα activation is regulated by exogenous GPCR agonists, cytoplasmic activation may be
stimulated through a kinase activation cascade.

Little is understood about the molecular mechanism by which Ric-8 homologs catalyze
nucleotide exchange on Gα and the absence of structural information about the Ric-8 family of
proteins has been a major obstacle for this field of research. Although the atomic structures of a
variety of Gα proteins have been determined in several conformational states (54), only
computational models are available for Ric-8A. (10, 29, 48) The computational models predicted
an elongated macromolecule composed primarily of α-helical Armadillo repeats, similar to
importin-β, the nucleo-transporter that binds Ran-GTPase. (83) (Figure 3-1) Although importinβ does not catalyze nucleotide exchange for Ran, the crystal structure of importin-β:Ran complex
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is the best structural model available to describe the paradigm where a protein macromolecule
composed of mainly Armadillo repeats, such as Ric-8, can interact with a Ras GTPase.

Figure 3-1 Crystal structure of importin-β:Ran complex showing importin-β Armadillo repeats, a
superhelix of repeating α-helices, in GREEN to CYAN and Ran GTPase in BLUE. (83)

Very briefly, X-ray crystallography is an experimental technique that exploits the fact that Xrays are diffracted by atoms in crystals. X-rays have the proper wavelengths (~10 -10 m) to be
scattered by the electron cloud of an atom. Based on the diffraction pattern obtained from X-ray
scattering off the periodic assembly of molecules or atoms in the crystal lattice, an electron
density map can be reconstructed. Additional phase information must be extracted either from
the diffraction data or from supplementing diffraction experiments to complete the
reconstruction. A model is then progressively built into the electron density, refined against the
data that generates the map.

Up to this point, structural analogs of Ric-8A have been very resistant to crystallization, possibly
due to highly dynamic motions of these proteins sampling multiple conformations in solution. In
this chapter, I will describe an atomic-resolution crystal structure of phospho-Ric-8A 1-452
(pR452) and our endeavor to solve the structure. This protein retains the two (of five) CKII
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phosphorylation sites that are critical for GEF stimulation. (3) We show that R452 retains partial
GEF activity that is stimulated by phosphorylation and forms a stable complex with Gαi1. The
crystal structure of pR452, in conjunction with the results of earlier HDX-MS experiments, small
angle X-ray scattering (SAXS) data and evolutionary conservation analysis, provides insight into
the mechanism of Gαi1 binding, and the global structural consequences of phosphorylation.
Practically, the structure will serve as a useful tool for further structural studies on Ric-8
homologs, as well as the more sought-after Ric-8:Gα complexes, by aiding construct design and
providing a homology model for molecular replacement.
3.1.1 Limited Trypsinolysis Suggests a Stable Core of Ric-8A
To approach the problem of protein crystallization, a common practice is making truncation
mutants of the full-length protein in the hope that a stable “core” motif or domain, which
contains fewer flexible regions, will be an easier target for crystal packing and ultimately form
protein crystals suitable for X-ray diffraction experiments. As described in the limited
proteolysis study in Thomas 2011(42), a large portion of full-length rat Ric-8A (1-530)
expressed in E. coli appears to be quite resistant to trypsinolysis. (Figure 3-2A, B) In light of
that finding, multiple N- and C-terminal truncations mutants (1-491, 1-452, 1-425, 1-401, 1-373,
12-491, 38-491) were generated and their GEF activity assayed. (Figure 3-2C, D, E) The assay
results suggest that both the N- and C-termini of Ric-8A participate in its GEF function towards
Gαi1. On the N-terminus, residues N-terminal to residue 38 are needed; on the C-terminus, a
peptide stretch composed of the last 40 residues contains a possible auto-inhibitory domain,
which upon removal elevates the GEF activity beyond that of the full-length WT protein; the
region between residues 425 to 491 appears to contain another important domain or motif. (42)
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In chapter II of this dissertation, we confirmed that this region indeed contains a crucial Gαi1
interactive site, 454-470.
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Figure 3-2 GEF activity of purified Ric-8A fragments defined by limited trypsinolysis and
secondary structure analysis

(A) Coomassie-stained SDS-PAGE analysis of Ric-8A after trypsinization for the times
indicated below each lane; unique fragments are identified by colored asterisks. (B)
Electrospray mass spectrometric analysis of Ric-8A tryptic digest fragments extracted from
the SDS-PAGE gel shown in panel A; peaks identified by asterisks refer to corresponding
bands shown in panel A. Fragment masses (Da) are indicated at each peak position. (C)
Amino acid sequence of rat Ric-8A; cylinders indicate helical segments predicted using
JPRED. Residue codes colored red indicate sites of proteolytic cleavage (see panel A).
Residue codes in green indicate N- or C-termini of recombinant Ric-8A fragments engineered
to coincide approximately with proteolytic sites or predicted secondary structure boundaries:
ΔC492 denotes the Ric-8A fragment comprising residues 1–492. Both N-terminal truncations
ΔN12 and ΔN38 were also C-terminally truncated at residue 492 and comprised residues 12–
492 and 38–492, respectively. (D) Kinetics of intrinsic (open symbols) or Ric-8A-stimulated
(filled symbols) GDP release (squares) from, or GTPγS binding to (circles) myristoylated
Gαi1 were determined by a filter binding assay using radiolabeled nucleotides. Upper left
panel, Gαi1 (200 nM) nucleotide binding and release in the presence of full-length Ric-8A
(200 nM); lower left panel, ΔC492Ric-8A (200 nM); upper right panel, ΔC453Ric-8A (200
nM); lower right panel, Gαi1 alone. Data for each panel are normalized to maximum GDP
released or GTPγS bound in a single experiment. Data points represent the average of three
experiments; standard deviation from the mean is <10%. Time course of GTPγS binding in
the absence of Ric-8A, shown at lower right, is replicated in the other panels for comparison.
(E) Histogram showing relative rates of Gαi1 GDP release (red bars) and GTPγS binding
(blue bars) catalyzed by Ric-8A and Ric-8A truncation mutants (200 nM). Error bars
represent +/- one standard deviation of the apparent first-order rate constants determined in
three replicates. (42)
Based on this 2011 study, it is safe to conclude that Ric-8A 1-491(R491), and Ric-8A 1-425
(R425) are the smallest continuous fragments of Ric-8A that retain full, and minimal GEF
activity, respectively. R425 was also identified by limited proteolysis as a unique fragment and
remained undigested after 30 minutes, (Figure 3-2A) it is likely the “core” fragment of Ric-8A
that still contains residues required for interaction with Gαi1. We started our crystal screens
using R491 and moved to the shorter constructs, R470, R452, R425, and R401, without prior
knowledge about the GEF/chaperon-activating phosphorylation of Ric-8A by CKII. After we
had obtained small crystals for R452, which happens to still contain the two important CKII
phosphorylation sites out of five sites, we were informed of the activating effects by
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phosphorylation. We proceeded to perform the kinase reaction as described(1) and were able to
significantly improve the size and quality of Ric-8A crystals by replacing R452 with pR452.
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3.2 Results & Discussion
3.2.1 Protein Expression and Purification
3.2.1.a Ric-8A 491, 470, 452, 425, 401 Expressed and Purified to High Homogeneity

His-tagged constructs of R491, R470, R452, R425, and R401 in pET28a vector all expressed
large quantities (>100 mg/Liter of cells) in BL21 DE3 RIPL E. coli using protocol described in
the method section of this chapter. Purification of R470, R452, and R425 were straightforward
using the existing R491 purification protocol with minor adjustments to accommodate less stable
truncation mutants such as R452. Typical yield at the end of anion exchange step of the
purification, where the samples are more than 95% homogeneous, was about 50 mg TEVdigested, purified, monomeric recombinant protein per liter of E. coli cells. All anion exchange
column-purified samples could be flash-frozen in liquid nitrogen and stored in -80 oC for long
term. For the purpose of functional assays or protein crystallization, flash-frozen aliquots of
protein samples were quickly thawed at room temperature and passed through a size-exclusion
column for effective buffer exchange and re-purification to segregate possible oligomeric species
from monomers.
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Figure 3-3 Gel-filtration chromatograms showing R401 dimerization
R425(blue), R401(red), R401 monomer(green) and R401 dimer(purple) were resolved using a
Superdex 200 size-exclusion column. Sample eluted at ~16.2mL and ~14.4mL corresponded to
approximately Ric-8A 401 or 425 monomers and dimers, respectively.

One interesting exception was R401, the shortest Ric-8A truncation construct I used for protein
crystallization screens. A large percentage of the protein sample appeared to dimerize judged by
SEC (Figure 3-3). The R401 dimerization interaction also appeared resistant to SDS
denaturation (Figure 3-4). We speculate that due to the C-terminal truncation, a large portion
(>75%) of the R401 protein preparation became mildly misfolded with part of Ric-8A
hydrophobic core exposed to solvent, forming hydrophobic interactions between two monomers.
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Figure 3-4 SDS-resistant R401 dimerization
(A) SDS-PAGE of R401 samples at different
stages of purification, samples were mixed 1:1
with 2X SDS-PAGE sample buffer without
heating. (B) Same set of samples boiled for 1 min
in SDS-PAGE sample buffer.
Lane# and the corresponding samples ID:
1. R401 IMAC elution (over-night in cold)
2. R401 IMAC elution (dialyzed and TEV
digested)
3. R401 2nd IMAC resins (post-TEV)
4. R401 2nd IMAC flow-through (post-TEV)
5. R401 Q-column flow-through
6. Ladder
7-10. R401 Q-column fractions

3.2.1.b Lower Yield Obtained for Seleno-Methionine R452

To obtain important phase information for Ric-8A, which has no suitable homology model in the
protein data bank (PDB) for molecular replacement (MR), multiple attempts with different
expression, purification, and post-translational modification methods were made towards
crystallizing a seleno-methionine derivative of R452 (SR452). SR452 was purified similarly to
R452 and the increase in mass due to heavy-atom incorporation was qualitatively confirmed by
Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOFMS) (Bruker), however, the extent of heavy-atom incorporation was never quantitatively
assessed by liquid chromatography Time of Flight Mass Spectrometry (LC-TOF-MS). It was
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expected that by following the existing protocol we should generate pure (>99%) selenomethionylated recombinant protein because the methiono-auxotrophic E. coli cells could only
synthesize protein using the supplemented seleno-methionine. Possible contamination of nonauxotrophic competent cells during cell growth was controlled by adding nitrofurantoin into the
growth media since the T7 Express Crystal competent cells confer resistance to nitrofurantoin
(Nit+) intrinsically. The final protein yield from each liter of cells (~5 mg) was routinely lower
than that of R452 due to several factors including the use of minimal growth media and an early
termination of the post-induction/expression phase, which caused lower cell mass and lower
protein yield/cell, respectively. Nevertheless, sufficient quantity of sample was obtained for
protein crystallization trials. Flash-freezing Q-column purified SR452 caused large (>50%)
sample loss after thawing therefore was not recommended.
3.2.2 Quality Assessment of the Extent of R452 Modification by in vitro CK II
Phosphorylation
It was crucial to confirm the extent of CK-II phosphorylation on Ric-8A. We approach the
problem through multiple different methods including high-resolution anion exchange
chromatography, mass-spectrometry, and a customized SDS-PAGE method.
Using a high-resolution anion exchanger, Source 15Q from GE Healthcare, we were able to
distinguish phosphorylated and unmodified Ric-8A. The more negatively charged pR452
routinely elutes at higher NaCl concentration than R452, therefore, the anion exchange column
run accomplishes both an analysis of protein phosphorylation status and a purification step to
separate pR452 from other contaminants in the CK-II reaction. Mass analysis of R452 and
pR452 showed an increase in mass of 160 Da upon treatment with CKII, consistent with
phosphorylation at residues S435 and S440. (Figure 3-5) These are the only two CKII
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phosphorylation sites within the amino acid sequence range of R452 that are shared with the
intact protein. (3)

Figure 3-5 LC-TOF-MS spectra of R452 and pR452 showed an increase in mass of 160 Da

upon treatment with CKII.

75

Figure 3-6 Phos-Tag SDS-PAGE results
(Left), samples run on a pre-cast Phos-Tag gel showing very
mild retardation of phosphorylated proteins, pR530 and
pR452, compared to their unmodified counterparts, R530 and
R452, respectively. (Bottom), published results from Tall
lab showing large mobility shifts caused by CKII
phosphorylation. (3)

According to recent publication regarding Ric-8A phosphorylation (3), there was another useful,
commercially available tool to assess the extent of protein phosphorylation, the Phos-Tag series
of products. In 2002, Prof. Koike's group (Hiroshima University) reported that a di-nuclear metal
complex (i.e., 1,3-bis[bis(pyridin-2-ylmethyl) amino]propan-2-olato dizinc(II) complex) acts as a
selective phosphate-binding tag molecule. The molecule is incorporated into biochemical
methods for analysis and isolation of phosphorylated proteins (51). We performed Phos-Tag
SDS-PAGE analysis on R452 and pR452 using precast gels purchased from Wako Incorporated.
The results were not as satisfying as we expected. (Figure 3-6) The retardation of
phosphorylated protein by the Phos-Tag reagent is very mild compared to what was reported. (3)
Apparently Tall’s group purchases the Phos-Tag reagent and poured their own gel for their SDS76

PAGE analyses. By doing that, they effectively stacked the protein samples during the stacking
phase without Phos-Tag; Phos-Tag only came into effect during the resolving phase. They also
heated their samples prior to experiments and ran the SDS-PAGE at a lower voltage for longer
time in a modified SDS-PAGE running buffer(3). We will attempt to use Tall’s method in the
future because the Phos-Tag SDS-PAGE provides a quick and qualitative way to assess protein
phosphorylation states during protein purification.
3.2.3 R452 Is a Viable GEF for Gαi1:GDP and Dual Phosphorylation Increases Its Potency
3.2.3.a Tryptophan Fluorescence Assays Showed Increased GEF Activity upon CK II Phosphorylation of
R452 and R491

Using the “GTP-binding” tryptophan fluorescence assay method detailed in Chapter II, we
examined the effect of in vitro phosphorylation on the GEF activity of R452. While being stirred
in a quartz cuvette, 1 μM mGαi1 was pre-incubated with Ric-8A (8µM, 4 µM, 2 µM, 1 µM, 0.5
µM, and 0 µM) for 5 minutes at room temperature before the addition of 10 μM GTPγS. The
intrinsic tryptophan fluorescence change was monitored, and the initial rate of nucleotide binding
calculated and plotted on an initial rate vs. [Ric-8A] plot. (Figure 3-6)
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Figure 3-6 GEF-concentration-dependent functional assays using tryptophan fluorescence
method to assess the effect of R452 phosphorylation. 1 μM mGαi1 was pre-incubated with Ric-8A
(8µM, 4 µM, 2 µM, 1 µM, 0.5 µM, and 0 µM) for 5 minutes at room temperature before the addition
of 10 μM GTPγS to start the reaction. The 8µM Ric-8A concentration time course was not measured
for full-length Ric-8A (R530). (Left), comparison among full-length Ric-8A, R452, and pR452.
(Right), comparison between R452 and pR452. Error bars represent the standard deviation among
three replicates.

At low Ric-8A concentration, the difference between the GEF activities of pR452 and R452 was
not significant, possibly due to the very low basal GEF activity of R452 compared to R491 or
full-length Ric-8A. At high Ric-8A concentrations, we started to notice marked elevation of
GEF activity caused by protein phosphorylation. R452 was a weak but still viable GEF for
Gαi1; the reduction in its GEF activity compared to the longer constructs could be due to the
absence of the crucial C-terminal Gαi1 interactive site(s) we characterized in Chapter II. At high
GEF concentrations (4 µM and 8 µM), the Ric-8A concentrations could be equivalent to or
above the KD of Gαi1:GDP for R452 or pR452, therefore, the effect of the phosphorylation on
elevating GEF activity becomes more apparent at those GEF concentrations.
3.2.3.b C-terminus of Gαi1 Inhibits GEF activity of pR452 toward Intact Gαi1

Thomas et al. 2011 demonstrated that a C-terminal peptide of Gαi1 binds to Ric-8A 1-491 and
inhibits the GEF activity of Ric-8A on full-length Gαi1, therefore, the peptide could represent
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the most intimate Ric-8A contact region on Gαi1(42). We then asked whether pR452 interacts
with Gαi1 by recognizing the C-terminus of Gαi1, similar to previous observation with R491. If
so, it was conceivable that R452 harbors at least part of the Gαi1 C-terminal recognition site,
therefore, could still be a viable Ric-8A molecule to study Ric-8A: Gαi1 interaction. To answer
the question, we incorporated a synthetic C-terminal peptide of Gαi1 into the GTPγS binding
assay.

Figure 3-7 Competitive inhibition of the GEF activity of Ric-8A constructs by 100 μM C18M1
peptide

Initial rates of GTPγS binding were presented as multiples of intrinsic rate. 100μM of
C18M1 peptide or equal volume of water (negative control) was pre-incubated with 1µM
R491 or 8µM pR452 for 1 hour . 1μM mGαi1:GDP were added and allowed to equilibrate
for 5 minutes before the addition of 10μM GTPγS to start the reaction. Error bars represent
the standard deviation among three replicates.
When a modified version of the Gαi1 C-terminal peptide (see section 3.3.3 for peptide details),
C18M1, is incorporated into the assay for R491, I saw similar inhibitory effect on the GEF
activity as previously seen(42). Interestingly, I also saw significant inhibition of the GEF
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activity of 8µM of pR452 on 1µM mGαi1 by 100µM C18M1. This indicates that the C-terminus
of Gαi1 could bind to the first 452 residues of Ric-8A, therefore, at least one important proteinprotein interaction surface was preserved in the R452 truncation mutant. (Figure 3-7)
3.2.3.c Steady-State GTPase Assay Showed Increased GEF Activity upon CK II Phosphorylation of R452

As an alternative and more sensitive approach to decipher the difference between R452 and
pR452 in their GEF activities towards Gαi1, we used a steady-state GTPase assay that measured
GTP hydrolysis rate of Gαi1 by counting 32P-labelled inorganic phosphate generated over time in
solution. The method was well-established and most recently used to assay the change in GEF
activity of Ric-8A towards Gαq(3). We adopted the assay for our system of Gαi1 and Ric-8A
and made some modifications.

Using radio-labelled GTP as a substrate, the steady-state GTPase assay provided a more sensitive
way to assess the effect of phosphorylation on Ric-8A. A few important factors needed to be
considered before interpreting the steady-state GTPase assay result. At the assay temperature
(30oC), the intrinsic, single-turnover GTP catalysis rate of Gαi1 was on the order of 2-3 min -1,
therefore, I expected the nucleotide exchange reaction to be the rate-limiting step even at high
R452 or pR452 concentrations (>5 µM) based on the information from the tryptophan
fluorescence GTPγS binding assay. On the contrary, for the full-length Ric-8A, I expected to see
maximum steady-state GTPase rate at comparatively low GEF concentrations (<4µM) because
the apparent nucleotide exchange rate was higher than the GTPase rate, making GTP hydrolysis
rate-limiting instead. (Figure 3-6)
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R452 and pR452 behaved as expected, showing elevated GTP hydrolysis rates due to CK-II
phosphorylation; however, to my surprise, the assay did not reach a plateau of maximum GTP
hydrolysis rate as I expected for even the highest concentration of R530 (10µM). More
surprisingly, pR530 did not show the typical concentration dependent behavior as the other
species; instead, I observed apparent inhibitory activity at high concentrations of pR530 (>2µM).
(Figure 3-8 top) This result was in contradiction with what was published for the effect of
phosphorylation on the Ric-8A, Gαq interaction. (3) With that said, Gαq was not only a different
Ric-8A-interacting Gα subunit but also an excellent target for the steady-state GTPase assaying
method due to its low maximum intrinsic GTPase rate (~0.1 min -1, compared to the ~2 min-1 for
Gαi1). As a result, plateaus in GTP hydrolysis rate were easily reached with sub-µM Ric-8A,
therefore, Ric-8A concentrations higher than 2µM were not needed.

To see whether the C-terminus of Gαi1 has an effect on Ric-8A:Gαi1 interaction, I also
preincubated 50µM of C18M1 peptide or water control with 10µM Ric-8A on ice for an hour
prior to performing the assay. The 50µM peptide showed modest inhibitory effects on the
unmodified Ric-8A constructs, however, did not show any significant inhibition on pR452 or
pR530, if not slightly activating the GTPase. (Figure 3-8 bottom)

Some of the results I present here might seem inconsistent or even contradictory to the
tryptophan fluorescence assay result in section 3.2.3.a and section 3.2.3.b. I would like to argue
that the steady-state GTPase assay was a different assay than either version (“GTP-binding” or
“nucleotide exchange”) of the tryptophan fluorescence GTPγS-binding assay. The tryptophan
fluorescence GTPγS-binding assay only measured the binding of nucleotide while the hydrolysis
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assay measured both GTP binding and hydrolysis, therefore, the results of the GTPase assay
included more aspects of the system being studied here. For instance, high concentrations of
pR530 could possibly function to inhibit the GTPase activity of Gαi1; a GTPγS binding assay
with unhydrolyzable nucleotide could not test for that while the steady-state GTPase assay could.
More importantly, the “GTP-binding” tryptophan fluorescence assays involved a 5-minute
incubation of the nucleotide-free, Ric-8A:Gαi1 complex in the absence of GTPγS. As suggested
earlier, Gαi1[ ] in the GEF:G-protein complex is in a dynamic, molten globule-like state (23, 42);
such state did not exist for a prolong period during the time course of the steady-state GTPase
assays because GTP was always present to dissociate the complex immediately after formation.
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Figure 3-8 Steady-State GTPase Assay

1µM mGαi1:GDP was added to different concentrations (10µM, 5 µM, 2.5 µM, 1.25 µM,
0.625 µM, 0.3125 µM, 0 µM) of different Ric-8A’s (R452, pR452, R530, pR530) and 30µM
GTP (doped with γ32P-GTP to >1000cpm/pmol GTP) to reach a 20µL final reaction volume
in assay buffer (50mM HEPES, pH 8.0, 100mM NaCl, 1mM EDTA, 1mM TCEP, and
10mM MgCl2). All reactions were allowed to proceed for 5 minutes and quenched with
180µL of cold 1 M NaH2PO4 pH 4.0. (Top) [GEF]-dependent assay results showing the
difference among R452, pR452, R530, and pR530. (Bottom) Incorporating 50 μM C18M1
peptide into the highest [GEF] (10 µM) data points to see competitive inhibition of Ric-8A
GEF activity by Gαi1 C-terminus. Error bars represent the standard deviation among three
replicates.
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3.2.4 CKII Phosphorylation Mildly Increases Gαi1 Binding Affinity towards Ric-8A
Surface Plasmon Resonance (SPR) is a powerful tool to measure protein-protein interactions in
real-time without labelling protein samples with fluorophores; the required sample
concentrations are also several orders of magnitude lower than needed for conventional methods
such as ITC. During an SPR experiment, one of the interactants (ligand) is immobilized to a
sensor surface, the other (analyte) is free in solution and passes over the ligand-occupied surface.
When the analyte binds the ligand, an increase in mass can be reflected on change in SPR and
detected by instruments, such as BiaCore system (GE Healthcare). For detailed physical theory
of SPR, please refer to this video clip from https://youtu.be/o8d46ueAwXI, which explains the
BiaCore SPR system interactively and concisely. More technical details can be found in the
handbooks from GE.(81)

The default BiaCore X100 analysis program (GE Healthcare) fits the experimental data using a
simple 1:1 kinetics binding model by default. The model fits all data curves generated from
different analyte concentrations globally for each data set. For a simple 1:1 binding system such
as an antigen to an antibody, the default kinetics model describes the system well; however,
when using Ric-8A as the ligand and Gαi1:GDP as the analyte, the system is more complex than
a simple 1:1 binding interaction. After Gαi1:GDP binds the anchored Ric-8A, Gαi1:GDP
undergoes a conformational change to release GDP, therefore, the identity of the analyte
(Gαi1:GDP) changes (to nucleotide-free Gαi1) as ligand-binding occurs while the model
assumes otherwise. Regardless, fitting the Gαi1, Ric-8A binding curves with the 1:1 model
(Figure 3-9) still yielded a reasonable estimation of the “on” and “off” rates, which describe the
rate at which Gαi1:GDP binds to Ric-8A and Gαi1 dissociates from the complex, respectively
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(Table 3-1). For the four different types of Ric-8A anchored on the Ni-NTA chip, Gαi1:GDP
appeared to bind at similar rates (2610 to 3300 M-1*sec-1). Phosphorylation did not significantly
affect the “on” rate of Gαi1:GDP to either R452 or R491. The dissociation curves, on the other
hand, suggested an apparently slower dissociation rate (8.94*10 -5 sec-1) of Gαi1 from the
pR491:Gαi1 complex compared to that from R491:Gαi1 (3.08*10 -4 sec-1). R452:Gαi1
dissociated slightly faster (1.52*10-4 sec-1) than pR452:Gαi1 (1.13*10-4 sec-1). Although these
observations agreed with the notion that phospho-Ric-8A binds Gαi1 more tightly, therefore is a
better GEF and folding chaperone for Gαi1, these koff values did not represent the real
dissociation rates of unexchanged Gαi1:GDP from an intermediate Ric-8A:Gαi1:GDP ternary
complex. Furthermore, the koff values were all slower than the k off confidence limit (10-4 sec-1) of
the BiaCore X100 fitting program (86), therefore, the differences among them are not necessarily
as significant as they appear (i.e. a 4-fold difference between k off values is not reliably for rates
slower than 10-4 sec-1). The same logic applies to the dissociation constants (KD = koff/kon)
calculated from the kon and koff values.

Table 3-1 BiaCore parameters describing the kinetics of Gαi1 binding to Ric-8A
All kinetics curves within a data set are fitted globally using a 1:1 binding model to generate
a single kon, koff, KD, Rmax and the standard error (SE) for each parameter, as well as a χ2
value, a measure of the average deviation of the experimental data from the fitted curve. See
Materials and Methods for an explanation of each parameter.
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Figure 3-9 BiaCore results showing change in Gαi1 binding affinity to different Ric-8A

All experiments were carried out at room temperature under a constant flow rate (30µL/min).
For each of R452 (A), pR452 (B), R491 (C), and pR491 (D), 2.5µM, 1.25µM, and 0.625µM
of Gαi1 W258A were applied for 3 minutes for the “on” phase, followed by a 6-minute wash
with buffer, thereby completing the “off” phase.
The small χ2-values of each fit indicated that the 1:1 binding model describes all four Gαi1, Ric8A interactions reasonably accurately.
𝑟 −𝑟
𝜒 =

𝑛−𝑝

where rf is the fitted value at a given point, rx is the experimental value at the same point, n is the
number of data points, and p is the number of fitted parameters (86).
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3.2.5 R452 Is the Longest Ric-8A Truncation Mutant Crystallized
3.2.5.a R452 and R425 Crystallized Whereas R491, R470 and R401 Did Not

Seeing some phase-separations but no crystal formation up to a month for R491, we turned to Cterminally truncated constructs of Ric-8A. Constructs including R452, R425, and R401 were
already available from a previous study (42); R470 was made by simply mutating residue 471 to
a stop-codon using the site-directed mutagenesis method discussed in Chapter II. R470 did not
crystallize either.

Figure 3-10 Photos of crystals of Ric-8A 1-452

(A), R452 crystallized in initial condition screen, R425 produces needle-shaped crystals of
similar morphology. (B), phosphorylation of R452 improves size of the crystals. (C), 10
mg/mL of pR452 forms thicker 2D needle crystals. (D), 25mg/mL of pR452 forms 3-D rods
at protein-to-reservoir volume ratio = 3:1. (E), 20mg/mL pR452 forms larger rods in an inhouse buffer screening block. (F), 20mg/mL pR452 forms crystals suitable for sulfur-SAD
data collection. All photos of crystals were taken using a light microscope (Olympus).
We saw needle-shaped crystals forming for R452 in the initial screen, more specifically, PEGs-II
suite from Qiagen. (Figure 3-10) After seeing that R452 crystallizes, R425 and R401 were tested
87

against the same crystallization condition as R452; R425 crystallized but R401 did not,
suggesting that R425 might be the shortest construct available to retain packing interactions
under the particular crystallization condition. As discussed in section 3.2.1, R401 appeared to be
in equilibrium between monomer and a stable homo-dimeric species which could be dissociated
by boiling in SDS-PAGE sample buffer for 1 minute, suggesting exposure of hydrophobic core
regions due to the C-terminal truncation. (Figure 3-4) The R401 dimer formed also might not
have the same interactions between the two pR452 molecules in the asymmetric unit described in
the following sections regarding pR452 crystal structure. The GEF activities of both R425 and
R401 (monomer) were assayed and compared to R452 and R491; R425 appeared to be the
shortest Ric-8A construct that retains minimal GEF activity towards Gαi1. (Figure 3-11)
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Figure 3-11 GEF activity of Ric-8A truncation mutants on mGαi1 presented in initial rates of

GTPγS binding (µM/min). Similar to the “nucleotide exchange” tryptophan fluorescence
assay described in Chapter II, 2µM Ric-8A and 20µM GTPγS were added to 2µM mGαi1 to
start the reaction.

3.2.5.b R452 and pR452 Crystallization Conditions were Optimized

Purified R452 or pR452 at 20mg/mL crystallized in 0.2M Li 2SO4, 0.1M common buffers with
good buffering capacity from pH7 to pH9 (Tris, HEPES, MES, EPPS, etc.), 20% to 30%
polyethylene glycol 3350 (PEG3350). Visible needle crystals were observed 72-hours after plate
set-up and they reached maximum sizes after a week in a 20 oC incubator. Crystal sizes were
optimized for both R452 and pR452 up to 30X10X5 μm 3 plates and 500X50X20 μm3 plates,
respectively, by varying the initial protein-to-reservoir liquor volume ratio. The biggest and
best-quality pR452 crystals, from which the merged SAD data set was collected, were grown in a
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Figure 3-12 Efforts made to improve pR452 protein homogeneity

(Left), SDS-PAGE result showing anion-exchange chromatography-purified Ric-8A 1-452
C329S mutant fractions (Lane 1-5), pRK793 TEV efficiency test (Lane 8-10) showing more
protease-digested product with increased protease dosage. (Right), native-PAGE results
showing the effect of C329S mutation on sample homogeneity of phospho-Ric-8A 1-452
construct. Lane 1 and 2: Q-column purified WT and C329S Ric-8A, respectively; Lane 3
and 4: Size-exclusion column purified WT and C3289S Ric-8A, respectively; Lane 5: BioRad gel-filtration standard; Samples were resolved in the absence of reducing agent (lane 15) and duplicated in 1mM TCEP (lane 6-10)
3:1 = protein: precipitant ratio. (Figure 3-10) The crystallization condition and parameters for
optimal crystal growth were still unclear. Based on my experience, big crystals with shapes and
sizes similar to the largest crystals grew in sporadic conditions (type of buffer, pH, %PEG3350,
incubation temperature, etc.) with large variations; there was no obvious trend for crystal
optimization for either R452 or pR452 within the range of conditions mentioned above. To
approach optimizing the crystals size and quality, a buffer screen block was made to randomly
sample conditions within a confined pH and precipitant concentration range (0.1M buffer pH 7
to pH 8.5, 0.2M Li2SO4, 25% to 30% PEG3350) and the following buffers were tested: Bicine,
Bis-Tris-Propane, EPPS, HEPES, TAPS, TES, Tricine, Tris.
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As part of extra effort to improve the quality of the crystals, we purchased a new TEV protease
expression plasmid (pRK793) for expressing TEV protease and we created a mutant Ric-8A 1452 construct (C329S). Our old TEV protease bound to anion-exchange columns and co-eluted
with Ric-8A. It also formed a ~50 kDa dimer so it eluted at almost the same elution volume as
R452 on a size-exclusion column. The new TEV protease cleaved the 6x His-tag with similar
efficacy (Figure 3-12) and was easier to remove from Ric-8A because it did not bind to anionexchange column. We mutated C329 to a serine because it is the only rat Ric-8A cysteine not
conserved in human Ric-8A. Based on a previous conversation with Celestine Thomas, SDSPAGE analysis of human Ric-8A does not show double bands as does rat Ric-8A. Therefore, we
suspected that C329 is responsible for Ric-8A sample heterogeneity by forming intramolecular
disulfide bonds. The C329S mutant expressed and purified similarly to the WT R452 and
showed a higher level of sample homogeneity on a native-PAGE (Figure3-12). The C329S
mutant crystallized under the same conditions as the wild type protein but crystal quality was
comparatively improved in the absence of the reducing agent, tris(2-carboxyethyl)phosphine
(TCEP), which was present in 1mM concentration in the WT crystallization condition,
suggesting possible crystal packing-disturbing disulfide linkages or conformational heterogeneity
within the WT protein sample due to the disulfide-linked cysteines. The mutant phospho-Ric-8A
452 construct (C329S) crystallized under the same condition as the WT pR452 and followed the
same pattern in terms of its preference for reducing agents as the non-phosphorylated C329S
mutant. However, no further improvement in either the size or quality of crystals was observed
for the phosphorylated R452 C329S or the seleno-methionine derivative (pSR452 C329S).
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3.2.5.c Seleno-Methionine R452 Crystallized but Was Not Optimized

The derivatized protein (SR452) crystallized in similar conditions as native protein, however, the
size and diffraction quality were inferior compared to native protein. To improve crystal size
and quality, phosphorylation of SR452 produced phospho-SR452 (pSR452) as judged by anion
exchange chromatography but the protein did not crystallize at all under similar conditions as
pR452. Initial condition screening of pSR452 was also fruitless.

Although the crystals of SR452 were small, we still hoped to collect low-resolution data sets to
obtain phasing information using multi-wavelength anomalous dispersion (MAD) or singlewavelength anomalous dispersion (SAD) methods. However, the available SR452 crystals did
not diffract at all at SSRL BL12-2 or NSLS-II FMX possibly due to the small size or inferior
quality of these crystals.
3.2.6 Experimental Phasing Using Extrinsic Heavy-Atoms Soaking Methods Was Not
Promising
Unfortunately for phasing experiments, phosphorylation of the seleno-methionine derivative not
only failed to improve crystal quality as it did for native R452, pSR452 did not crystallize at all
under similar conditions, possibly due to oxidation of surface seleno-methionine residues, which
could introduce sample heterogeneity. Soaking pR452 crystals with numerous heavy atoms
(iodine, lead, platinum, mercury, gold, xenon, bromine) and heavy atom-containing compounds
yielded little success in crystal derivatization. 5-Amino-2,4,6-triiodoisophthalic acid (I3C), a
compound that contains three iodine atoms, produced derivatized crystals of marginally
acceptable quality for x-ray diffraction experiments and a noticeable anomalous signal for single-
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wavelength anomalous dispersion (SAD) phasing. (50) Due to the nature of the I3C compound,
which not only binds with relatively low affinity to the surface of protein and is also sensitive to
X-ray radiation damage, more careful soaking experiments need to be conducted and data
collection strategies adjusted to improve the heavy atom incorporation and anomalous signal,
respectively, which ultimately translate to phasing power of these I3C derivatives. Cocrystallization with I3C produced deformed crystal-like protein aggregates, which are certainly
not suitable for X-ray diffraction experiments.
3.2.7 Decision and Strategy to Use Sulfur SAD Phasing
To get from the diffraction data to a model of the actual protein structure, we were left with few options
to obtain phase information for the pR452 data sets. Before I describe our final decision of phasing
method used, I would like to briefly introduce the theory of X-ray diffraction and anomalous signal with
information from the text book “Biomolecular Crystallography”(46) and “Structure Determination by XRay Crystallography” (113).

In an X-ray diffraction experiment, we measure the intensities (I) and the positions of spots (or
reflections) that are recorded on the detector. From the position of a reflection we can determine its Miller
indices (h,k,l) in reciprocal space and assign the intensity to it. This intensity is proportional to the square
of the structure factor amplitude, |Fhkl|. Fhkl is the vector sum of waves from all atoms within the unit cell,
defined as

𝐅

= 𝐹

𝑒

=∑

𝑓𝑒

(

)
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(11)

where the sum is over all atoms in the unit cell, h, k, l are the Miller indices of the structure
factor, xj, yj, zj are the positional coordinates of the jth atom, fj is the scattering factor of the jth
atom, and αhkl is the phase of the diffracted X-ray in the direction h, k, l.
The complex exponential function is periodic, and with the above parameters it is limited
between -1,1 for its real part and -i, i for the imaginary part. In such cases of periodic functions,
we can apply a Fourier transformation (FT) and we obtain for our formula (equation 11) the
following FT:

𝜌

=

∑ ∑ ∑ |𝐹

|𝑒

(

)

(12)

where V = volume of the unit cell. In order to perform the FT, we need the complex structure
factors Fhkl but we only measure the magnitude |Fhkl|. In terms of physics, this means that we
know only the absolute value of the complex vector Fhkl but not its phase, αhkl. To obtain phase
information without a suitable homology model for molecular replacement, anomalous scattering
from heavy atoms can be exploited. Briefly, Friedel's Law (named after Georges Friedel) states
that a reflection, Fhkl and the inverse, F-h-k-l have the same magnitude and inverse phases:

|𝐹

| = |𝐹

𝜑

= −𝜑

|

(13)
(14)

Symmetry-related reflections are called Friedel pairs. When the incident photons with
wavelength near the absorption edge of an atom hit the atom, some photons are absorbed and
immediately re-emitted at the same energy. The scattered photon gains an imaginary component
to its phase and we observe anomalous scattering. Anomalous scattering causes small but
measurable differences in intensity of the Friedel pairs, Fhkl and F-h-k-l, differences that are
normally absent, thereby breaking Friedel's Law. (Figure 3-13)
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Figure 3-13 Breaking Friedel's Law
On an Argand diagram, Fhkl and F-h-k-l appear to be reflected across the real axis for any crystal in the
absence of anomalous scattering (left). If all atoms scatter equally, then the amplitudes remain equal,
(Equation 13) but the phase relationship no longer holds (Equation 14) because the f'' (red arrows)
imaginary term is always positive (middle). If some atoms scatter anomalously and some do not,
then both the amplitude, f’ (blue arrows), and phase, f” (red arrows), relationships are broken, and we
are able to measure the differences between Fhkl and F-h-k-l(right). (46)

The scattering factor, f, in equation (11) becomes complex:

𝑓 = 𝑓 + 𝑓 + 𝑖𝑓"

(15)

where fo = normal scattering factor, f’ = real anomalous correction factor, and f” = imaginary
anomalous correction factor.
The structure factor equations for the Friedel pairs, Fhkl and F-h-k-l, then become:

𝐹

= (𝑓0 + 𝑓′ + 𝑖𝑓")𝑒

(

= (𝑓0 + 𝑓′ + 𝑖𝑓")𝑒

(

)

(16)

and

𝐹

)

(17)

Bijvoet pairs are the pairs of symmetry-related intensities and their inversion-related intensities.
For example, if the unit cell has a two-fold symmetry axis along the b axis, hkl = -hk-l, and

(18)
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Each hkl has true symmetry equivalents. These true symmetry equivalents of a Bragg reflection
have equal amplitude even in the presence of anomalous scattering. True symmetry equivalents
of one member of a Friedel pair form a set, all of whose members have the same amplitude |F +|;
while all symmetry equivalents of the inverse member of the Friedel pair form a second set,
whose members share a different amplitude |F-|. For crystals with significant anomalous
scattering, the Bijvoet difference, the difference in the measured amplitude for a Bijvoet pair is
detectable.

(19)
Several comprehensive reviews written in the past few years have addressed major issues in
sulfur-SAD phasing experiments at the level of both synchrotron hardware and crystallographic
software and describe methods to enhance anomalous signals by reducing the systematic errors
(5-7, 11, 15, 22, 25, 28). There is no homology model for Ric-8A for use in molecular
replacement phasing and neither seleno-methionine derivatization of Ric-8A nor heavy-atom
soaking of the pR452 crystals yielded appreciable results. Thus, we attempted to obtain phase
information using the anomalous difference arising from 9 native cysteines and 10 native
methionines, which make up 4.2% of total Ric-8A amino acids composition. The decision has
proven to be a bold yet fruitful adventure for many reasons, some more obvious than the others.
For a well-diffracting crystal, the anomalous signals from a sulfur atom within practical X-ray energy
range (6.0 keV to 14.0 keV) is comparatively much weaker (i.e. f” = 0.72e at 7.0keV) than that from
other anomalous signal-generating heavy-atoms such as selenium (i.e. f” = 3.85e at 12.7keV) or iodide
(i.e. f” = 8.53e at 7.0keV). It is especially challenging for protein crystals with modest diffraction quality
and relative low sulfur content.
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Figure 3-14 Expression used in phenix.plan_sad_experiment to calculate expected anomalous
signal
Sano is the expected useful anomalous signal and determines the chance to find a heavy-atom
substructure; CCano is the correlation of observed anomalous differences with ideal one for the
structure, therefore, determines phase accuracy and the quality of the resulting electron density map.

(15)
We analyzed the anomalous differences measurability of the R452 construct following the pipeline
method developed by Thomas Terwilliger and his colleagues. (20) The anomalous signal (Figure 3-14)
and anomalous correlation, (16)

(20)
(where Δano is the “useful” anomalous difference from the atoms that make up the target anomalous
substructure, Δobsano is the observed anomalous difference, which is just the sum of Δano and errors such as
radiation damage and “not useful” anomalous difference from other atoms)
with specific anomalous substructures can be calculated using the Phenix program,
“phenix.plan_sad_experiment”, by providing the number and type of anomalously scattering atoms, the
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X-ray source energy/wavelength, the target resolution (the number of unique reflections to be measured),
and the protein amino acid sequence for calculating anomalous contributions from oxygen, nitrogen, and
carbon atoms.(16) fB is the second moment of the values of the scattering factors,

Where factors fh,B are the anomalous scattering factors adjusted for the effects of the atomic displacement
factor B at the resolution of reflection h and are given by
(15)
For the pR452 crystals, the correlation of useful anomalous scattering from sulfur atoms to total
anomalous scattering is 0.91. At a target resolution at 3.0 Å, the anomalous signal (S ano) is at most 8 with
maxima I/σ up to 100, where the anomalous correlation is 0.55. The estimated probability of finding the
sulfur substructures is about 76%, and the estimate figure-of-merit (FOM) of phasing, the expected value
(probability-weighted average) of the cosine of the phase error, is 0.33 if all data up to 3.0 Å is used. The
probability and figure-of-merit drop to 28% and 0.27, respectively if I/σ is 100 only up to 5.0 Å. These
estimations are performed under the assumption that all 19 sulfur atoms are highly ordered, each with
100% occupancy in the crystal lattice, and the data are collected with minimal radiation damage.
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Figure 3-15. Result of running “phenix.plan_sad_experiment” for collecting sulfur SAD data
from pR452 crystals
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Based on the anomalous signal analysis, assuming the reflection data are collected accurately, and the
atomic displacement factor (B-factor or temperature factor, which accounts for the fact the atom is on
slightly different positions in each unit cell with average position x,y,z) of the sulfur atom is low, pR452
crystals will generate marginally enough anomalous signal at the highest diffraction resolution (3.0Å) we
can obtain at synchrotron sources. (Figure 3-15) Thus, we expect it to be challenging to solve the phase
problem of Ric-8A structure with sulfur SAD even if we manage to collect and merge large number of
datasets from a very reliable and precise synchrotron source.

3.2.8 Cryoprotectants and Loops Used for Crystal Harvesting Were Optimized for SAD
Data Collection
Two different cryo-protectants were used to harvest the pR452 crystals, a 20% polyethylene glycol
(PEG) 400 solution in the mother liquor and an oil-based cryo-solution, Paratone-N, which was also
suggested by Tzanko Doukov from SSRL. The oil-based cryo-protectant appeared to cause shrinking of
unit cell parameters and the degree of non-isomorphism/shrinkage vary upon the time crystals spend
soaked in oil. The crystal, which was used to collect the data set for the “oil” structure, was left in
Paratone-N overnight and cryo-frozen the next day. Crystals harvested and cryo-frozen with the 20%
PEG-400 cryo-protectant were largely isomorphous with differences in cell parameters within 0.1%
among the collected data sets, therefore, were suitable for SAD phasing experiments. The oil soaked
crystals, however, vary in their extent of crystal lattice shrinkage in a soaking time-dependent manner,
therefore were not suitable for data set merging or SAD phasing based on our experience with BLEND
and Phenix scale-and-merge.

As suggested by SSRL beamline scientist, Tzanko Doukov, it was necessary to minimize systematic error
from crystal vibrations during the data collection by using a 20μm (nylon fiber diameter) crystal
mounting loop to harvest the crystals. The thicker nylon loops effectively decreased the mechanical
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vibration caused by cryostream and improved overall quality of data sets collected from similar crystals,
eventually helping us merge data from multiple datasets. We also harvested pR452 crystals using
MiTeGen MicroLoops E loops, which have an inclined, elongated aperture especially useful for
orientating needle- or rod-shaped crystals for effective data collection. We have collected data sets from
crystals mounted with these loops at SSRL BL9-2 and BL12-2 in the past and received satisfactory results
compared to conventional loops. The pins used to mount the MiteGen microloops were not compatible
with the auto-mounting robot at FMX, therefore, crystals harvested using MiteGen loops were not
collected at NSLS-II. It is worth mentioning that the MiteGen loop has a feature for easy removal of
excess solution from crystal to reduce background scattering from liquid. When harvesting crystals using
viscous cryo-protectant such as Parabar 10312(Hampton Research, previously known as Paratone-N), this
feature significantly reduced maneuver time compared to conventional nylon loops, for which I had to
slowly blot excess cryo-protectant. With proper usage, the MiTeGen loop could prove to be more useful
in collecting data sets that require high accuracy since the rigid MiTeGen loop body provides the same
benefits a 20μm conventional loop offers in terms of reducing vibration during data collection.

3.2.9 Sulfur-SAD Data Processing and Merging
After 18 SAD data sets of pR452 were collected at NSLS-II FMX, we used two different
methods to merge those data sets. BLEND in “analysis mode” first performed multiple pair-wise
comparisons of all data sets and then groups the closely “related” data sets into several clusters
based on variation in unit cell parameters among data sets. After defining the clusters and
plotting them on a dendrogram, the most appropriate data sets to be merged were manually
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Figure 3-16 Dendrogram generated by BLEND analysis mode showing closely related clusters
of data sets from eighteen pR452 data sets

The linear cell variation (LCV) give an indication of cell similarity among all crystals
included in the specific cluster; thus, ultimately, they can be associated with isomorphism
between different data sets. The dendrogram presents two major clusters, a larger cluster with
1.35% LCV and a smaller cluster. The variability is increased to 1.52% when these two
clusters merge into the overall cluster containing all 18 data sets; this is indicative of minor
form of non-isomorphism between the small and large clusters of data sets.
chosen based on the result of the cluster analysis. (Figure 3-16) BLEND also made suggestions
for user to exclude frames that show obvious radiation damage from each data set and using
global scaling method to generate a merged data set for each sub-cluster on the dendrogram. The
program halted while merging some of the data sets for a prolonged period (>72 hours) without
writing any error message or terminating the program. Excluding the problematic data sets from
the merging task solved the issue but the resulting merged data do not contain a strong enough
anomalous signal for SHELX to determine a good substructure solution. The cause of the
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prolonged halt of BLEND programs that eventually led to the exclusion of data sets remains
unknown.

All (18-merged) or only the top 2 (2_14 and 2_10) or 3 (2_14, 2_10, and 2_7) datasets ranked by
anomalous coefficient were merged by phenix.scaled-and-merged program using the local scaling method
(Table 3-2). The highest resolution limit of these merged datasets was 3.4 or 3.0 Å where the resolution
at which the overall anomalous signals were maximal. Both BLEND and phenix.scaled-and-merged
programs remove radiation damaged frames that would degrade the anomalous signal. All 18 datasets
from 14 crystals were successfully merged by Phenix scaled-and-merged program eventually. The
resolution limit of the dataset was set at 3.4 Å where the anomalous signal was maximal.

18-merged

Top 2 merged
(2_10,2_14)

Total reflection
Unique reflections*
Redundancy*
Completeness (%)*
Mean I/ (I)*
CC1/2
Rmeas†,*

67.1 103.7 141.9
90 90 90
20.00 - 3.4
(3.72 - 3.40)
11088284 (2681047)
14109 (1980)
785.9 (803.4)
99.5 (100)
118.3 (67.1)
0.994 (1.0)
0.226 (0.373)

67.1 103.7 141.9
90 90 90
20.0 -3.00
(3.18-3.00)
5821121 (885390)
20387 (3258)
285.5 (271.8)
99.6 (99.8)
65.6 (12.7)
0.999 (0.996)
0.166 (0.787)

67.1 103.7 141.9
90 90 90
20.0 -3.00
(3.18-3.00)
6861300 (1047918)
20409 (3269)
336.2 (320.6)
99.7 (100)
70.1 (14.8)
1.000 (0.997)
0.168 (0.734)

Rp.i.m.†,*

0.008 (0.013)

0.010 (0.047)

0.009 (0.041)

CCano **

0.58

0.51

0.50

Datasets
Unit cell dimensions
a, b, c (Å)
, ,  (◦)
Resolution range (Å)*

Top 3 merged
(2_10,2_14,2_7)

Table 3-2 Statistics of merged datasets for S-SAD phasing
*

Data for highest resolution shell are given in brackets. † Rmeas=∑hkl (n/n-1)1/2∑i |Ii(hkl)-<I(hkl)>|/ ∑hkl ∑i
Ii(hkl), where Ii(hkl) is the ith observation of the intensity of the reflection hkl and <Ihkl >is the mean
over n observations. Rp.i.m.=∑hkl (1/n-1)1/2∑i |Ii(hkl)-<I(hkl)>|/ ∑hkl ∑i Ii(hkl). Correlation coefficients: CC =
∑i((xi - <x>)(yi - <y>))/(∑i((xi - <x>)2(yi - <y>)2)1/2, where xi and yi are the ith of n observations of
quantities whose mean values are <x> and <y>; for CC1/2, xi, and yi correspond to intensity
measurements derived from each of two randomly selected half-data sets from the set of unmerged
data; CCano = <ano ano,obs>/( <2ano>1/2 <2ano,obs>1/2, where ano and ano,obs are the anomalous
structure factor amplitude differences (F+ - F- ), respectively, computed from the anomalously
scattering atomic substructure, and the observed anomalous differences. CCano was calculated using
data truncated to dmin= 3.4 Å or 3.0 Å for all merged data or top 2/3 merged data, respectively.
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3.2.10 Heavy-Atom Substructure Determination
The merged and scaled data was input into the HKL2map(69), a graphical user interface (GUI) for the
SHELXC/D/E program suite. SHELXC evaluated the anomalous signal to be significant up to 3.4 Å
(Figure 3-17).

Figure 3-17 Data Analysis using SHELXC

(Top left) SHELXC setup and data input screen. Analysis of the merged data set <I/σ> (top
right), completeness (bottom left), and <d’’/σ> (bottom right) over resolution indicates
significant (d’’/σ > 1.5) anomalous signal up to 3.4Å.

< 𝑑"/𝑠𝑖𝑔 >=<

∆
∆

>

(21)

The substructure search by SHELXD, which gave the highest CCall and CCweak

(22)
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(where Eo and Ec are the observed and calculated normalized anomalous difference, respectively) and
judge the number of sites by the occupancies (fraction, from 0 to 1, of the sulfur atom occupying a realspace position x,y,z), was performed with up to 10,000 iterations (Figure 3-18). Characteristic bi-modal
distribution was observed in the CCall vs. CCweak graph. The best solution had the following values
CCall=32.0 and CCweak=11.1. The substructures were successfully determined by SHELXC/D dual-space
substructure search. The same merged dataset was also used to search for substructures with Phenix
Hybrid Substructure Search (HySS), a likelihood-based method, but could not find the correct sulfur sites.

Figure 3-18 Heavy-Atom Substructure Search using SHELXD

(Top left) SHELXD setup and data input screen. Two best substructure solutions with the
high CC values (top right and bottom left) remote from the rest at the end of approximately
5000 iterations of heavy atom sites searches; the CC values serve as preliminary indicators of
correct phase solutions. The solution on the upper right corner of the top right plot (CCall =
32.0 and CCweak = 11.1) was selected for phase-determination and calculating the initial
electron density map. The site occupancy vs. Peak Number plot (bottom right) shows 30
high-occupancy sulfur sites out of the 40 sites searched in the best solution; occupancy = 0.3
is an empirical cut-off that often proves useful in ambiguous cases.
The substructure determination was only successful when using merged data up to 3.4 Å. Only one
substructure solution after SHELXC/D searching with 10,000 tried (default is 1,000) was correct. We did
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not obtain any native anomalous substructure other than sulfur atoms from this Ric-8A crystal form from
the above software programs we applied.

3.2.11 Determination and Refinement of pR452 Structure
After 38 sulfur sites in the asymmetric unit were obtained by SHELXD, the sulfur substructure and
structure factor data were input into Phenix Autosol. Phenix.AutoSol uses SOLVE for phasing,
RESOLVE for statistical density modification, phenix.AutoBuild and phenix.refine to generate and
refine, respectively, an initial model, and HySS to find additional sulfur sites. Two additional sulfur sites
in the substructure were identified by HySS with a FOM of 0.378. The initial crystallographic phases
were also determined by AutoSol and followed by iterative phase improvement, which are statistical
density modification, optimization of parameters, iteration of positional optimization of anomalous
scattering atoms, calculating phases and solvent flattering density modification. The non-crystallogaphic
symmetry (NCS) operator was calculated from the given sulfur sites during the phase refinement. A
promising solution was obtained from the final AutoSol result where the R factor,

(23)
map skew (skew of histogram of electron density map), and model-map cross-correlation (measures the
similarity between model and electron density map) are 0.2473, 0.10 and 0.79, respectively. Visual
inspection of the substructure sites and electron density map under WinCoot also shows continuous
electron density resembles a predominantly α-helical polypeptide chain, thereby confirming the validity
of the heavy-atom substructure and its handedness. (Figure 3-19)
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Figure 3-19 Structure of pR452 solved using sulfur SAD

(Left), real-space 2.2Å pR452 electron density map, contoured at 1.5σ, superimposed on the
structure of pR452 in the crystal lattice. (Right), structure of pR452 (rainbow) superimposed
on the heavy-atom substructure consisting of 40 sulfur sites (green dots) in the asymmetric
unit. 4 sulfate molecules are labelled.
The initial model built by phenix.AutoBuild program correctly traced 16% of the structure in the
asymmetric unit. After removing all the questionable residues, the main chains were retraced manually
with sigma-weighted 2Fo-Fc map at 3.4Å using WinCoot, initially around the sulfur substructure sites
(cysteines and methionines) and the Autobuild model. Two pR452 molecules can be outlined in an
asymmetric unit. The starting phases were further refined and extended to 2.2 Å by phenix.refine using a
dataset collected at 0.979Å/12.7keV, termed “native” dataset, and the partially-build model from sulfurSAD phasing. Fragments of additional main chains were constructed after iterations of manual model
rebuilding with WinCoot and refinement with phenix.refine program. The registry of the sequence was
determined from the residues around the sulfur sites or bulky residues (W, F, Y, etc.) at both chains. The
final model confirmed that 40 sulfur sites in the initial sulfur substructures corresponded to the 9
methionine and 9 cysteine residues from each Ric-8A molecule in the asymmetric unit, while the four
remaining sites corresponded to sulfate ions from the reservoir solutions (Li 2SO4). Met-426 was not
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located possibility due to its location at the flexible C-terminus of the structure. In addition, the NCS
refinement was only carried out in the first few refinement cycles since the 2 molecules in the asymmetric
unit are not identical (RMSD of Cα=0.718 between chain A and B). The final refinement statistics,
including correlation coefficients, show good agreement between the Ric-8A model and experimental
native dataset (Table 3-3).

The crystal structure of pR452 consists of ~425 residues in the final model, which is composed of nine
ARM and HEAT repeat domains (Figure 3-20). The phosphorylation sites at S435 and T440 were part
of the flexible C-terminal region and not observed in the electron density map. Based on this structural
information, insights regarding the biological function of Ric-8A and its complex with Gαi1 will be
discussed in the next section.
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Table 3-3 pR452 crystal data collection and refinement statistics
*
Data for highest resolution shell are given in brackets. † Rmeas=∑hkl (n/n-1)1/2∑i |Ii(hkl)<I(hkl)>|/ ∑hkl ∑i Ii(hkl), where Ii(hkl) is the ith observation of the intensity of the reflection
hkl and <Ihkl >is the mean over n observations.
Rp.i.m.=∑hkl (1/n-1)1/2∑i |Ii(hkl)-<I(hkl)>|/ ∑hkl ∑i Ii(hkl). § Rwork=∑hkl || Fobs|-|Fcalc||/ ∑hkl |Fobs|,
where Fobs and Fcalc are the observed and calculated structure-factor amplitudes for each
reflection hkl. Rfree was calculated for 5% of the diffraction data that were selected randomly
and excluded from refinement. Correlation coefficients: CC = i((xi - <x>)(yi - <y>))/(i((xi <x>)2(yi - <y>)2)1/2, where xi and yi are the ith of n observations of quantities whose mean
values are <x> and <y>; for CC1/2, xi, and yi correspond to intensity measurements
derived from each of two randomly selected half-data sets from the set of unmerged
data; For CCwork and CCfree xi and yi refer to observed structure factor amplitudes and
structure factor amplitudes computed from the refined atomic model, respectively, for
the working data set and the set used to compute Rfree. CCano = <ano ano,obs>/( <2ano>1/2
<2ano,obs>1/2, where ano and ano,obs are the anomalous structure factor amplitude
differences (F+ - F- ), respectively, computed from the anomalously scattering atomic
substructure, and the observed anomalous differences. CC ano was calculated using data
truncated to dmin= 3.4 Å. §Bijvoet ratio [(<|F+/-|>)/(<F>)], was calculated using James
Holton’s xtalsize server (http://bl831.als.lbl.gov/xtalsize.html). ††Calculated using
MolProbity (Chen et al., 2010). **Anomalous correlation coefficient was calculated using data
truncated to dmin= 3.4 Å.
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Figure 3-20 2.2Å phospho-Ric-8A 1-452 WT
Crystal Structure

(Left) Two monomers, termed chain-A
(top) and chain-B (bottom) in an
asymmetric unit. Chain-A alone colored
from N (blue) to C-terminus (green)
looking sideways (top right) and down the
ARM super-helix (bottom right)

3.2.12 “Oil-Immersed” pR452 Crystal Structure Shows Large Unit-Cell Variance but
Small Structural Rearrangements
Experiment performed by Tzanko Doukov from the SSRL showed that immersion of crystals in ParatoneN oil before data collection results in shrinkage along the a, b and c axis of 4Å, 6.5Å and 11.5Å,
respectively, an observation which indicated either high water content of the crystals and/or alternative
packing of protein molecules in the shrunken crystals. Using the pR452 structure determined from the
regular cryo-protectant protected crystals as starting model for molecular replacement, we determined
another crystal structure of Ric-8A 452 WT, which showed subtle conformational changes induced by
compression and/or dehydration of crystals by oil. Since the second (oil immersed) structure differed
slightly from the first (native) structure, molecular replacement (MR) by “phenix.Phaser-MR (simple one-
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component interface)” resulted in a near-complete model (LLG = 578.471, TFZ = 25.9). Iterations of
manual model building mostly focused on small adjustments of side-chain orientations to improve R work
and Rfree values.

Lattice compaction by Paratone-N soaking resulted in little distortion of the structure itself (RMSD at Cα
positions = 0.61Å and 0.66Å for chains a and b, respectively). Rather, symmetry-related molecules
within underwent relative translations and reorientations within the lattice that largely preserve the
original molecular packing. The crystals used to collect the “oil-immersed” data set with the most unit
cell shrinkage were left soaked in Paratone-N in a cold room overnight. ARM repeats in the core region
(residues 162 to 282) remained relatively unchanged while helices in the N and C-termini underwent
more pronounced shifts in the oil structure. Loop regions were slightly stabilized compared to the
unshrunk structure. (Figure 3-21)
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Figure 3-21 Chain-A conformation changes induced by soaking, harvesting, and cryoprotection of Ric-8A crystals in Paratone-N

Crystal structure of chain-A in regular cryo-protectant (red), PEG-400, superimposed on
chain-A of “oil-immerse” structure (green) showing unchanged core region. Chain-Bs from
both structures are in (coffee).

3.2.13 Structural Analysis of pR452 Crystal Structures
Two slightly different structures of pR452 were determined, a regular cryo-protectant (20%
PEG-400) harvested structure and an oil-immersed and cryo-protected (Paratone-N) structure.
Data collection and refinement statistics were recorded in Table 3-3. Refinement statistics of the
initial model built using the merged sulfur SAD data set was not shown because the model was
very incomplete and not further refined. In both crystal structures, chain B of the model was
more complete than chain A both at the C-terminus and loop regions, therefore, I will be
referring to chain B for the remainder of the discussion on pR452 structure.
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3.2.13.a Overall Shape, Dimensions, and Residues Built-in/Omitted in the Model

Using the PyMol script, “Draw_Protein_Dimensions.py”, an approximate, rectangular minimal
bounding box (MBB) was drawn and the dimensions measured. Viewed from one angle, the
structure is 93.3Å wide, 50.9Å tall, and 41.4Å deep. (Figure 3-22)

Figure 3-22 Dimensions of pR452 crystal structure

Chain B of pR452 crystal structure enclosed in an approximate minimal bounding box
(MBB) to extract the dimensions. The image is generated by PyMol script
“Draw_Protein_Dimensions.py”. The lengths are in Å.
Based on sequence-based computational analysis, Ric-8A was predicted to comprise mainly
Armadillo (ARM) repeats which form a superhelix. (48) The crystal structure of pR452 is
mainly α-helical as predicted, yet in contrast to an all ARM repeat protein, comprises both twohelix HEAT motifs and three-helix ARM motifs. (Figure 3-23) For the three-helix ARM repeats,
the second helix serves as a linker between the nearly antiparallel first and third helix.(76) Using
another PyMol script, “draw_rotation_axis.py”, a rotation axis was drawn for each adjacent
HEAT or ARM repeat pair with the rotation angle and vertical translation distance along rotation
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axis calculated. (Table 3-4) The rotation angles between adjacent repeat pair are small (20o to
40o) for the first five pairs and larger (60o to 110o) for the last three pairs. The vertical transition
distance between repeats of pairs are very similar (9.8Å to 13.3Å) throughout the model. Using
the “get_area” command built in PyMol, the buried solvent assessible surface area (SASA) intraand inter- repeats are calculated. (Table 3-4, Figure 3-23) (30) SASA’s buried by the structural
elements of each repeat (intra-repeat SASA) range from 560Å2 to 2250Å2 with the first, second,
and last repeats burying the least amount of SASA due to the sizes of these repeats. The last
repeat is also the beginning of a highly disordered C-terminus, therefore, comprises secondary
structural elements packed far less tightly than preceding repeats. For the same reason, SASA’s
buried between repeats (inter-repeat SASA) of pairs are quite uniform (1950Å 2 to 2490Å2) with
the exception of the last pair (1550Å2), suggesting that the entire pR452 structure undergoes very
limited dynamic motions except the C-terminus (residue 430-452, of which electron density is
not observed).
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Figure 3-23 HEAT or ARM repeats in the pR452 crystal structure

(Left)pR452 comprises 9 Armadillo/HEAT repeats. HEAT repeats (repeat 1, 2, 6, and 9) are
composed of two helices (labelled A and B); the N-terminal and C-terminal helix of each
repeat is colored red and yellow, respectively. Armadillo repeats (repeat 3, 4, 5, 7, and 8)
comprise three helices (labelled with 1, 2, and 3); the first, second, and third are colored
green, red, and yellow, respectively. (Right), sequence composition of secondary structural
elements. α-helical secondary structure is shown as a series of loops above the amino acid
sequence. Helices with 310 hydrogen bonding and geometry are so labeled. Straight-line
sections indicate loop segments. No electron density is observed beyond residue 423
(molecule A) and 429 (molecule B). The two phosphorylation sites, S435 and T440, are
highlighted in yellow. Blue and cyan bars shown below the amino acid sequence indicate
residues that are solvent accessible (blue), partially accessible (cyan) or buried (white).
Figure modified from output from ESPript 3.0 server: http://espript.ibcp.fr (30)
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Table 3-4 pR452 HEAT and ARM repeats
Intra-repeat and inter-repeat parameters including solvent assessible surface area, rotation
angle, translation displacement are calculated.
Generally, for structural model refinement of any protein molecule, the electron density at the
loop regions that connect α-helices or β-strands is usually more equivocal than the helices. Yet,
most of the loops in the pR452 structure were reasonably modeled although with comparably
higher B-values than those of helices; no large segments of connecting loops adopt significant
alternative conformations in the crystal lattice with the except of the C-terminus. An interesting
observation is that all visible loops seem to project towards the convex surface of pR452. The
longer loops (>10 residues) connect helical elements intra-repeat, rather than between HEAT or
ARM repeats.

Unfortunately for the more sought-after functional assessment of pR452, the phosphorylation
sites were not visible in either chain of the two structures due to their location at the C-terminus.
According to secondary structure prediction by DISOPRED3 predictor, the unmodelled Cterminal region of pR452 contains a region of ~20 residues that has high probability for adopting
117

a highly disordered conformation, therefore, also has a high potential to serve as a proteinprotein interactive site(21). (Figure 3-24) Interestingly, the N-terminal helices are all
unexpectedly well-ordered while biochemical data on the N-terminal truncations of Ric-8A
suggests crucial GEF-functional motif(s) at the extreme N-terminus(42).

Figure 3-24 DISOPRED3 analysis of predicts composition of Ric-8A 1-452 secondary structure
elements

Residues 284-289 in α17 form an unusually long 310 helix and is observed in both chain A and
chain B in the asymmetric unit. L283, L286, and L289 are all aligned, and the 3 10 conformation
of this stretch of residues allows those residues all to project into a hydrophobic pocket. (Figure
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3-25) 310 helices are not uncommon in HEAT/ARM repeat proteins such as importin-β, however,
are typically 3-4 residues long to make up one α-helical turn. (83) Although importin-β also
contains a long 310 helix, no amount of attention was directed to its function other than stating it
as a repeat-connecting helix(83). Without direct structural data of a Ric-8A:Gαi1 complex, we
cannot draw any conclusion about the 310 helix either.

Figure 3-25 A 310 helix on pR452 crystal structure

(Left), “ribbon” presentation of the 310 helix showing three residues per helical turn.
(Right), three leucine residues aligned by the 310 conformation and projected into a
hydrophobic pocket.

3.2.13.b Crystal-Packing in the Lattice

The two C-shaped molecules of pR452 in the asymmetric unit are related by a 110° rotation and
a 29Å translation about an axis that passes obliquely through the ab plane of the unit cell. This
packing interaction arises from an extensive interface formed by α18 and αA9 motifs of
molecule B with the C-shaped cavity formed by multiple Armadillo/HEAT repeats of molecule
A. The corresponding surface of molecule B forms similar, but less intimate contacts with the
α18 and αA9 motifs of a symmetry-related copy of Molecule A. It is interesting that the C-
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termini of both molecules of the asymmetric unit appear to be extended. That of chain B projects
into a solvent-filled cavity formed by symmetry-related chain A and is disordered beyond
residue 429. The C-terminus of Molecule A is disordered beyond residue 423, where it likewise
projects into a large cavity between symmetry-related molecules. Thus, no electron density is
observed for phospho-Serine 335 and phospho-Threonine 440, which are solvated within the
crystal lattice.
3.2.13.c Mapping of Properties on the Structure of pR452

In the absence of direct Ric-8A:Gαi1 complex structural information, amino acid sequence
conservation scores, protection factors from hydrogen-deuterium exchange experiments, and the
distribution of electrostatic potential, provide clues to the function of residues exposed on the
surface of pR452.

Using the CONSURF server (61) to rank the conservation of amino acids for a broad selection of
Ric-8A and Ric-8B homologs, we assess the general importance to the function of all members
of the Ric-8 family. Generally, residues within the concave surface of pR452, formed largely by
the αB and α3 helices of HEAT and Armadillo repeats, respectively, are evolutionarily
conserved. (Figure 3-26)
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Figure 3-26 pR452 structure viewed from two angles and rendered with amino acid
conservation scores calculated by CONSURF server
Yellow residues have unreliable conservation scores due to insufficient data in the multiple sequence
alignment.

The electrostatic contact potential map rendered at the molecular surface of R452 reveals
dispersed and non-contiguous regions of positive and negative charge density. Exceptions are of
negatively charged surface near the N-terminus of the molecule and a striking positively charged
surface near the C-terminus (Figure 3-27). The latter arises from a constellation of ten arginine
and lysine side chains projecting from α18 and αA9, all but two of which are highly conserved
among Ric-8 homologs. Notably, the conserved Arg345/R348/K349 triad forms the binding site
for a sulfate ion from the crystallization buffer and may serve as a recognition site for one of the
C-terminal phosphorylated serine or threonine residues.
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Figure 3-27 Charged residues on pR452

(Left), the charged side-chains are shown as sticks and colored red and blue for negative and
positive charges, respectively. (Right), the same color scheme is applied on the electron
density surface of pR452.
Now with the actual crystal structure in hand, we mapped the HDX protection profile of Ric-8A
by Gαi1 on the structure using the PyMol script, “spectrumany.py”. Changes in
hydrogen/deuterium exchange (HDX) rates upon Gαi1 binding have been determined for R491,
a highly active GEF (10). Two distinct surfaces, the first formed by residues in α23, α14 and
α15, and the second by residues in α37 and α18, are protected to different degrees, by Gαi1
(Figure 3-28). Projection of evolutionary conservation scores of Ric-8A homologs (Figure 326) onto the structure of pR452 shows that residues that comprise these protected structural
elements are not more highly conserved than other positions in the multiple sequence alignment.
An exception is the contiguous surface that is partially or wholly encompassed by the V-shaped
helical hairpin formed by α37 and α18 for which the average conservation score exceeds 7 and
the mean protection factor is -8%. We propose that this surface, which partly overlaps the
positively charged region described above, harbors a Gαi1 binding site, or is otherwise occluded
upon Gαi1 binding.
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Figure 3-28 Mapping of HDX Protection and Evolutionary Conservation Profiles on the
Structure of pR452

Helix key (left) is oriented to the same viewing angle as the HDX protection factors-rendered
map (right) for easy reference. Gradients of blue and red indicate regions that are HDXprotected and deprotected, respectively, by Gαi1-binding.
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3.3 Materials and Methods
3.3.1 Protein Expression and Purification
3.3.1.a Myristoylated Gαi1 (mGαi1) and Ric-8A 1-491 WT

Myristoylated Gαi1 (mGαi1) and Ric-8A 1-491 used for nucleotide-binding and steady-state
GTPase assays were expressed and purified as described in Chapter II. Expression and
purification of full-length Ric-8A (1-530) is discussed in detail in Chapter V.
3.3.1.b Rat Ric-8A 1-452, 1-470, 1-425, 1-401

Rat Ric-8A 1-452 construct, which will be referred as R452 for simplicity, was expressed and
purified as described (42) with some alterations. Briefly, the N-terminal hexa-histidine-tagged
protein construct (Figure 2-19) in pET28a expression vector is expressed in E. coli BL21 (DE3)RIPL cells in TB media containing kanamycin (100mg/L) and induced with 50μM isopropyl βD-1-thiogalactopyranoside (IPTG) at 20oC. After cell lysis and fractionation in lysis buffer
(50mM Tris, pH 8.0; 250mM NaCl; 5% Glycerol; 2mM β-mercaptoethanol; 2mM PMSF), Nterminally His-tagged Ric-8A is isolated from the soluble faction using a gravity Profinity
IMAC(Bio-Rad) column and eluted with elution buffer (50mM Tris, pH 8.0; 250mM NaCl; 5%
Glycerol; 2mM β-mercaptoethanol; 2mM PMSF; 300mM Imidazole). The concentrations of
imidazole and NaCl in the buffer are reduced by two rounds of dialysis in Q-buffer A (50mM
Tris pH 8.0, 5mM β-mercaptoethanol, 50mM NaCl, 5% glycerol); TEV protease is added to the
protein sample after the first round of dialysis and the proteolysis reaction proceeds for the
duration of the second round of dialysis. The protein sample is further purified by first passing
through a fresh IMAC column (Bio-Rad) again to recover TEV-cleaved Ric-8A. The IMAC
flow-through is then loaded onto a HiTrap Q XL anion exchange column (GE Healthcare) and
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eluted with a NaCl gradient (0mM to 500mM). Tag-less R452 eluted at about 200mM NaCl and
is already at high purity after elution from anion exchange column. A final polishing step using
a Superdex 200 10/300 GL size-exclusion chromatography column (GE Healthcare) is used to
isolate monodisperse, monomeric Ric-8A from aggregated protein and to buffer exchanges the
sample into crystallization buffer (50mM HEPES, pH 8.0, 150mM NaCl and 1mM TCEP) right
before sample crystallization. Several other Ric-8A truncation constructs including 1-470, 1425, and 1-401 were expressed and purified in similar fashion as R452.
3.3.1.c Seleno-Methionine Derivative of R452 (SR452)

To obtain important phase information for Ric-8A, which has no suitable homology model in the
protein data bank (PDB) for molecular replacement (MR), multiple attempts were made towards
crystallizing a seleno-methionine derivative of R452 (SR452). Briefly, the pET28a expression
plasmid containing the hexa-His-R452 construct is transformed into either B834(DE3)
(Novagen) competent cells or T7 Express Crystal (NEB, discontinued on January 02, 2018)
competent cells. The methionine auxotrophic E. coli expressing Ric-8A were grown using a
media kit, SelenoMethionine Medium Complete (Molecular Dimensions), following the kit
protocol. SR452 protein was purified using methods identical to R452.
3.3.2 Phosphorylation and Purification of Phospho-Ric-8A
Purified Casein Kinase II hetero-tetramer (CKII) is purchased from New England Biolabs
(Catelog#P6010S). The kinase reaction is carried out by largely following an established
protocol(1) with minor alterations. For every 10 mg of R452, powdered adenosine 5′triphosphate (ATP) disodium salt is first adjusted its pH by mixing with 110µL of 10X reaction
buffer (200 mM Tris-HCl, 500 mM KCl, 100 mM MgCl 2 pH 7.5 @ 25°C) to reach 10mM ATP
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and then the 110µL of mixture were added to 1mL of 10mg/mL Q-column purified R452 in gelfiltration buffer (50mM HEPES, pH 8.0, 150mM NaCl and 1mM TCEP) to achieve final kinase
reaction condition (1mM ATP, 20 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl 2, 50mM
HEPES, pH 8.0, 150mM NaCl and 1mM TCEP) without heavily aggregating R452. 3000 units
of CKII were then added to the mixture (1110µL) and incubated over-night (>10 hours) at room
temperature (~25oC) R452, which contains two high-affinity CKII phosphorylation site, reach
>90% phosphorylation using this method. It is important to dissolve solid ATP in 10X reaction
buffer first before adding to Ric-8A due to a large pH shift caused by high concentration of unbuffered ATP (di-sodium salt); R452 precipitates heavily when solution pH drops too rapidly.

Doubly-phosphorylated R452 (pR452) elutes at different NaCl concentration than contaminants,
such as nucleotides, CKII or R452, on an anion exchange column. The entire kinase reaction is
then re-purified with a high-resolution anion exchange column, Source 15Q (GE Healthcare),
followed by a size-exclusion step using Superdex 200 SEC column (GE Healthcare) in
crystallization buffer (50mM HEPES, pH 8.0, 150mM NaCl and 1mM TCEP) before
crystallization. Samples of purified R452 and pR452 were sent to CBSD Mass Spectrometry
Core Facility at University of Montana for LC-TOF-MS (Bruker micrOTOF) analysis. SR452
was phosphorylated and re-purified using the same approach.
3.3.3 Competition Assays with Gαi1 C18 Peptide
C18M1, a modified version of the rat Gαi1 C18 peptide (DAVTDVIIKNNLKDCGLFKK)(42),
was purchased from GenScript. C18M1 was soluble in water up to 5.5mM. The peptide
competition assays were performed similarly to the “GTP-binding” tryptophan fluorescence
assays described in Chapter II. Briefly, 100μM of C18M1 peptide or equal volume of water
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(negative control) was pre-incubated with 1µM R491 or 8µM pR452 for 1 hour on ice. Each
pre-incubated mixture is then transferred to the quartz fluorescence cuvette (quartz SUPRASIL
macro/semi-micro cell, PerkinElmer) with stirring at room temperature. 1μM mGαi1:GDP were
added and allowed to equilibrate for 5 minutes before the addition of 10μM GTPγS. Triplicated,
10-minutes time courses of GTPγS binding events were recorded and fit to the same single
exponential equation mentioned in Chapter II using SigmaPlot (Systat Software):

y = a*(1-e-kt) (8)
3.3.4 Steady-State GTPase Assay
All samples (mGαi1, R452, pR452, R530, and pR530) were SEC-purified on a Superdex 200
SEC column (GE Healthcare) so they are effectively buffer exchanged into the assay buffer
(50mM HEPES, pH 8.0, 100mM NaCl, 1mM EDTA, 1mM TCEP, and 10mM MgCl 2) before
experiments. γ-32P-GTP (6000Ci/mmol, 10mCi/ml, 250 µCi) was purchased from PerkinElmer.
All samples were pre-warmed in a 30oC water bath for 3-minutes. To start the reaction, 1µM
mGαi1:GDP was added to different concentrations (10µM, 5 µM, 2.5 µM, 1.25 µM, 0.625 µM,
0.3125 µM, 0 µM) of different Ric-8A’s (R452, pR452, R530, pR530) and 30µM GTP (doped
with 32P-GTPγS to >1000cpm/pmol GTP) to reach a 20µL final reaction volume. All reactions
were allowed to proceed for 5 minutes and quenched with 180µL of cold 1M NaH 2PO4 pH 4.0.
Immediately after quenching, 200µL of quenched reaction mixture were vigorously mixed with
800µL of a suspension of cold 5% w/w Norit activated charcoal in 50mM NaH 2PO4 pH 4.0. The
1mL of charcoal mixture were then centrifuged under 10,000 x g for 10 minutes at room
temperature. After centrifugation, triplicates of 150µL of clarified supernatant solution were
added into scintillation vials containing 10mL of 3a70B scintillation cocktail (RPI) and counted.
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To control for residual CKII contamination, which could use GTP as a phosphate source and
produce counts not originated from GTPase, a negative control was included for each Ric-8A
concentration series at [Ric-8A] = 10µM, [mGαi1] = 0µM, [GTP] = 30µM.

The C18M1 peptide described in section 3.3.3 was incorporated into the steady-state GTPase
assay as well. 50µM of C18M1 peptide or water control with 10µM Ric-8A on ice for 1 hour
prior to performing the assays.
3.3.5 SPR Binding Assay
Using the BiaCore X100 system (GE Healthcare), we measured the binding kinetics of
Gαi1:GDP to Ric-8A by anchoring hexa-Histidine-tagged Ric-8A on a Ni-NTA sensor chip (GE
Healthcare) surface and flow difference concentrations of Gαi1 or buffer through the surface at a
constant flow-rate and temperature while monitoring association as well as dissociation
measured in response units (RU) in real time.

In preparation for the experiments, it was mandatory that all protein samples used in the BiaCore
analysis were buffer exchanged into the running buffer (50mM HEPES pH 8.0, 150mM NaCl,
1mM TCEP) by passing them through a Superdex-200 SEC column (GE Healthcare); small
buffer components mismatch deterred SPR data quality significantly by introducing large
baseline shifts.

Each experiment consisted of three main phases, ligand anchoring and equilibration phase,
analyte binding phase (“on” phase), and analyte unbinding phase (“off” phase); all experiments
were carried out at room temperature under a constant flow rate (30µL/min). During ligand
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anchoring, 0.1µM His-Ric-8A was applied to the Ni-NTA sensor chip surface for 5 minutes
followed by a 7-minute wash with buffer to remove unbound/loosely bound ligand molecules.
Once the baseline was stable, a range of concentrations (10µM, 5µM, 2.5µM, 1.25µM,
0.625µM) of Gαi1 W258A (analyte) was applied to the ligand-coated sensor chip surface for 3
minutes for the “on” phase, followed by a 6-minute wash with buffer, thereby completing the
“off” phase. The Ni-NTA sensor chip surface was regenerated by first stripping the nickel cation
with 350mM Ethylenediaminetetraacetic acid (EDTA), followed by double-distilled water
(ddH2O) to remove the EDTA, followed by 0.5mM NiCl2, 3mM EDTA, then back to the running
buffer.

Each data set contains multiple curves corresponding to the range of concentrations of analytes
binding to the same Ric-8A species (R491, pR491, R452, or pR452; we do not have a His-tagged
construct for the full-length Ric-8A). Using BiaCore X100 evaluation software (GE Healthcare),
all kinetics curves within a data set are fitted globally using a 1:1 binding model to generate a
single kon, koff, KD, Rmax and the standard deviation for each parameter, as well as a χ 2 value of
the fit for the ligand, analyte pair. (85, 86, 100)

The “on” phase is fitted with the integrate rate equation:
∗

𝑅( ) = 1 − 𝑒

∗

𝑅

(24)

And the “off” phase with:
∗

𝑅( ) = 𝑒
where 𝑅

=

(25)

𝑅
∗
∗

𝑅

(26)
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Rmax = Maximum possible relative response (RU) if all ligand molecules on the chip are saturate with
analyte. A theoretical value that is not attainable for a non-zero koff.
Req = Relative response (RU) at equilibrium for each “on” curve. Depending on k off, Req could be smaller
or equal to Rmax.
kon = Pseudo-first order “on” rate in (M-1s-1), a C-dependent value if Rmax is C-dependent
koff = “Off” rate in (s-1), a C-independent value
C = Analyte concentration in (M)
R(t) = Relative response (RU) at time t
t = Elapsed time in seconds

3.3.6 Protein Crystallization and Optimization
3.3.6.a Ric-8A 491

The protein sample in gel-filtration buffer (50mM HEPES pH 8.0, 150mM NaCl, 1mM TCEP )
was concentrated to 20mg/mL before setting up initial crystal screens in commercial screening
blocks including PEG-I, PEG-II, JCSG-I, JCSG-II, JCSG-III, JCSG-IV, Wizard, Morpheous,
ProPlex, etc. (Qiagen, Hampton Research, Molecular Dimensions) The crystal screens were set
up on an Intelli-Plate 96 (Art Robbins Instruments) using a Crystal Gryphon robot (Art Robbins
Instruments), which rapidly sets up plates containing up to 96 screening conditions under 15
minutes/plate. For each condition, a 0.5µL sitting drop was set up by spotting 0.25µL sample on
0.25µL reservoir solution and sealed with ClearSeal Film (Hampton Research) immediately after
plate setup.
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3.3.6b Ric-8A Truncation Constructs

R470 and R452 were screened similarly to R491. Screening of R425 and R401 constructs were
not started until we saw R452 crystallizing, therefore, these shorter constructs were not screened
using the full arsenal of initial screening conditions; instead, PEGs-II suite and an in-house R452
screening suite were used. The in-house R452 screening suite was created using Scorpion
Screen Builder (Art Robbins Instruments). It screens around the original crystallization
condition (0.1mM Tris pH 8.5, 0.2M Li2SO4, 30% w/v PEG 3350) by only fixing the Li 2SO4
concentration at 0.2M and varying the pH of buffer (pH 7.0 to pH 8.5), percentage of PEG 3350
(25% to 30% w/v), and the types of pH buffers (Bicine, Bis-Tris Propane, EPPS, HEPES, TAPS,
TES, Tricine, Tris) with good buffering capacity at the desired pH range. Seleno-methionine
derivatized R452 and R452 C329S mutant, on the other hand, were screened using the full set of
initial screening suites mentioned in section 3.2.8a.
3.3.6.c Phospho-Ric-8A 1-452

pR452 as well as pR452 C329S mutant were screened in the same fashion as R491. After seeing
no new crystallization conditions besides those for R452, both WT and pR452 C329S proteins
become the primary targets for aggressive condition optimization trials. Based on the original
condition, we varied the concentration of Li2SO4, length and concentration of PEGs, type and pH
of 100mM pH buffer by creating in-house screening blocks using the Scorpion Screen Builder
(Art Robbins Instruments). We also attempted additive screening and detergent screening using
commercial screening suites from Hampton Research. Finally, we varied the incubation
temperature (20oC, 12oC, and 4oC), drop size (0.5µL and 1µL) as well as the volume ratio of
protein-to-reservoir (i.e. 1-part sample to 2-part reservoir, 1 to 1, 2 to 1, etc.) in the hope of
changing the kinetics of nucleation and crystal growth. Larger hanging drops were also set up by
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hand on Greiner pre-greased 24 well Combo Plates (Molecular Dimensions). Seeding
experiments using conventional seeding methods such as streaking seed crystals into fresh
crystallization drops with a cat-whisker or micro-seeding methods such as the seed-beads method
described here (112) were performed.
3.3.7 pR452 Experimental Phasing Using Heavy-Atom
Without a suitable homology model to perform molecular replacement, we attempted to solve the
phase problem using conventional heavy-atom soaking. I will not go into detail about all the
different types of heavy-metals or metal-containing compounds we have tried using different
soaking method. In general, we follow established soaking protocols as described(13). Briefly,
protein crystals were either slow-soaked by adding heavy-atom-containing mother liquor or
cryo-protectant solution (recipe of mother liquor and cryo-protectant solution varies for crystals
picked from different wells of crystallization plate, see details in section 3.2.10) of different
heavy-atom concentrations to crystals in the drop and incubated for 1 to 24 hours or fast-soaked
for 1 to 20 minutes. The soaked crystals were back-soaked into regular cryo-protectant to
remove excess heavy-atoms before plunging into liquid nitrogen. For soaking experiments of
pR452 crystals in NaBr, back-soaking rapidly reduces heavy-atom incorporation, therefore was
skipped; crystals were harvested from soaking solution and flash frozen at the end of soaking
experiments.
3.3.8 Crystal Harvesting and Cryo-protection
Due to rapid dehydration and crystallization of the precipitant solutions at room temperature (crystals of
Li2SO4 form inside the Ric-8A crystallization drop after exposing to air for 5 minutes), all crystals were
harvested in a 4oC cold room with minimal time of air exposure. 20μm (nylon fiber diameter) mounted
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CryoLoops (Hampton Research) and MicroLoops E loops (MiTeGen) were both used to harvest crystals.
Two different cryo-protectants were used to harvest the pR452 crystals, a 20% PEG400 solution in the
mother liquor, in which the crystals were grown, and an oil-based cryo-solution, Paratone-N (Hampton
Research). To minimize ice build-up on the mounting loop, cryo-freeze techniques discussed in Pflugrath
2015 was employed during crystal harvesting.(24) Briefly, liquid nitrogen used for flash-freezing were
kept devoid of ice; magnetic wands used to harvest crystals were kept dry by occasionaly heating and
wiping; crystals mounted on loops spent minimal time in air and were plunged rapidly into liquid nitrogen
without hovering over the liquid nitrogen.

3.3.9 Data Collection
In a collaborative effort with Brookhaven National Laboratory (BNL, NSLS-II), Tung-Chung Mou and I
collected 18 high-multiplicity sulfur-SAD data sets with a low energy X-ray beam (7000eV) at NSLS-II
FMX from a group of randomly orientated native pR452 crystals at 100K . These crystals diffracted up to
2.0Å resolution with sulfur anomalous signal extending to at least 3.4Å. We used the helical data
collection method at NSLS II FMX, which was equipped with an Eiger16M pixel array detector with a
133Hz framing rate. The helical collection strategy increased the data redundancy and accuracy by
collecting multiple 360o cycles of data while moving down the center axis of crystals so that unexposed
portions of the rod-shaped crystal are continuously fed through the X-ray beam path to reduce radiation
damage. (Figure 3-29)
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Figure 3-29 Helical data collection mode and typical pR452 crystal diffraction pattern

(Left), helical data collection mode using a 10 µm x 10 µm beam avoids irradiation of the
crystal at a single volume of the crystal. (Right), typical X-ray diffraction pattern of pR452
crystals.
The crystal-to-detector distance was set to 200 mm to measure diffraction to 2.73 Å resolution. A beam
size of 10μm x 10μm was used with a flux of ~5.0 x 1012 photons/sec. Each crystal was collected with a
thin-slice oscillation range (0.1o-0.2o per image) for a total of 360o to 5760o per dataset at 20%
transmission and 0.05 – 0.1 second exposure time depending on the size of crystal and radiation damage.
The differences in cell parameters are within 0.1% among these datasets, as a result, data sets collected
from multiple isomorphous crystals merged well to enhance the anomalous signal.

The high-resolution “native” and “oil-immersed” data sets were collected at APS 19BM and SSRL BL92, respectively (Table 3-3). The “native” data set was collected from one crystal with a 100μm x 100μm
X-ray beam tuned at 0.98Å/12.7 keV. The crystal-to-detector distance was set to 175 mm. The crystal
was collected with a 0.5o oscillation/frame for a total of 360o. Each frame was exposed for 5 seconds with
no attenuation. The “oil-immersed” data set was collected from one crystal with X-ray beam tuned at
0.98Å/12.7 keV. The crystal-to-detector distance was set to 350 mm. The crystal was collected with a
0.2o oscillation/frame for a total of 720o. Each frame was exposed for 2 seconds with ?% attenuation.
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3.3.10 Data Processing and Merging
The sulfur-SAD datasets collected at NSLS-II FMX were processed automatically by “fast_dp”,
an automated XDS-based(44) streamline program developed by NSLS-II scientists, using space
group P 21 21 21 and unit-cell cell parameters of a = 66.7 Å, b = 104.0 Å, c = 141.7 Å.
Information about the pR452 crystal space group were learned from previous data collection and
processing experiences at the Stanford Synchrotron Radiation Lightsource (SSRL). Data sets
collected from SSRL were indexed, integrated, and scaled using HKL2000 program suite(87),
which contains three programs: “XdisplayF” for visualization of the diffraction pattern, “Denzo”
for data reduction and integration, and “Scalepack” for merging and scaling of the intensities
obtained by “Denzo” or other programs. The high-resolution “native” and “oil-immersed” data
sets were also indexed, integrated, scaled and merged by XDS-based, automated data reduction
programs unique to the synchrotron beamlines at which they were collected, APS 19BM and
SSRL 9-2, respectively. Both datasets, “native” and “oil-immersed” were optionally processed
by HKL2000, which was available either pre-installed on the synchrotron site servers during data
collection or on the CBSD Macromolecular X-ray Diffraction Core Facility workstation after
datasets were transferred back to Montana. The final decision to use reduced datasets processed
by the XDS-based programs was made because HKL2000 routinely rejects weak (I/σI < 1)
reflections while XDS keeps those reflections and weak reflections could always be rejected
during MR and structure refinement cycles.

To create a heavy atom substructure map for phasing, it was necessary to merge multiple sulfur
data sets to achieve high signal/noise due to the naturally weak anomalous signal of sulfur atoms.
(Table 3-5) Using BLEND(33) from the CCP4 program suite, I attempted to scale and merge 18
135

data sets collected from 14 relatively isomorphous crystals. Simultaneously, Tung-Chung Mou
manually performed pair-wise merging of the same 18 data sets using phenix.scaled-and-merged
program(16).
Crystal

Dataset

1

Average
multiplicity*
12.6 (9.2)

Completeness
(%)*
97.1 (71.1)

Rmeas (%)*†

I/(I)*

15.5 (92.6)

12.2 (1.7)

15730

13.0 (11.5)

98.0 (82.5)

13.0 (91.3)

14.6 (2.6)

50

0.2

0.05

13950

12.8 (10.9)

98.7 (91.0)

13.9 (91.4)

13.0 (2.1)

30

0.2

0.05

14531

12.0 (10.5)

96.2 (52.6)

18.6 (100.2)

10.1 (1.5)

20

0.2

0.1

13402

12.6 (8.6)

96.4 (55.3)

15.9 (95.5)

12.0 (1.6)

20

0.2

0.1

22912

50.6 (45.7)

99.1 (88.4)

7.4 (83.5)

50.0 (5.8)

27004

13.3 (13.1)

97.7 (93.5)

6.5 (68.5)

27.1 (3.1)

Resolution (Å)*

1_1

Total
range (o)
360

30.0-3.27 (3.36-3.27)

Unique
reflections
15336

1_2

360

30.0-3.24 (3.33-3.24)

1_3

360

30.0-3.39 (3.48-3.39)

2_1

360

30.0-3.32 (3.40-3.32)

2_2

360

30.0-3.41 (3.50-3.41)

7

7_1

1440

30.0-2.86 (2.94-2.86)

8

8_1

1080

30.0-2.70 (2.78-2.70)

2

𝐶𝐶𝑎𝑛𝑜
@3.5Å

0.43

%
Trans.
20

Oscil.
(o)
0.2

Expo.
(s)
0.05

20

0.2

0.1

20

0.2

0.1

8_2

1080

30.0-2.81 (2.88-2.81)

24457

29.7 (20.1)

95.7 (75.1)

11.2 (78.5)

29.4 (4.7)

9

9_1

1080

30.0-2.77 (2.84-2.77)

24489

34.6 (21.2)

95.4 (89.1)

9.2 (82.8)

38.2 (3.5)

0.35

10

10_1

2880

30.0-2.97 (3.05-2.97)

21312

80.2 (75.1)

94.2 (73.7)

13.8 (79.2)

40.3 (5.5)

0.50

10

0.2

0.1

13

13_1

1440

30.0-3.25 (3.33-3.25)

15982

46.7 (37.1)

98.7 (84.0)

17.5 (93.0)

21.0 (3.6)

0.22

20

0.2

0.1

14

14_1

5760

30.0-2.97 (3.05-2.97)

22225

134.8 (83.1)

99.7 (90.6)

15.9 (69.7)

42.0 (10.4)

0.53

10

0.2

0.1

15

15_1

3600

30.0-3.37 (3.44-3.37)

14122

100.1 (80.2)

95.6 (75.5)

13.1 (70.5)

34.3 (3.7)

0.25

15

0.2

0.1

17

17_1

360

30.0-2.43 (2.50-2.43)

37043

12.8 (11.4)

99.6 (94.9)

7.3 (76.4)

23.8 (2.7)

0.23

20

0.2

0.1

18

18_1

1080

30.0-3.46 (3.55-3.46)

13414

37.1 (26.4)

97.6 (69.7)

16.2 (92.4)

22.0 (3.5)

0.22

20

0.2

0.1

19

19_1

720

30.0-2.77 (2.84-2.77)

25093

26.6 (24.2)

97.7 (90.5)

11.0 (79.9)

24.4 (3.8)

0.27

28

28_1

1080

30.0-3.11 (3.19-3.11)

17574

37.8 (28.9)

96.2 (67.7)

13.1 (89.4)

29.9 (3.1)

34

34_1

1080

30.0-2.81 (2.88-2.81)

24582

38.6 (35.5)

99.5 (94.5)

7.8 (79.5)

44.9 (5.2)

0.33

20

0.2

0.1

20

0.2

0.2

20

0.2

0.1

20

0.2

0.1

20

0.2

0.1

Table 3-5 Parameters and statistics of data sets that were merged for Sulfur-SAD
phasing
*Data for highest resolution shell are given in brackets. † R
1/2
meas=∑hkl (n/n-1) ∑i
|Ii(hkl)-<I(hkl)>|/ ∑hkl ∑i Ii(hkl), where Ii(hkl) is the ith observation of the intensity of the
reflection hkl and <Ihkl >is the mean over n observations. CCano = <ano
ano,obs>/( <2ano>1/2 <2ano,obs>1/2, where ano and ano,obs are the anomalous
structure factor amplitude differences (F+ - F- ), respectively, computed from the
anomalously scattering atomic substructure, and the observed anomalous
differences.

3.3.11 Heavy-Atom Substructure Searches; and Determination + Refinement of pR452
Structure
The merged and scaled data was input into the HKL2map(69), a graphical user interface (GUI) for the
SHELXC/D/E program suite, and Phenix Hybrid Substructure Search (HySS), a likelihood-based method,
for sulfur substructures searches.
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After the sulfur substructure was determined, the substructure (*.PDB) file and structure factor data file
were input into Phenix Autosol for calculation of experimental phases and building of an initial model.
Further automated model building was performed using phenix.AutoBuild program. The AutoBuild
model was then manually built using WinCoot. The phases were extended to higher resolution using the
“native” dataset discussed in section 3.3.9 and the partially-built model from sulfur-SAD phasing.
Fragments of additional main chains were constructed after iterations of manual model rebuilding using
WinCoot and refinement using phenix.refine.

Using the “oil immersed” dataset discussed in section 3.3.9 and the pR452 structure built from the regular
cryo-protectant protected crystals as starting model for molecular replacement (MR) to generate an initial
model, another structure of pR452 was determined following manual model rebuilding with WinCoot and
refinement of the MR solution.

3.3.12 Structure Validation
MolProbity (43) was incorporated into “phenix.refine” as an add-on feature, therefore, was performed
after every iteration of manual model building and refinement to make suggestions for subsequent
refinement steps. Final structural models were validated by wwPDB Validation Server (Protein Data
Bank).
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Chapter IV: Ric-8A SAXS Envelopes
4.1 Introduction
Ric-8A is phosphorylated in vitro at five sites (Ser435, Thr440, Ser522, Ser523, and Ser527)
near the C-terminus(3). Among them are Ser435 and Thr440 that, when phosphorylated by
casein kinase II (CKII) in vitro, elevate the function of Ric-8A as a guanine nucleotide exchange
factor (GEF) for Gαi1.(3) Using small-angle X-ray scattering (SAXS), the molecular envelopes
of Ric-8A and phospho-Ric-8A were determined to see in low-resolution the effect of
phosphorylation on Ric-8A. Ric-8A also forms a stable, nucleotide-free complex with Gαi1 in
vitro; therefore, the low-resolution SAXS envelope of the Ric-8A:Gαi1 complex was also
determined readily. By fitting the SAXS envelope of the complex with the crystal structure of
pR452 (Chapter III) and Gαi1(95), we hoped to discern large conformational changes induced by
complex formation at low resolution and, if possible, the effect(s) of Ric-8A phosphorylation on
the complex. While we had large quantities of highly pure protein samples (Ric-8A and Gαi1)
which were required for crystallization, the molecular envelopes of Ric-8A and Ric-8A:Gαi1
complex were determined by SAXS with less effort. We tested the hypothesis that the CKII
phosphorylation of Ric-8A induces conformational changes, thereby activating Ric-8A to
become a more potent GEF for Gαi1:GDP, following the regulation paradigm for many other
proteins that are phosphorylated and dephosphorylated inside the cells.
4.1.1 Theory of SAXS
Small-angle x-ray scattering (SAXS) not only enables low-resolution structural determination of
protein molecules in solution, but also overcomes the limitation of studying only snapshots of
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conformationally dynamic protein molecules that become constrained by a crystal lattice.
Limitations of SAXS include the most obvious low-resolution and difficulty in model generation
with dynamic protein molecules which sample multiple conformations in solution, therefore,
data interpretation can be ambiguous. Nevertheless, SAXS remains a stand-alone, powerful
structural tool as well as a good alternative to the high-resolution methods, namely X-ray
crystallography, Cryo-electron microscopy (Cryo-EM), and nuclear magnetic resonance (NMR),
for visualizing protein molecules.

In a basic SAXS experiment, incident X-rays are scattered by protein molecules tumbling in
solution and the scattered X-ray photons hit a detector, similar to X-ray diffraction in X-ray
crystallography except the molecules are not periodically packed in a crystal lattice. As a result,
almost no intensities can be measured at resolution beyond 10Å. (Figure 4-1) The intensity is
expressed as a function of the scattering vector q resulting from a photon of wavelength λ
scattering off the sample at an angle 2θ (17).

𝑞=

( )

(27)
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Figure 4-1 X-ray interactions with sample for SAXS or crystallography
(a) Both SAXS and X-ray crystallography involve placing a sample (orange) in the path of a highly
collimated X-ray beam (red) and measuring the scattered/diffracted X-rays. The angle of any scattered
position with the direct beam is 2θ; (b) X-ray scattering pattern from a solution of yeast PCNA; (c)
diffraction from a nickel superoxide dismutase crystal. The equivalent position of the highest
resolution of the SAXS experiment in (b) is indicated as a red circle in (c). The blue circle indicates
the highest resolution achievable (q=0.6 Å-1) for SAXS data collection at the “Structurally Integrated
Biology for the Life Sciences” (SIBYLS) beamline. Both images collected at beamline 12.3.1
(SIBYLS) at the Lawrence Berkeley National Laboratories. (53)

The scattering pattern is recorded and radially integrated into a one-dimensional SAXS intensity
profile. (Figure 4-3) Based on the experimental SAXS data, a theoretical intensity profile can be
calculated using models that describe spherical or cylindrical particles(17). For monodisperse
particles in solution, the theoretical intensity profile for a particle is expressed as

𝐼 (𝑞) = (Δ𝜌) 𝑉 𝑃(𝑞)

(28)

where P(q) = the form factor, (Δρ)2 = electron contrast, and Vp2 = particle volume. The total
intensity profile is the sum of Ip(q) of all particles,
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(29)

𝐼(𝑞) = ∑ 𝐼 (𝑞)

The analysis of the 1-D experimental SAXS profile ultimately yields information about size and
shape of the molecules in solution (53).

Figure 4-2 Regions of SAXS profile and data that may be extracted from each.

(35)
To extract structural information from a SAXS experimental profile, three distinct regions,
Guinier, Fourier, and Porod, are analyzed (35) (Figure 4-2). In the Guinier region, Rg, the radius
of gyration, is determined by fitting a line through the ln(I) vs. s2 (Guinier) plot (34, 35, 49, 111)
(Figure 4-2, 4-3).

ln[𝐼(𝑠)] = ln[𝐼(0)] −

[

]

(30)

In the Fourier region, ρ(r), the pair distribution function, is determined by an indirect Fourier
transformation of P(q), the experimental form factor, and plotted against a radius, r, to show the
distribution of electrons in the molecule (34, 35, 49, 74, 111) (Figure 4-2, 4-3),
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(31)
In the Porod region (Figure 4-2), the Porod invariant, Q, is determined,

(32)
providing surface information such as the surface to volume ratio (S/V) and specific surface
estimation for compact particles (35, 49).

(33)
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Figure 4-3 SAXS data processing using ATSAS
An integrated, 1-D SAXS intensity profile (top left), plotting I vs. s; the Guinier plot (top right), ln(I)
vs. s2; and the ρ(r) vs. r plot (bottom) showing elections distribution. All plots were generated by
PRIMUSQT in the ATSAS program suite. (s = q = 4πsinθ/λ)
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4.2 Results & Discussion
4.2.1 HPLC-SAXS Revealed Overall Shapes of Gαi1, Ric-8A, and Gαi1:Ric-8A Complex
We successfully collected SAXS data sets at the Advanced Photon Source (Argonne, National
Laboratory) BIOCAT 18.1 beamline for R491, pR491, and Ric-8A:Gαi1 complex. We also
collected high-quality data sets at SSRL for R452 and pR452.

The ATSAS software package was used to analyze and reconstruct 3-D models for the molecular
envelopes of protein samples. Each X-ray scattering image was radially averaged to produce a
one-dimensional plot of scattering intensity vs. q (q=4πsin(θ)/λ). PRIMUSQT was used to
estimate molecular weight, maximum particle dimension (D max), and the distance distribution
function, ρ(r). 3-D reconstructions of the SAXS data were performed using the ab initio
modeling programs, DAMMIN and DAMMIF to generate ten dummy atom models. Using
DAMAVER, a theoretical Guinier plot of each dummy model was then back-extrapolated and
aligned with experimental data to select for the best candidates for building an averaged model.
The final averaged molecular envelopes resulted from multiple rounds of refinement with
DAMMIN/DAMMIF were visualized using Chimera (UCSF). (66)
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Figure 4-4 HPLC-SAXS Revealed Overall Shapes of Gαi1, Ric-8A, and Gαi1:Ric-8A Complex

SAXS envelopes of (A) Ric-8A 491, (B) phospho-Ric-8A 491 showing apparent bending of
the molecule, and (C) Ric-8A 491:Gαi1 complex showing possible location of Gαi1 in the
complex.
The model for R491:Gαi1 complex envelope implied large conformational changes including
possible Gαi1 domain separation since an intact Gαi1:GDP crystal structure failed to fill
confidently the extra density near the top region of R491 in the complex envelope (Figure 4-4).
Unpublished evidence provided by SAXS envelopes of R491:nanobodies complex (data not
shown) suggested that the protrusion on the R491 envelope is the C-terminus of R491. Taken
together, the SAXS envelope of R491:Gα1i complex agreed with the notion that Gαi1 interacts
with the C-terminus of Ric-8A.
The SAXS envelope of pR491 showed significant conformational changes compared to R491.
The characteristic protrusion, the putative Ric-8A C-terminus, was not observed in the model of
pR491. Since the SAXS model was an ensemble average of ten best DAMMIN models, the Cterminus of pR491 might sample multiple conformations, suggesting dynamic motions of Ric-8A
C-terminus induced by CKII phosphorylation/activation.
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4.2.2 Comparing R452 and pR452 SAXS Envelopes with Normal Mode Analysis
(cm-1)

I(0)
from Guinier
Rg (Å) from Guinier
qRg limitation for Guinier analysis
I(0) (cm-1) from P(r)
Rg (Å) from P(r)
Dmax (Å) from P(r)
Porod Volume estimate (Å-3)

Ric-8A 1-452
84.65 ± 0.081
29.7 ± 0.57
1.17
84.63
30.01
101
69042.7

Phos-Ric-8A 1-452
106 ± 0.18
29.2 ± 0.53
1.18
106.2
29.59
92
69990.9

Table 4-1 SAXS data of R452 and pR452 in solution
The Rg calculated using two different programs/methods, AUTORG for Guinier analysis and
AUTOGNOM for pair distribution function analysis, were similar to each other.

Using the same set of programs described in section 4.2.1, SAXS envelopes of both R452 and
pR452 were also successfully determined by ab initio modelling, however, the differences
between the two molecular envelopes were subtle (Table 4-1, Figure 4-5 A+B, 4-6). To further
characterize conformational changes on R452 caused by CKII phosphorylation, pR452 crystal
structure was converted into coarse-grains model and fitted into the experimental SAXS data of
R452 and pR452 in solution by using SREFLEX program in the ATSAS software package.
SREFLEX performed a normal mode analysis as described before(12, 66) that included a large
domain rigid body refinement and local structural rearrangement. Tung-Chung Mou performed
the entirety of the normal mode analysis for R452 and pR452 and generated models for each,
(Figure 4-5 C+D) therefore, I will refrain from elaborating on the details of the modelling
process.

In a comparison of molecular envelopes of pR452 and R452, we saw an apparent bending of the
R452 envelope relative to that of pR452, suggesting small domain movements induced by CKII
phosphorylation. Superposition of the R452 and pR452 normal mode analysis models by
146

aligning the first four N-terminal helices confirmed the observation that pR452 is a more
elongated molecule than R452 (Figure 4-6). Phosphorylation of R452 might relax the molecule,
making the concave surface of R452 slightly more exposed to solvent.
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Figure 4-5 Comparing R452 and pR452 SAXS data and pR452 crystal structure-based normalmode fitted models

(A) Measured scattering data of R452 (closed circle) and pR452 (open circle); Guinier plot
for each sample is shown in the inlet; straight-lines are linear fit of the measured data; (B)
Kratky plot (Fagherazzi et al. 1983) (1) for the same data in (A); (C) and (D), comparison of
experimental scattering data with CRYSOL (Svergun et al. 1995) (80) calculated theoretical
scattering curves of crystal structure of pR452 (blue), normal-mode fitted R452 model (red),
and normal-mode fitted pR452 model (green). The bottom panels of (C) and (D) are the
error-weighted residual difference plots ΔI/ = [Iexp(q) – c*Imod(q)]/(q) versus q. The
theoretical scattering profiles of normal-mode pR452 model (green) and R452 model (red)
show good agreement to the corresponding SAXS data while the profile for pR452 crystal
structure (blue) deviates from the SAXS data of R453 in panel (C).
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Figure 4-6 Ric-8A conformational changes caused by CKII phosphorylation

(Left and middle), the final SAXS envelopes of R452 (cyan) and pR452 (wheat) are shown
in superposition with its respective normal mode analysis model (blue and rose). The
superposition of models to SAXS envelopes was carried out by volume fitting function in
UCSF Chimera software package. (Right), superposition of the normal mode analysis
models of R452 (black) and pR452 (red) by aligning the first four N-terminal helices.
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4.3 Materials & Methods
4.3.1 Protein Expression, Purification, and SAXS Samples Preparation
See Chapter III
4.3.2 HPLC-MALS-SAXS at APS 18ID and FPLC-SAXS at SSRL BL4-2
We sent highly purified protein samples in milligram quantities to synchrotron beam-lines for
SAXS data collection coupled to size-exclusion chromatography (SEC-SAXS). At APS 18ID,
the protein samples (1mg/mL to 10mg/mL) were resolved using a Superdex200 SEC (GE
Healthcare) column connected to a high-performance liquid chromatography (HPLC) system
(Agilent) in tandem to a DAWN HELEOS II multi-angle light scattering (MALS) detector
(Wyatt Technology). As the samples were eluting from the column, they were first continuously
injected through the MALS system for light scattering analysis, followed by a capillary that
intercepts the X-ray beam. SAXS data collection happened concurrently, therefore, the samples
being irradiated were significantly more homogeneous and monodisperse. The
background/buffer SAXS were also collected before and after the sample peak eluted from the
column so they could be baseline-subtracted from the data to yield actual SAXS from the
samples. Sample application, MALS+SAXS data collection, and data processing were handled
exclusively by the beamline scientist at 18ID, Srinivas Chakravarthy. At the end of the
experimental session, processed MALS data and averaged SAXS profiles were made copies and
stored in an external hard drive and transported back to Sprang lab for further analysis.
FPLC-SAXS data collected at the Stanford Synchrotron Radiation Lightsource (SSRL) beamline
BL 4-2 used BlueIce software with a focused 12 keV X-ray source (0.3mm x 0.3mm beam size)
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and recorded on a Pilatus3 X 1M detector at a sample-to-detector distance of 1.7m and over a
range of momentum transfer 0.0065<q<0.42Å-1 [q=4πsin(θ)/λ]. The samples were continues
flowing through a 1.5 mm quartz capillary sample cell with 1 sec exposure time. To ensure the
mono-dispersity of the samples, the sample cell was tandemly connected to an AKTA-FPLC
system (GE Healthcare) and a Superdex 200 Increase 1.3/300 column (GE Healthcare) with flow
rate at 0.5ml/min. (Figure 4-7) Scattering data were radially averaged to produce onedimensional profiles of scattering intensity vs. q. Data were corrected for background scattering
by subtracting the buffer curve from sample curves. Data reduction and analysis were performed
using the beamline software SAStool and PRIMUS of the ATSAS suite(4). The program
AUTOGNOM was used to generate Guinier curves and pair distribution function, P(r) to the
determine maximum particle dimensions (Dmax) and radius of gyration (Rg) from the scattering
intensity curve (I(0) versus q) in an automatic, unbiased manner, and rounds of manual fitting in
GNOM were used to verify these values(101). Ab initio molecular envelopes were computed by
the programs DAMMIN(82). Ten bead models were reconstructed in DAMMIF(47), which were
aligned and averaged in DAMAVER(75) with no rejections and a normalized spatial discrepancy
of 0.486 ± 0.015 and 0.490 ± 0.019 for R452 and pR452 respectively.
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Figure 4-7 FPLC-SAXS data collection at SSRL BL4-2

(A) SEC-SAXS chromatography of R452 (closed circle) and pR452 proteins (open
circle). I(0) and Rg were plotted as a function of time as samples passed through a
Superdex-200 Increase 1.3/300 column; (B) pair-distribution function of the data sets
obtained from fractions under the SEC peaks.
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Chapter V: Conclusions, Future Directions, and
Preliminary Results
5.1 Conclusions
As important as the GPCR-stimulated Gα nucleotide exchange is, intracellular activation of Gα
by Ric-8 implies a more intricate physiological regulatory system in G-protein signaling. Even
after more than two decades of extensive research, the molecular mechanism of Ric-8-stimulated
Gα nucleotide exchange remains elusive. To gain better understanding of the regulation, we
focused on investigating Ric-8A, which acts as a folding chaperone for nascent Gαi1 and
catalyzes nucleotide exchange for Gαi1:GDP, in the rat model.

This dissertation focused on two main aspects of the system: (A) protein-protein interaction
between Ric-8A and Gαi1, and (B) 3-D architecture of Ric-8A and its phosphorylated
counterpart. To characterize the binding of Ric-8A to Gαi1, a mutagenesis analysis on a putative
Gαi1 binding site, suggested by HDX-MS, on Ric-8A was performed. The collection of assays
agreed with the hypothesis that the region encompasses Ric-8A residues 454-470 indeed harbors
crucial Gαi1 interactive elements.

To visualize Ric-8A at both high/atomic- and low/domain- resolutions, a large fragment Ric-8A
(R452), which possesses GEF activity towards Gαi1, was crystallized in two forms,
phosphorylated and unphosphorylated. The crystal structure of the phosphorylated form of R452
(pR452) was determined showing a superhelix made of ARM and HEAT α-helical repeats as
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predicted by previous computational approaches. Mapping of sequence conservation profile,
electrostatic potentials, and HDX protection profile on the structure suggested another putative
Gαi1 interactive site (α37 and α18) on Ric-8A.

Low-resolution, solution structures of Ric-8A:Gαi1 complex, Apo-Ric-8A, Gαi1:GDP, R452,
and pR452 were determined by SAXS. The SAXS envelope of R491:Gαi1 complex suggested
that (A) Gαi1 very likely interacts with C-terminal regions of Ric-8A and (B) in the nucleotidefree Ric-8A:Gαi1 complex, the α-helical domain and Ras-homology domain of Gαi1 might
assume dynamic “open” conformations instead of a “closed” conformation as in the nucleotidebound states. At first glance, R452 and pR452 SAXS envelopes alone did not provide a wealth
of information regarding the effect of CKII phosphorylation except that pR452 looks different
from R452. By combining information from the crystal structure of pR452 and experimental
SAXS data in a normal mode analysis, normal mode structural models of R452 and pR452 in
solution were generated. Comparison of the normal mode models to both their experimental
SAXS envelopes and each other suggested that R452 is more kinked and less elongated than
pR452.

SPR binding results and biochemical assay results suggested that the subtle conformational
changes induced by CKII phosphorylation could still activate/enhance the GEF activity of R452.
As an exception among the other evidence, the steady-state GTPase assays comparing the effect
of R530 or pR530 stimulation on Gαi1 steady-state GTP hydrolysis suggested an aberrant yet
interesting inhibitory mechanism under which phosphorylation of full-length Ric-8A might
suppress/inhibit the GTPase activity of the Ras-homology domain on Gαi1. The possible pR530
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inhibitory activity at high Ric-8A concentration, as we reported in Chapter III, towards the
GTPase activity of Gαi1 is interesting because the observation suggests that in addition to acting
as the chaperone and GEF, Ric-8A might also stimulate G-protein signaling by locking the
activate form, Gαi1:GTP.
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5.2 Future Directions and Preliminary Results
The goal of the study is to understand the molecular mechanism under which Ric-8A interacts
with Gαi1. Structural information of the rat Ric-8A:Gαi1 complex pair could provide insight
into the mode of action for the Ric-8 family of intracellular proteins as Gα chaperones and
nucleotide-exchange factors. With the crystal structure of pR452, which includes >80% of all
530 residues of the full-length Ric-8A, and full-length Gαi1 in hand for molecular replacement,
future structural studies on the topic should focus more toward the Ric-8A:Gαi1 complex
structure.
5.2.1 Gαi1 Ras Domain
In order to eventually obtain a Ric-8A:Gαi1 complex crystal structure that depicts the proteinprotein interaction, we attempted to stabilize nucleotide-free Gαi1 in the complex by truncating
the helical domain of Gαi1. Based on ideas from Carpenter et al 2016, we designed a Gαi1
helical-domain truncation mutant, termed Rαi1 (Figure 5-1) (9). The DNA oligo coding for
Rαi1 construct was purchased from IDT and cloned into pDEST15 vector (Gateway System).
Rαi1 was expressed and purified using identical methods as the full-length Gαi1 W258A
(Figure.) (See Chapter II for details).
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Figure 5-1 FASTA sequence of Rαi1 construct design

Possibly due to the absence of the helical domain to stabilize the bound nucleotide, GDP, the
Rαi1:GDP intrinsic guanine nucleotide exchange (in the absence of Ric-8A) appeared to
proceed faster than the full-length Gαi1. Rαi1 formed a stable complex with Ric-8A 1-491 and
the complex could be isolated by size-exclusion chromatography (SEC). Initial crystallogenesis
experiments of Rαi1:GDP and Rαi1:R491 are underway; small rod-shaped crystals were
observed in the initial screen (0.5μL 20mg/mL protein + 0.5μL reservoir solution in a sitting
drop, 20% w/v PEG3350, 0.2M CaCl 2, 48 hours at 4oC) for Rαi1:GDP but not Rαi1:R491
complex. (Figure 5-2) No crystals had formed for the Rαi1:R491 complex.

Unpublished NMR results suggest that Rαi1 becomes completely disordered or assumes rapid
dynamic motions in the Rαi1:R491 complex. In either case, our current Rαi1 construct will not
be a suitable crystallization target. In the future, the Rαi1 construct should be re-designed and
hopefully stabilized for complex crystallization.
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Figure 5-2 Rαi1 purification, Ric-8A complex formation, functional assays, and protein
crystallization

SDS-PAGE results of (A) samples from Rαi1 purification steps (Lane #1, GST-resin after
TEV digestion and elution of Rαi1; lane #2, recovered Rαi1 after TEV digestion; lane #3, Qcolumn flow-through; lane #4, protein standard; lane #5-10, Q-column-purified fractions of
Rαi1) and (B) fractions under the gel-filtration chromatogram (C) of Rαi1:R491 complex
showed Rαi1 expressed and purified similarly to full-length Gαi1 and binds to R491. (D)
Tryptophan fluorescence GTPγS-binding assay (see Chapter II for materials and methods)
results showing rapid intrinsic nucleotide-exchange of Rαi1:GDP for GTPγS; 2μM R491 or
negative control were added to 2μM Rαi1:GDP at 0 minutes; 20μM GTPγS were added after
5-minute incubation. Pictures of crystals of Rαi1:GDP were taken using a light microscope
(Olympus) (E) or a UVEX-M microscope (JANSi) (F).

5.2.2 Full-Length Ric-8A
The rat full-length Ric-8A (Ric-8A 1-530, which will be referred to as R530), when multiphosphorylated at sites in addition to S435 and T440 (pR530), appears to bind to Gαi1 with
higher affinity than the un-phosphorylated protein (3). The previous finding showing reduced
GEF activity of the full-length protein compared to R491 were based on experiments conducted
with the unmodified, E. coli-expressed Ric-8A(42). It will be interesting (A) if phosphorylation
rescues the GEF activity of R530 to the level of R491 and (B) if phospho-Ric-8A 1-530 forms a
better complex with Gαi1. No matter what we find out about the modified full-length protein, it
remains a never-attempted target for crystallogenesis.
5.2.2.a Protein Expression and Purification

The brief method discussed here was modified based on existing protocol from the Tall lab(1).
N-terminally glutathione-S-transferase (GST)-tagged full-length Ric-8A construct in pET21a
expression vector was expressed in E. coli BL21 (DE3)-pLysS cells in LB media containing
carbenicillin (100mg/L) and induced with 30μM isopropyl b-d-thiogalactopyranoside (IPTG) at
17oC. After cell lysis using an EmulsiFlex-C5 cells disruptor (Avestin) and fractionation in lysis
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buffer (20mM HEPES pH 8.0, 150mM NaCl, 5mM Ethylenediaminetetraacetic acid (EDTA),
1mM Dithiothreitol (DTT), and protease inhibitors), GST-fusion Ric-8A 1-530 was protease
digested and recovered similarly to Gαi1 W258A(52). Briefly, the GST-fusion protein was
isolated from the soluble faction using GST-affinity resins in a glass gravity column. TEV
protease was added to the washed GST-affinity resins with protein sample bound. The on-beads
proteolysis reaction proceeded in 4oC overnight. The digested/tagless protein was recovered by
eluting the column with anion-exchange buffer A (20mM HEPES pH 8.0, 100mM NaCl, 1mM
DTT, 1mM EDTA, and protease inhibitors) and loaded onto a Source 15Q anion-exchange
column. High-purity Ric-8A 1-530 was eluted using a salt gradient (100mM to 1M NaCl). CKII
kinase reaction to phosphorylate R530 was performed similarly to R452 (see details in Chapter
III) with 2.5X the doses of adenosine triphosphate (ATP) and CKII since R530 contains five,
instead of two on R452, phosphorylation sites. Purification of pR530 was also accomplished
similarly to pR452. (Figure 5-3)
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Figure 5-3 Source 15Q anion exchange chromatography results

(Top) Unphosphorylated R530 after on-bead TEV digestion eluted at
conductivity~25mS/cm. (Bottom) The entire over-night CKII kinase reaction was resolved
and pR530 eluted from the column at conductivity~30mS/cm, separated from other protein
species (R530 and CKII) in the kinase reaction.
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5.2.2b G-protein:Ric-8A Complex Formation and Purification

mGαi1:GDP was expressed and purified as described in Chapter II. To make a complex with
pR530, 2X molar excess of mGαi1:GDP was incubated with pR530 on ice overnight and gelfiltered using a Superdex 200 SEC column (GE Healthcare). Although the 100kDa
heterodimeric mGαi1:pR530 complex separated well from excess monomeric G-protein, higherorder oligomers of the complex were formed and have been challenging to separate using a
Superdex 200 SEC column. The two species of 1:1, mGαi1:pR530 complex resolved well using
a HiLoad Superdex 200 16/600 SEC column (GE Healthcare). (Figure 5-4) However, the
heterodimeric complex and the higher-order oligomer also seemed to be in a temperature and/or
concentration-dependent equilibrium between each other (data not shown). We were not
confident with the sample homogeneity; therefore, no crystallization trial was set up for the
mGαi1:pR530 complex.

Gαi1 W258A:GDP was expressed and purified as described(52). 2X molar excess Gαi1 W258A
was incubated with pR530 on ice overnight and gel-filtered with a Superdex 200 SEC column.
A single species of 100kDa heterodimeric Gαi1:pR530 complex resolved well from excess
monomeric G-protein. Fractions contain the Gαi1:Ric-8A complex were concentrated to
10mg/mL and used for initial crystallization trials set-up.
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Figure 5-4 Size-exclusion chromatography results of mGαi1:pR530 complex

(Top), mGαi1:pR530 complex resolved using a Superdex 200 SEC column showing higher
order oligomeric species (1st peak near 12.7mL) and 1:1 complex (2nd peak near 14.5mL)
with small amount of excess unbound mGαi1 (3rd peak near 16.5mL). (Bottom), resolving
the 1:1 complex fraction from “top” on a 16/600 SEC column (GE Healthcare) showing good
separation of the large oligomer and 1:1 complex. SDS-PAGE analyses of fractions under
the curves validated the 1:1 ratio of mGαi1:pR530 in the complex. (Inlets), SDS-PAGE
results showing fractions under the curves.
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5.2.2.c GEF Activity Assay

The tryptophan fluorescence assays as well as steady-state GTPase assays described in Chapter
II and Chapter III were used to test the viability of R530. Both R530 and pR530 were assayed
for their GEF activities toward mGαi1. No obvious difference in the initial rate of nucleotide
exchange was observed between the two using the tryptophan fluorescence GTPγS-binding
assay; however, drastic difference was seen between R530 and pR530 in the steady-state GTPase
assay. (See Chapter III for results and discussion) The effect(s) of Ric-8A phosphorylation by
CKII on its function towards Gαi1 need to be more characterized more carefully. A study with
similar scope to the 2018 publication (29), which used Gαq as the main model instead of Gαi1,
should be conducted.
5.2.2.d Protein Crystallization & Optimization

Initial condition screening for both the Apo-pR530 and complex with Gαi1 W258A were
accomplished using commercial screening blocks from Hampton Research and Qiagen. Ten
different screening suites were used (PEGI-II, JCSG I-IV, Morpheus, Shotgun, Crystal Screen-1,
and Proplex) for the initial screen. For each screening condition, two protein-to-reservoir
solution ratios (2:1 and 1:1) were setup (See Chapter III for screening plate setup methods) and
incubated in a 20oC incubator. Over 3-months, no crystal grew for Apo-pR530, either directly
received from Gregory Tall or expressed and purified in Sprang lab; however, a few Gαi1:Ric8A complex crystals grew at different conditions and/or different time points over the period of
90-days. (Figure 5-5) The complex crystals are UV sensitive; SDS-PAGE analysis confirmed
the identity of protein samples in the crystals. Samples of the crystals from the initial screening
plates were sent to SSRL and screened by Tzanko Doukov. The small crystals that were grew in

164

“PEG” conditions diffracted to as far as 7Å on BL12-2 using a 10µm X 10µm micro-focused
beam; unfortunately, the largest crystals (Figure 5-5) did not diffract at all.

Figure 5-5 pR530:Gαi1 complex crystals in the initial screens

Crystallization condition and parameters are labelled above each photo. All photos of
crystals were taken using a light microscope(Olympus) the same magnification.
The 2nd and 4th figures (Figure 5-5) show crystals grew in presumably identical conditions but
differed drastically in sizes. The variation suggest that these crystallization conditions need to be
more carefully reproduced and properly controlled in the future. For the complex crystals that
diffracted to low resolutions, vigorous optimization trials need to be performed to improve the
size and diffraction quality. For the larger crystals that did not diffract at all, seeding
experiments, detergents/additives screens, and many other optimization techniques (57) could
change the crystal packing. If all attempts fail, we can always try other combinations of Ric8A:Gαi1 complex using different Ric-8A and Gαi1 constructs.
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